Stereoselective Synthesis of Highly Substituted Tetrahydropyrans through an Evans Aldol-Prins Strategy by Álvarez Méndez, Sergio J. et al.
Stereoselective Synthesis of Highly Substituted Tetrahydropyrans
through an Evans Aldol−Prins Strategy
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‡Laboratorio de Investigacioń y Desarrollo de Bioactivos (LIDeB), Departamento de Ciencias Bioloǵicas, Facultad de Ciencias
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ABSTRACT: A direct and general method for the synthesis of naturally occurring 2,3,4,5,6-pentasubstituted tetrahydropyrans
has been developed, employing β,γ-unsaturated N-acyl oxazolidin-2-ones as key starting materials. The combination of the
Evans aldol addition and the Prins cyclization allowed the diastereoselective and efficient generation of the desired oxacycles in
two fashions: a one-pot Evans aldol−Prins protocol, in which five new σ bonds and five contiguous stereocenters were
straightforwardly generated, and a two-step version, which additionally permitted the isolation of β,γ-unsaturated alcohol
precursors bearing an N-acyl oxazolidin-2-one in the α position. From these alcohols were also obtained halogenated
pentasubstituted tetrahydropyrans as well as 2,3,4,5-tetrasubstituted tetrahydrofurans, shedding light on the mechanism of the
process. Computational studies were consistent with the experimental findings, and this innovative Evans aldol−Prins strategy
was performed for the preparation of a battery of more than 30 densely substituted tetrahydropyrans, unprecedentedly fused to
a 1,3-oxazinane-2,4-dione ring, both in a racemic fashion and in an enantiomeric fashion. These novel molecules were
successfully submitted to several transformations to permit simple access to a variety of differently functionalized
tetrahydropyrans. Most of these unique molecules were evaluated for their antimicrobial activity against Gram-positive and
Gram-negative bacteria and the yeast Candida albicans, and some structure−activity relationships were established.
■ INTRODUCTION
The tetrahydropyran (THP) motif is commonly found in
biologically active secondary metabolites isolated from marine
and terrestrial sources, such as those shown in Figure 1, and is
found to be part of complex cyclic polyether systems.1 For
example, 2,3,5-trisubstituted THPs can be found in morinols A
and B, isolated in 1999 from Morina chinensis, a plant
employed in traditional Chinese medicine.2 Morinols and
some derivatives show antiproliferative,3 antimicrobial,4 and
antifungal activity.5 More substituted THPs can be found in
clavosolides A and B, which exhibit two 2,3,4,6-tetrasubstituted
THPs in their structures. They were isolated from the
cytotoxic extract of the sponge Myriastra clavosa from the
Philippines.6 The same substitution and stereochemical pattern
appears in the tetrasubstituted THP borne by members of the
polycavernoside family of toxins, isolated from the red alga
Gracilaria edulis (also known as Polycavernosa tsudai).7
Kendomycin, which was isolated from several Streptomyces
strains, shows a 2,3,4,5,6-pentasubstituted THP with the
substituent at C5 adopting an axial disposition. This compound
acts as an endothelin receptor antagonist and also exhibits
cytotoxicity against multiple human cell line and antiosteopor-
otic and antibiotic activities.8 Phorboxazoles A and B were
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isolated from Indian Ocean sponge Phorbas sp. and show
antitumor activity and antifungal activity against Candida
albicans.9 Four THP rings appear in their structures, under-
lining the presence of the THP labeled as B (Figure 1) with
substituents at all its positions and the same substitution
pattern found in kendomycin. Besides being part of bioactive
natural products, it has been demonstrated that the THP ring
can even improve the efficacy of antiviral drugs10 and can show
bioactivity itself, such as antinociceptive activity,11 serotonin
and norepinephrine transporter inhibitory activity,12 antimi-
crobial activity by the inhibition of bacterial topoisomerase,13
and antiproliferative activity.14
The number of natural products containing a THP ring has
encouraged the development and application of many
synthetic strategies, such as Pd-catalyzed oxaheterocycliza-
tion,15 the Petasis−Ferrier union/rearrangement tactic,16
Michael-like reactions,17 SN-mediated and metal-promoted
cyclizations,17 ester enolate Claisen rearrangement,18 ring
expansion of tetrahydrofurans,18 1,5-cyclization,18 iodolactoni-
zation,18 epoxide opening-ring closure reactions,18 etc.19
Among the existing tactics, the Prins cyclization20 has emerged
in the past several years as a handy tool that affords access to
desired THPs.21 Throughout the past decade, our research
group has taken advantage of the Prins cyclization to
synthesize differently substituted six- and seven-membered
oxa- and aza-heterocycles.22 Nevertheless, the application of
the Prins cyclization to access challenging 2,3,4,5,6-pentasub-
stituted THPs has not been systematically studied. On one
hand, there are only a few examples that have been part of
methodological works that aimed to obtain THPs with a less
populated substitution design.22e,23−26 On the other hand,
Rychnovsky and co-workers have employed Prins cyclization
to build pentasubstituted THPs to synthesize some natural
products.27−29
This absence of a general method encouraged us to propose
a strategy based on the combination of the well-known Evans
Figure 1. Examples of natural products containing nonfused densely substituted THPs.
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aldol addition, as a powerful tool to construct the necessary
homoallylic alcohol, and the Prins cyclization to yield the
target highly substituted THPs (Scheme 1).30 Thus, this Evans
aldol−Prins (EAP) protocol suggests that a 2,3,4,5,6-
pentasubstituted THP 1 could be accessed via the Prins
cyclization of an aldehyde R3CHO and syn-aldol 2.31 β,γ-
Unsaturated alcohols 2 bear an N-acyl oxazolidin-2-one moiety
at the α position. This auxiliary is the key for introduction of
the stereochemistry into the aldol and, therefore, into the
subsequent THP 1. Evans aldol addition was proposed as the
diastereoselective pathway to obtain aldol 2 starting from a
generic aldehyde R2CHO and β,γ-unsaturated N-acyl oxazo-
lidin-2-one 3.32 Compounds 3 may be prepared from the
appropriate oxazolidin-2-one via an N-acylation of β,γ-
unsaturated carboxylic acids 4.33 Several of these acids are
commercially available, though they also can be readily
synthesized via a modified Knoevenagel condensation starting
from aldehydes R1CH2CHO.
34 Thus, the envisioned tactic
should allow stereoselective access to an enormous degree of
structural complexity by the consecutive combination of three
different aldehydes in four reaction steps. Prior to the
establishment of an asymmetric strategy, nonchiral oxazoli-
din-2-one was first selected as the Evans auxiliary to evaluate its
influence in this unprecedented process. In this report, we
expand the results previously published30 to exhaustively detail
all the studies that led us to establish a protocol to yield
2,3,4,5,6-pentasubstituted THPs in a general and diastereose-
lective fashion. Special emphasis has been placed on the
different reaction condition screenings and the identification of
all the byproducts and minor stereoisomers associated with the
EAP protocol. We have also delved into mechanistic studies,
the enantiomeric approach, and the derivatization and
biological evaluation of the novel family of compounds
synthesized.
■ RESULTS AND DISCUSSION
As shown in Scheme 1, our synthetic approach first requires
the preparation of a set of N-acyl oxazolidin-2-ones 3
employing carboxylic acids 4 as starting materials (Table 1).
Acids 4a−4c were commercially available, whereas acids 4d−
4f were straightforwardly obtained via a solvent-free con-
densation/decarboxylation sequence.34 Acids 4 were differ-
ently activated prior to their subsequent treatment with the
lithiated oxazolidin-2-one to yield 3. Both DMF/oxalyl
Scheme 1. Retrosynthetic Analysis for Accessing 2,3,4,5,6-
Pentasubstituted THPs via an Evans Aldol−Prins Strategy
Table 1. Synthesis of the N-Acyl Oxazolidin-2-ones 3 and Aldols 2
N-acylation Evans aldol addition
entry acid R1 R′ R″ 3 (%) entry 3 R2 2 (%)c
1 4a Et H H 3a (68)a 10 3a i-Bu 2a (81)d
2 4b H H H 3b (39)b 11 3a Me 2b (75)
3 4c (Z)-Me H H 3c (75) 12 3a Bu 2c (84)
4 4d PhCH2 H H 3d (60) 13 3a Ph 2d (81)
5 4e n-pentyl H H 3e (90) 14 3a PhCH2CH2 2e (81)
6 4f BnOCH2CH2 H H 3f (60) 15 3b Me 2f (76)
7 4a Et (R)-Bn H 3g (90) 16 3c i-Bu 2g (48)e
8 4a Et (S)-i-Pr H 3h (83) 17 3a 4-Br-Ph 2h (59)
9 4a Et (R)-Me (S)-Ph 3i (87) 18 3g Me 2i (75)f
19 3g PhCH2CH2 2j (60)
f
20 3h Me 2k (86)g
21 3h PhCH2CH2 2l (69)
g
22 3i Bu 2m (64)f
aFor 3a, 7.7 g of product was obtained from 7 g of 4a. bIt was isolated as 54% of an inseparable 2.5:1 mixture of the desired product, β,γ-3b, and its
positional isomer, E-α,β-3b. cOnly syn-aldols were detected by 1H NMR analysis of the reaction crudes, unless noted otherwise. dTraces of its
diastereoisomer, anti-2a, were also isolated when a non-properly stored n-Bu2BOTf was employed.
e1H NMR analysis of the crude revealed that
aldol 2g was obtained as a 2:1 mixture of the Z- and E-isomers due to an isomerization of the double bond, although the yield given corresponds
exclusively to the desired Z-isomer. f2S,3R. g2R,3S.
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chloride35 and DCC/DMAP36 systems proved to be efficient,
but we eventually selected TEA and pivaloyl chloride33 as
reagents because of their compatibility with the multigram
synthesis of 3a (Table 1, entry 1). With these conditions in
hand, nonchiral N-acyl oxazolidin-2-ones 3b−3f (entries 2−6,
respectively) and chiral N-acyl oxazolidin-2-ones 3g−3i
(entries 7−9, respectively) were efficiently synthesized with
yields ranging from 60 to 90%, except when the starting acid
bore a terminal double bond (4b, where R1 = H), because
undesired E-α,β-3b was also obtained as a consequence of the
isomerization of the double bond (entry 2).37 N-Acyl
oxazolidin-2-ones 3a−3c were submitted to the Evans protocol
to gain access to various syn-aldols 2 with good yields and
showed excellent tolerance to aromatic groups and both linear
and branched aliphatic chains (entries 10−17).32 Similarly,
chiral aldols 2i−2m were obtained from N-acyl oxazolidin-2-
ones 3g−3i (entries 18−22). As expected, in all cases, syn-
aldols were exclusively obtained except when a non-properly
stored n-Bu2BOTf solution was employed (entry 10), because
the diastereoselectivity of the aldol addition may be sensitive to
the concentration of that reagent.38 Isolation of traces of anti-
2a invited us to try the efficient and selective access to that
aldol, although employment of the methods previously
published by Evans39 and Hoye40 was unsuccessful. Addition-
ally, when N-acyl oxazolidin-2-one 3c, bearing a double bond
with a Z geometry, was selected as the starting material, a
partial isomerization of the double bond was observed in the
final product, leading to the desired 2g with a moderate yield
(entry 16).
Scheme 2. Fe-Based Prins Cyclization of Aldol 2a To Yield Unexpected Bicycle 5a
Table 2. Screening of Lewis Acids (LAs)
entry LA equiv X 1b-X (%)a 5b (%)a 6b (%)b 7b-X (%)a
1 Fe(acac)3/TMSCl 0.1/1.5 − − 38 1 −
2c Fe(acac)3/TMSCl 0.5/1.5 − − 59 − −
3d Fe(acac)3/TMSCl 0.02/1.5 − − 28 3 −
4 FeCl3 1.5 − − 41 2 −
5 InCl3 1.5 − − 61 15 −
6 BF3·THF 2.5 − − 70 13 −
7 BF3·OEt2 2.5 − − 78 − −
8 BF3·OEt2 5 − − 79 − −
9 BF3·OEt2 1 − − 68 3 −
10d BF3·OEt2 0.05 − − 58 7 −
11d,e BF3·OEt2/TMSCl 0.05/2.5 Cl − − 10 46
12f BF3·OEt2/TMSCl 0.5/2.5 Cl − − 6 67
13g TMSCl 2.5 Cl − − 6 45b
14h TMSI 2.5 I 17 − − 58
15i TMSBr 2.5 Br 30 − − 46
16 FeBr3 2.5 Br 23 34 9 −
aIsolated yield, unless noted otherwise; >95:5 dr (determined by 1H NMR spectroscopy). bCalculated by 1H NMR spectroscopy. cThe
employment of 1 equiv of Fe(acac)3 led to a decrease in the yield of 5b and to traces of 7b-Cl.
dThe reaction was stopped after 20 h. eUnreacted
starting material (44%) was recovered. fThe reaction was stopped after 2 h. gThe reaction was stopped after 44 h, and 49% of unreacted starting
material was found. hThe reaction was stopped after 20 min. iThe reaction was stopped after 3 h.
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With aldols 2 in hand, we decided to test the Prins
cyclization conditions previously optimized in our research
group, employing the Fe(acac)3/TMSCl system as a
promoter.22d 4-Chloro-THP 1a-Cl was selected as a target
molecule, and aldol 2a and isovaleraldehyde were selected as
starting materials (Scheme 2). The presence of each i-Bu at
positions 2 and 6 of the ring should avoid the production of
undesired THPs as a consequence of the side chain exchange
due to the 2-oxonia-Cope rearrangement, a [3,3]-sigmatropic
rearrangement concomitant to the Prins cyclization.41 Aldol 2a
yielded two products after 30 min, one of them more nonpolar
than the substrate and the other more polar and UV−visible.
With regard to the nonpolar product, 1H NMR analysis
confirmed the presence of a THP ring with the expected side
chains. However, mass analysis revealed that the molecule did
not include a chlorine atom. Fortunately, X-ray crystallography
unambiguously determined that the product was 5a, in which
the THP ring appeared to be fused to a 1,3-oxazinane-2,4-
dione ring (Scheme 2). Thus, bicycle 5a was obtained as a
mixture of two diastereoisomers (85:15 dr) in 43% total yield.
The X-ray analysis, together with the J coupling of >9 Hz42 and
GOESY experiments,43 allowed us to establish an all-trans
configuration in the major diastereoisomer. GOESY experi-
ments also revealed that the minor diastereoisomer was the C5
epimer (Scheme 2). On the other hand, the polar product was
obtained in 7% yield and identified as alcohol 6a, a skeletal
isomer of aldol 2a, obtained because of the 2-oxonia-Cope
rearrangement (Scheme 2).41 Once the products of the
reaction were identified, we directed our attention to the
unprecedented synthesis of bicycle 5. Rearrangements of N-
acyl oxazolidin-2-ones to yield these kinds of heterocycles had
been previously reported,44 though, to the best of our
knowledge, this was the first example in which the 1,3-
oxazinane-2,4-dione ring was fused with a THP. Additionally,
it should be remarked that both heterocycles usually are related
with varied biological activities such as antiepileptic,45
analgesic,46 and antiproliferative11 activities. A synergistic
biological activity might be expected from these structures.
Despite its unexpected bicyclic structure, compound 5a is a
2,3,4,5,6-pentasubstituted THP, so it consequently satisfies our
initial synthetic goal (Scheme 1). Additionally, the uniqueness
of this bicyclic core encouraged us to delve into the synthesis
of these kinds of compounds.
We first screened a series of Lewis acids (LAs) to pursue
better yields of bicycles 5. We chose alcohol 2b and MeCHO
as the most simple starting materials to access a 2,3,4,5,6-
pentasubstituted THP (Table 2). First, those reagents were
submitted to the previously published conditions with the
Fe(acac)3/TMSCl system (Scheme 2),
22d yielding expected
bicycle 5b only as a diastereoisomer with a yield (38%) similar
to that of 5a (43%), together with traces of undesired
rearrangement isomer 6b (Table 2, entry 1). A higher level of
Fe(acac)3 improved the yield of 5b and avoided the formation
of 6b (entry 2 vs entry 3). Nevertheless, when Fe(acac)3 and
TMSCl were employed separately as catalysts, the cyclization
did not occur after reaction for 5 h. The yield of 5b did not
improve when an excess of FeCl3 was employed as an
alternative source of Fe(III) (entry 4), although a supra-
stoichiometric quantity of InCl3 led to 5b with an interesting
61% yield (entry 5). When 0.1 equiv of those iron and indium
compounds was tested, unaltered starting material was
recovered. Other promoters were tested47 until we discovered
that BF3·THF allowed the synthesis of 5b with a remarkable
70% yield, although with a higher proportion of 6b (entry 6).
To our delight, a better yield was obtained when BF3·OEt2 was
chosen as the LA, and 6b was not detected (entry 7). Almost
the same yield was obtained when a larger amount of BF3·OEt2
was employed (entry 8), but when the amount of the LA was
progressively reduced, the yield of 5b decreased in favor of an
increase in the yield of nondesired 6b and a longer reaction
time (entries 9 and 10). Then, we decided to evaluate the
combined effect of BF3·OEt2 with TMSCl as the promoter of
the EAP cyclization (entries 11 and 12). We repeated the
reaction shown in entry 10 (0.05 equiv of BF3·OEt2), including
2.5 equiv of TMSCl in the set of reagents. Surprisingly, under
these conditions, the main product of the reaction was
halogenated bicycle 7b-Cl instead of bicycle 5b (entry 11).
Additionally, rearranged alcohol 6b was also obtained together
with part of the unreacted starting material. When the amount
of BF3·OEt2 was increased to 0.5 equiv, the starting aldol was
consumed, yielding 67% 7b-Cl along with traces of 6b (entry
12). By contrast, when 2.5 equiv of TMSCl was employed as
the sole promoter, a practically equimolar mixture of
halogenated product 7b-Cl and starting material was detected
after 44 h (entry 13). Next, we decided to check the influence
of the halogen on this process. When TMSI was employed as
the promoter, full conversion of aldol 2b was observed after
only 10 min, and two products were identified (entry 14):
expected halogenated bicycle 7b-I (58%) and 4-iodine-THP
1b-I (17%), with the originally pursued structure (Scheme 1).
In the same vein, TMSBr allowed access to 7b-Br (46%) and
1b-Br (30%) after reaction for 3 h (entry 15).48 We eventually
tested the EAP cyclization employing FeBr3 both as a LA and
as a bromide source. The reaction was complete after 30 min,
yielding 4-bromo-THP 1b-Br (23%), hydroxylated bicycle 5b
(34%), and rearranged alcohol 6b (9%), but no traces of
halogenated bicycle 7b-Br were detected (entry 16).
Once the benefits of BF3·OEt2 as promoter of the EAP
cyclization had been verified, the effect of the solvent was
studied (Table 3). Bicycle 5c was obtained as a sole
diastereoisomer in 66% yield from aldol 2c and n-pentanal
employing DCM as the solvent (entry 1). Second, the reaction
was repeated several times replacing DCM with solvents such
Table 3. Screening of Solvents
entry aldol solvent bicycle yield (%)a
1 2c DCM 5c 66
2 2c acetonitrile 5c 55
3 2c benzene 5c 52
4 2c toluene 5c 43
5 2c Et2O 5c 21
6b 2c acetic acid 5c-Ac 71
7 2b DCM 5d 69
8 2b CHCl3 5d 50
9 2b n-hexane 5d 31
aIsolated yield; >95:5 dr (determined by 1H NMR spectroscopy).
bThe bicycle was obtained as its O-acetylated derivative.
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as acetonitrile, benzene, and toluene, although the yield did not
improve (entries 2−4, respectively). The crude mixtures of
those reactions were thoroughly studied by 1H NMR to check
that no byproducts associated with competitive Prins−Ritter49
or Prins−Friedel−Crafts50 processes (both associated with
nucleophilic solvents) were obtained. The selection of Et2O as
the solvent led to the poorest yield (entry 5). Interestingly,
when acetic acid was employed as the solvent, bicycle 5c was
obtained as its O-acetylated derivative (entry 6). However, if
the acetic acid remained as the solvent and BF3·OEt2 was
omitted as the promoter, the reaction did not take place. The
Prins cyclization between aldol 2b and n-pentanal was also
tested employing DCM as the solvent to access bicycle 5d in
69% yield (entry 7). There was a drop in the yield when the
reaction was repeated in the presence of CHCl3 or n-hexane as
the solvent (entry 8 or 9, respectively).
The studies described above allowed us to conclude that the
optimized conditions for the EAP cyclization imply the use of
2.5 equiv of BF3·OEt2 and DCM as the solvent at rt.
51 This
EAP cyclization has proven to be a diastereoselective method
for synthesizing 2,3,4,5,6-pentasubstituted THPs with an all-
trans stereochemistry, placing their substituents in equatorial
positions. The substituents at C2 and C6 of the THP adopt a
preferred syn stereochemistry to minimize the 1,3-diaxial
interaction in the chairlike transition state (Scheme 3, eq 1).52
The position of the oxygen atom linked to C4 is a consequence
of the position adopted by the oxazolidin-2-one in the
transition state, as will be discussed in the mechanistic section
(Scheme 7). With regard to the stereochemistry of C3 and C5,
it is controlled by the stereochemistry of the starting alcohol.
On one hand, the trans disposition of the substituents of the
syn-aldol31 leads to the trans orientation of the substituents at
C2 and C3 (eqs 1 and 3); by contrast, an anti-aldol should
develop a cis orientation of those substituents (eq 2). On the
other hand, an E geometry of the olefin is conducted to the
equatorial position of the substituent at C5 (eqs 1 and 2),
whereas a Z geometry should favor the axial position (eq 3). A
further mechanistic discussion appears in Scheme 7.26 As we
had obtained a small amount of anti-2a (Table 1, entry 7), we
decided to evaluate it in the EAP cyclization to synthesize
bicycle 5e with the substituent at C3 in an axial position
(Scheme 3, eq 2). Thus, anti-2a was subjected to each reaction
employing FeCl3 (method A) and BF3·OEt2 (method B) as
Lewis acids. In both cases, the main product was expected
bicycle 5e, whose relative stereochemistry was confirmed by
GOESY analysis. However, the employment of anti-2a as the
starting material yielded the synthesis of two undesired minor
diastereoisomers in a 3:1 proportion: the main one was
identified as all-trans bicycle 5a, whereas the other was its C5
epimer.53 When syn-aldol 2g, bearing a Z-olefin, was submitted
to the optimized EAP cyclization conditions, desired bicycle 5f
was diastereoselectively obtained in 76% yield (Scheme 3, eq
3). As bicycles 5e and 5f, bearing axial substituents, can be
accessed via EAP cyclization, it therefore constitutes an
Scheme 3. Synthesis of Bicycles with Different Stereochemical Patterns
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interesting tool for accessing the core of natural products such
as kendomycin or phorboxazols (Figure 1).
Afterward, we selected syn-aldol 2b as the starting material
to check the robustness of the optimized conditions (BF3·
OEt2, DCM, rt) by broadening the scope of the aldehydes
(Table 4). Entries 1 and 2 show the previously described
syntheses of bicycles 5b (Table 2, entry 7) and 5d (Table 3,
entry 7), respectively. Besides these linear chains, the bulkier i-
Bu was successfully introduced at the C6 position of the THP
5g in 70% yield (entry 3). Hex-5-ynal and pent-4-ynal were
synthesized through a PCC-mediated oxidation of the
corresponding commercial alcohols,54 and they were employed
in the Prins cyclization without further purification, yielding
bicycles 5h and 5i, respectively (entries 4 and 5, respectively).
Together with 5i, a small amount of bicycle 5b was detected
because of the release of MeCHO to the medium as result of
the 2-oxonia-Cope rearrangement.41 We also chose oct-2-ynal
to test an α,β-unsaturated aldehyde, and bicycle 5j was
obtained in 46% yield (entry 6). It should be noted that oct-2-
ynal protected as its diethylacetal led to the same product with
a slightly inferior 39% yield. Cyclopropanecarbaldehyde is an
apparently problematic aldehyde because of the presence of an
acid-sensitive motif,55 but to our delight, it reacted properly to
give 5k in 63% yield (entry 7). Cyclohexanone was also tested
as a carbonylic compound in the EAP cyclization to study the
production of spirotetrahydropyrans,56 providing 5l in 23%
Table 4. Synthesis of Differently Substituted THPs
aIsolated yield; >95:5 dr, unless noted otherwise (determined by 1H NMR spectroscopy). bCalculated by 1H NMR spectroscopy, except in entry 1,
where 5b is the expected product. cIsolated yield; 80:20 dr, unless noted otherwise (determined by 1H NMR spectroscopy). dA 90:10 dr
(determined by 1H NMR spectroscopy). eA 39% yield was obtained when aldehyde was employed protected as diethylacetal. fAn 85:15 dr
(determined by 1H NMR spectroscopy). gReaction performed at 0 °C. hForty percent of 6b was also isolated; when n-hexane (0.05 M) was
employed as the solvent, 50% of 5w and 30% of 6b were isolated. i6x (35%) and 5w (14%, >95:5 dr) were calculated by 1H NMR spectroscopy. j6y
(10%) and 5w (14%, >95:5 dr) were calculated by 1H NMR spectroscopy.
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yield, although with excellent diastereoselectivity (entry 8).
The low yield is a consequence of the influence of the 2-
oxonia-Cope rearrangement, which leads to bicycle 5b as the
main product. Additionally, 2,3,4,5,5-pentasubstituted tetrahy-
drofuran (THF) 8l was isolated as a 4:1 mixture of the epimers
at C4 with a 19% yield. It is proposed that THF 8l is a
consequence of a 5-exo-trig attack of the olefin on the
oxocarbenium ion,57 instead of the 6-endo-trig attack that is
conducive to bicycle 5. Afterward, benzaldehyde (entry 9) and
several electron-poor aromatic aldehydes (entries 10−12) were
evaluated. An electron-rich aromatic aldehyde carrying a MeO
group in the para position also provided a similar good yield
(entry 13), though a drop in the yield was observed when the
same donor group was located in the orto position (entry
14).58 As seen when cyclohexanone was employed as the
carbonylic compound (entry 8), corresponding 2,3,4,5-
tetrasubstituted THFs 8 were generally identified (entries 9−
11, 13, and 14), unlike the results when aliphatic aldehydes
were used as starting materials.
Once the effectiveness of the Prins cyclization between the
simplest secondary aldol 2b (R2 = Me) and several aldehydes
(R3CHO) was demonstrated, we decided to modify both
substituents R2 and R3 (Table 5). As illustrated in entry 15,
when R2 = R3 = i-Bu, bicycle 5a was efficiently synthesized as
the sole diastereoisomer by performing the reaction at 0 °C
(traces of the C5 epimer were obtained when the reaction was
performed at rt). Entry 16 shows the previously discussed
synthesis of bicycle 5c (Table 3, entry 1). When the synthesis
of bicycle 5s was addressed, it was essential to perform the
reaction at 0 °C to avoid obtaining traces of bicycles 5a and 5c,
as a consequence of the processes associated with the 2-oxonia-
Cope rearrangement (entry 17).41 However, when MeCHO
was combined with 2d (R2 = Ph), the presence of an aromatic
group directly attached to the hydroxy group of the aldol led us
inevitably to a mixture of desired bicycle 5t (35%) and side
chain-exchanged byproduct 5b (55%) as the main product
(entry 18). This phenomenon can be explained considering
that if R2 is an aromatic group, it stabilizes by resonance the
intermediate oxocarbenium obtained after the 2-oxonia-Cope
rearrangement.59 As expected, the presence of an electron-
withdrawing group in the aromatic moiety of aldol 2h (R2 = 4-
Br-Ph) led to a decrease in the yield of undesired byproduct 5b
and yielded bicycle 5u diastereoselectively (entry 19).60,61 The
presence of a two-unit methylene bridge between the aromatic
and hydroxy groups of aldol 2e (R2 = PhCH2CH2) allowed
likewise an improvement in the yield in the synthesis of bicycle
5v (entry 20). Then we tested the EAP cyclization employing
aldol 2f (R1 = H) as the starting material. When it was
combined with MeCHO, the absence of an aliphatic chain
attached to the olefin led to bicycle 5w in 38% yield (entry 21),
Scheme 4. Two-Step EAP Cyclization versus One-Pot EAP Cyclization
Table 5. Synthesis of 2,3,4,5,6-Pentasubstituted THPs via the One-Pot EAP Cyclization
entry substrate R1 R2 R3 bicycle yield (%)a yieldav (%)
b
1 3a Et Me Me 5b 54 88
2 3a Et 4-Br-Ph Me 5u 22c 74
3 3a Et n-C13H27 Me 5z 41 84
4 3a Et i-Bu Me 5aa 42 84
5 3a Et Bu Ph 5ab 31d 79
6 3a Et i-Bu i-Bu 5a 60e 90
7 3d PhCH2 Bu Bu 5ac 32 80
8 3e n-pentyl Me Bu 5ad 31 79
9 3e n-pentyl Bu Me 5ae 30 79
10 3f BnOCH2CH2 Me Me 5af 54
f 88
aIsolated yield; >95:5 dr, unless noted otherwise (determined by 1H NMR spectroscopy). bAverage yield of each of the five new σ bonds generated
during the one-pot EAP cyclization. c5b was also isolated (4%, >95:5 dr). dA 90:10 dr (determined by 1H NMR spectroscopy). eA total of 5.3 g
was obtained with an 85:15 dr. fObtained as a 1.3:1 benzylated/nonbenzylated THP mixture.
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significantly lower than the yield of 78% obtained during the
synthesis of 5b (R1 = Et; entry 1). Moreover, 2-oxonia-Cope
byproduct 6c (R1 = H, and R3 = Me) was also isolated in 40%
yield, the highest of all the examples shown until now.62 This
result will be addressed again at the end of the mechanistic
section (Scheme 7). Similar results were found when aldol 2f
was combined with aromatic aldehydes to yield bicycles 5x and
5y, and in these cases, traces of bicycle 5w (entries 22 and 23)
were also isolated. In spite of the low yield, it should be
remarked that 2,3,4,6-tetrasubstituted THPs 5w−5y bear their
substituents in equatorial positions; hence, they share the same
core shown by natural products such as polycavernosides and
clavosolides (Figure 1), which enhance the synthetic utility of
the EAP protocol.
In summary, this EAP protocol allows the two-step
conversion of N-acyl oxazolidin-2-ones 3 into bicycles 5 via
the formation of aldols 2. During the first step, the Evans aldol
methodology permits the generation of a σ C−C bond and two
stereocenters in a diastereoselective fashion. The Prins
cyclization of those aldols implies the creation of four σ
bonds (three C−O and one C−C) and the insertion of three
stereocenters (in Scheme 4, new bonds are highlighted in bold
and the stereocenters with asterisks). Therefore, starting from a
molecule with no chiral centers such as 3a, one may
straightforwardly generate a high degree of structural complex-
ity: bicycle 5b was obtained in 59% yield as a single
diastereoisomer after just two steps. Nevertheless, we
wondered if an even simpler alternative could be performed,
by combining both Evans aldol and Prins cyclization in a one-
pot process. Thus, N-acyl oxazolidin-2-one 3a and MeCHO
were submitted to the Evans protocol to yield 2b; once TLC
analysis showed that the reaction was complete, another
portion of MeCHO and 2.5 equiv of BF3·OEt2 were added to
the reaction medium (Scheme 4). To our delight, bicycle 5b
was obtained in 54% yield, comparable to that of the two-step
process. It should be emphasized that this is a truly excellent
yield for a method in which five contiguous stereocenters are
diastereoselectively installed and five σ bonds are generated,
meaning an average yield for each bond of 88%. Additionally,
this simplified protocol avoids the workup and purification of
aldol 2b, with the consequent saving of organic solvents and
time.
The efficacy of the one-pot EAP protocol in the synthesis of
5b encouraged us to expand the scope by combining several N-
acyl oxazolidin-2-ones 3 and diverse aldehydes (Table 5).
Entry 1 shows the result previously shown in Scheme 4. N-Acyl
oxazolidin-2-one 3a also yielded bicycles 5 bearing different
aliphatic and aromatic groups at C2 and C6 (entries 2−5).
Entry 6 shows that this one-pot EAP protocol was perfectly
compatible with a multigram synthesis, allowing the prepara-
Scheme 5. Influence of the Nature of the Substituent Directly Attached to the Carbonyl Group
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tion of 5.3 g of bicycle 5a from 3a with no loss of yield and
enhancing the synthetic utility of this methodology. The one-
pot EAP protocol was also efficient starting from N-acyl
oxazolidin-2-ones bearing an aromatic group (entry 7) and a
longer linear aliphatic chain (entries 8 and 9). When a benzyl
ether was present at starting material 3f, the corresponding
bicycle was achieved in 54% overall yield, as a 1.3:1
benzylated/nonbenzylated product mixture (entry 10).
In summary, in the two-step and one-pot versions, the EAP
protocol becomes a powerful tool for the synthesis of valuable
2,3,4,5,6-pentasubstituted THPs with the general structure of
5. However, in spite of its contrasting efficacy, we still kept in
mind our original aim of accessing densely substituted 4-halo-
THPs 1 (Scheme 1). During the related studies described
above through an understanding of the EAP cyclization, the
isolated synthesis of such 4-halo-THPs (Table 2, entries 14−
16) really grabbed our attention, because those were the only
examples in which the oxazolidin-2-one moiety acted as a mere
spectator instead of undergoing a rearrangement to form the
bicyclic structure. For this reason, we were interested in
studying the influence of the nature of the substituent directly
attached to the carbonyl group in the aldol employed as the
starting material in the Prins cyclization (Scheme 5).
Thus, we devised a variation of the aldol−Prins cyclization
with aldols 9a and 9b, whose structures are identical to those
of Evans aldols 2a and 2b, respectively, except for the
substitution of the oxazolidin-2-one moiety for an ester group.
syn-Aldol 9a was combined with i-BuCHO in a Prins
cyclization promoted by FeCl3 to produce 4-chloro-THP 10a
in 47% yield (eq 1, top). The isolation of a small amount of
homoallylic alcohol 11 (7%) demonstrated that the Prins
cyclization was competing with the 2-oxonia-Cope rearrange-
ment. Fortunately, the generation of this undesired byproduct
was suppressed when the promoter system was replaced by the
Fe(acac)3/TMSCl system, allowing the synthesis of 10a in
70% yield (eq 1, bottom). anti-Aldol 9a was also submitted to
this Fe-based Prins cyclization to evaluate the influence of the
stereochemistry present in the starting material (eq 2). The
reaction was first stopped at 20 min and the nonpolar product
analyzed by NMR, revealing the expected 4-chloro-THP 10b
(17%), the C3 epimer of 10a, whose stereochemistry was
unequivocally assigned on the basis of the GOESY analysis and
the J coupling values (eq 2, top). When the presumed
remaining starting material was checked by NMR, we
surprisingly discovered that it was actually a mixture of
unreacted anti-aldol 9a (44%) and δ-lactone 12 (26%). When
the reaction time was increased to 4 h, a similar yield of THP
10b was obtained (20%), although a higher proportion of
lactone 12 (42%) with respect to the unreacted starting aldol
(10%) was detected (eq 2, middle). Eventually, when the
Fe(acac)3/TMSCl system was employed as the promoter and
the reaction time was set at 21 h, the starting material was
completely consumed and lactone 12 was isolated in 62%
yield, although the yield of THP 10b did not improve (eq 2,
bottom).63 Next, we decided to evaluate the efficacy of Fe-
based Prins cyclization for synthesizing THPs with different
chains at positions 2 and 6. Thus, syn-aldol 9b was combined
with BuCHO and treated with the Fe(acac)3/TMSCl system
(eq 3). Unfortunately, expected THP 10c was obtained with a
poor 20% yield together with a 16% yield of THP 10d, in
which a side chain exchange occurred as a consequence of the
2-oxonia-Cope rearrangement. syn-Aldol 9b was also submitted
to the Prins cyclization mediated by 2.5 equiv of BF3·OEt2 in
pursuit of the synthesis of 4-hydroxy-THP 13 (eq 4). In
contrast to the efficient synthesis of 5b achieved when the
analogous syn-aldol 2b was treated under the same conditions
[78% and >95:5 dr (see Table 4, entry 1)], herein desired
THP 13 was obtained in 12% yield and as a 1:1 epimeric
Scheme 6. Derivatization of Bicycles 5
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mixture at C4. Thus, according to these results, the oxazolidin-
2-one moiety directly attached to the carbonyl group of the
aldol seems to be crucial, not only to guarantee the prevalence
of the Prins cyclization product facing the 2-oxonia-Cope
byproducts but also to achieve the THPs with good yields and
diastereoselectivities.
Prins cyclizations illustrated in Scheme 5 constitute an
unsuccessful pathway to the desired 2,3,4,5,6-pentasubstituted
THPs differently functionalized at C3 and C4, which are
interesting intermediates for the synthesis of THP-containing
natural products. However, the EAP protocol provides efficient
and robust access to this kind of THPs, although they are fused
to a 1,3-oxazinane-2,4-dione ring (5). Thus, the removal of this
second heterocycle should be an alternative way to access
highly substituted nonbicyclic THPs, such as those commonly
found in natural products (Figure 1). Bicycle 5a was chosen as
the starting material, and the cleavage of the nitrogenated
heterocycle was tackled through different transformations
(Scheme 6). First, 5a was refluxed with an aqueous HCl
solution for 4 h; under these conditions, the bicyclic structure
remained stable, although a chlorine atom replaced the
terminal hydroxy group, yielding halo-bicycle 7a-Cl in 57%
yield. Homologous product 7b-Cl had been previously
obtained with a similar yield when aldol 2a was submitted to
the Prins cyclization mediated by the BF3·OEt2/TMSCl system
[67% (see Table 2, entry 12)]. Similarly, when 5a was refluxed
with a HBr aqueous solution, halo-bicycle 7a-Br was obtained
in 81% yield. Bicycle 5a was also submitted to an elimination
reaction by being treated with KHMDS to obtain dihydropyr-
an 14 with an amide at C3.
64 That elimination reaction allowed
the release of a CO2 molecule to permit the cleavage of the
bicyclic structure. Another protocol for transforming bicycle 5a
into an amide was tested, affording simple access to β-hydroxy
amide 15.65 Afterward, a basic hydrolysis protocol was
employed in an attempt to produce a THP embedded in a
β-hydroxy acid.66 Thus, treatment of 5a with freshly prepared
lithium hydroperoxide yielded THP 16 with a carboxylic acid
at C3 and a carbamate at C4, which was successfully hydrolyzed
at reflux with LiOH to allow access to β-hydroxy acid 17.
Eventually, several reductive protocols with DIBAL-H were
analyzed, revealing noteworthy differences according to the
nature of the reagent and the order of addition. When bicycle
Scheme 7. Computed Reaction Profile for the Cyclization of Oxonium E-INT1 and Oxonium Z-INT1
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5a was added over an ice-cooled DIBAL-H solution, 4-
hydroxy-THP 18, bearing a tertiary amine, was obtained
because of the total reduction of both carbonyl groups.
However, when DIBAL-H was added in a dropwise fashion to
a solution of bicycle 5a in THF and then refluxed, diol 19 was
obtained.67 The use of NaBH4 as the source of hydride led to
carbamate 20;68 hydrolysis of 20 yielded diol 19.66 The
conclusion deduced from this derivatization screening is that
bicycles 5, easily obtained via our EAP protocol, constitute a
versatile platform for accessing a substantial family of highly
substituted THPs bearing various functional groups.
A mechanistic model for the Prins cyclization using E- and
Z-homoallylic alcohols 2 obtained from the Evans aldol
addition is outlined below. Considering that the variation of
the reaction temperature almost did not affect the diaster-
eoselectivity of the reaction and modified only the reaction
time,51 a kinetically controlled mechanism would be expected.
In addition, from the experimental results, it seems that the
oxazolidin-2-one group is not a mere spectator in the process,
because the reaction fails when it is replaced by an ester group
(Scheme 5). We performed DFT calculations to delve into the
complete diastereoselectivity of the Lewis acid-catalyzed Prins
cyclization described above. In this regard, we computed the
reaction profile [SCRF(CH2Cl2)-B3LTP/6-31g(d) level]
involving the oxocarbenium that resulted from the condensa-
tion of simple allylic alcohol 2b (R1 = Et, and R2 = Me) for
both E- and Z-isomers (E-INT1 and Z-INT1, respectively) in
the presence of BF3 as the Lewis acid (Scheme 7). We
speculate that trifluorohydroxyborate is formed from the BF3
used and will be important during the overall mechanism
leading to the final tetrahydropyran. Relative enthalpies ΔG
(298 K) and bond distances are given in kilocalories per mole
and angstroms, respectively. The numbering of the figures is
arbitrary and used for discussion. Only representative hydro-
gens are shown. DFT calculations, in the gas phase, were
performed at the B3LYP/6-31G(d) level and punctually
corrected to include solvation in DCM, using the SCRF
method, used by default in Gaussian. The transition states were
confirmed with the corresponding force calculations, ensuring
the presence of a single imaginary frequency in all cases. For
the determination of the E-INT3 and Z-INT3 complexes, the
basis set superposition error was taken into account using the
“counterpoise” method.
We first discuss the cyclization for the E-isomer of the
double bond at the homoallylic alcohol. As depicted in Scheme
7, oxonium ion E-INT1 evolves exothermically (ΔEr = −15.3
kcal/mol) to carbocation E-INT2 through double-bond
nucleophilic attack. Transition state E-TS1 (ΔEr = +5.4
kcal/mol) adopts a chairlike conformation caused by the
arrangement of the N-acyl oxazolidin-2-one on the substrate.
In this transition state, all substituents are located in the
equatorial position setting the relative configurations of C5 and
C6 in the product. The obtained carbocation, via E-TS1, allows
the carbonyl nucleophilic equatorial attack of the oxazolidin-2-
one ensuring the stereochemistry at C4 in E-INT2. This step is
highly exothermic (ΔEr = −15.3 kcal/mol) as a result of the
stabilization of the positive charge by the adjacent
heteroatoms. The existence of a true bond between the
oxazolidin-2-one carbonyl oxygen and the electron deficit
center (numbered as 4 in the scheme), shown with a dotted
Scheme 8. Prins Cyclization of Enantiomeric Aldolsa
aReaction conditions: MeCHO (1.5 equiv), Lewis acid, DCM (0.1 M), rt, 30 min. All products were obtained with a >95:5 dr except 5ah (92:8
dr).
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line, was confirmed by the AIM (atom in molecules)
methodology [6-311+g(d, p)//B3LYP/6-31G(d)], which
justifies the stereochemistry of this center. In a similar manner,
the double-bond nucleophilic attack on the electrophilic
position in Z-INT1 generates cyclic tetrahydropyran Z-INT2
in an exothermic process (ΔEr = −16.5 kcal/mol). Transition
state Z-TS1 (ΔEr = +3.9 kcal/mol) adopts again a chairlike
conformation, placing the ethyl group in a pseudoaxial
position. The obvious consequence of this location is the
resulting geometry at the C5 position yielding diastereoisomer
Z-INT2, as it was observed experimentally (Scheme 3, eq 3).
The reaction ends with an SN2 nucleophilic attack of the
trifluorohydroxyborate (formed during the condensation
reaction) generating the primary alcohol and the correspond-
ing 1,3-oxazinane-2,4-dione as the leaving group. We first
performed calculations over van der Walls complex E-INT3
having as its origin the E-isomer of the double bond of the
homoallylic alcohol. This process is highly exothermic yielding
E-INT4 (ΔEr = −21.2 kcal/mol) through a low computed
activation barrier for E-TS2 (ΔEr = +5.8 kcal/mol). Lineal
intermediate E-INT4 evolves to the more stable and final BF3
complex E-FIN stabilized by an intramolecular O···HO
hydrogen bond. An experimental confirmation of this last
SN2 nucleophilic attack is provided for the formation of the
corresponding acetate when acetic acid was used as a solvent,
presumably via the formation of a BF3·HOAc complex (Table
3, entry 6).69 As expected, calculations over Z-isomer Z-INT3
provide results almost identical to those for the E-isomer,
providing exothermically Z-INT4 (ΔEr = −21.2 kcal/mol) via
low-energy transition state Z-TS2 (ΔEr = +6.6 kcal/mol). In a
similar manner, the reaction ends with the intramolecular
formation of an H-bond in final THP complex Z-FIN. Thus,
Scheme 7 justifies the formation of bicyclic compounds 5,
ratifying the experimental results. However, it was surprising
that when we started from aldol 2f bearing a terminal alkene
(R1 = H), the 2-oxonia-Cope products were observed at
significant levels (Table 4, entries 21−23). To find a
theoretical justification of this phenomenon, we proceeded to
repeat the same calculations shown in Scheme 7 for R1 = H,
also generating a reaction coordinate from the approach C5−
C6. We observed that in the product equivalent to E-INT1 (or
Z-INT1), the hypothetical carbocation at C4 is not assisted by
the carbonyl of the oxazolidin-2-one. In theses cases, the
approach leads directly to rearranged product 6 (ΔEr = −9.0
kcal/mol, and ΔEr* = 3.0 kcal/mol). Clearly, the substitution
of the terminal vinyl position in aldols 2 (R1 ≠ H) stabilizes
the charge at C4 to induce the approximation of the oxazolidin-
2-one ring, favoring the formation of tricyclic intermediate E-
INT2 or Z-INT2 (Scheme 7). Otherwise, the [3,3]-
sigmatropic rearrangement is observed.
To extend the applicability of the EAP cyclization, the
enantiomeric version was tested employing chiral alcohols 2i−
m previously obtained (Table 1, entries 18−22, respectively).70
Thus, Prins cyclization of acetaldehyde and aldol 2i, bearing a
benzyl group in the oxazolidin-2-one, allowed us to obtain
expected bicycle 5ag in 62% yield but also led to the
unprecedented isolation of THP 21a in 9% yield (Scheme 8,
eq 1).71 THPs as 21 (termed THP-Xc to highlight the
presence of the nonrearranged oxazolidin-2-one in their
structures) were not detected in any of the Prins cyclizations
previously studied; therefore, we reasoned that the chiral
nature of the oxazolidin-2-one motif was involved in their
generation. In an attempt to control the relative amount of
isomers 5 and 21, a screening of Lewis acids was unsuccessfully
performed.72 However, it must be pointed out that, from a
synthetic point of view, the presence of this pair of products is
not a handicap because under hydrolysis or reduction
conditions both must evolve to the same 2,3,4,5,6-pentasub-
stituted THP (see products 17 and 19 in Scheme 6). When the
Prins cyclization was performed by employing acetaldehyde
and aldol 2k, in which the oxazolidin-2-one presents an i-Pr
group instead of a benzyl group, both bicyclic product 5ah
(43%) and THP-Xc 21b (16%) were obtained again, as
reflected in eq 2. In a similar manner, cyclization using
aromatic alcohol 2l provided a mixture of bicycle 5ai and
THP-Xc 21c in 57% overall yield (eq 3). Finally, we decided to
study the Prins cyclization between n-pentanal and aldol 2m,
in which the oxazolidin-2-one motif presents substituents at
both positions adjacent to N and O (eq 4). THP-Xc 21d was
obtained with an apparently disappointing 10% yield, though
this result is really meaningful from a mechanistic point of
view. As shown in Scheme 7, the nucleophilic attack of the
trifluorohydroxyborate on the position adjacent to the O of the
oxazolidin-2-one usually leads to the generation of bicycles 5.
Nevertheless, in this case, the presence of the phenyl
substituent in that position prevents the nucleophilic attack
over the oxazolidin-2-one, yielding exclusively a THP-Xc 21.
Eventually, many of all these new products were biologically
evaluated. Our interest in the development of biostudies
concerning THPs arises from the high incidence of this
structural motif in bioactive natural products (Figure 1) and
from their inherent bioactivity. As antimicrobial and antifungal
activities are recurrently associated with THPs,4,5,8,9,13 we
decided to evaluate the antimicrobial activity of 33 of the
compounds obtained in the current study73 against Gram-
positive and Gram-negative bacteria and the yeast C. albicans.
The MIC50 values listed in Table 6 clearly show that the effect
of the compounds is limited to Gram-positive bacteria. B.
subtilis was more sensitive than the genus Staphylococcus,
although compounds 5c and 5ad displayed activity against
Staphylococcus aureus methicillin resistance (MIC50 = 28 μg/
mL). Structural analyses of the compounds suggest that the
growth inhibitory capacities of such products are strictly linked
to the presence of the bicyclic structure and to a
functionalization at positions 2 and 6 different from the
methyl group. The presence of i-Bu groups in these positions
and a chlorine atom replacing the terminal hydroxy group, as
observed in compound 7a-Cl, increased the activity (MIC50 =
Table 6. Antimicrobial Activity (MIC50, μg/mL) of Selected









5c 28 28 25
5n >40 >40 11
5z >40 >40 40
5ad 28 28 18
7a-Cl >40 >40 3
aAll assays were performed in triplicate. All the compounds assayed
were inactive (MIC50 > 40 μg/mL) against Gram-positive (Bacillus
cereus and S. aureus) and Gram-negative (E. coli, Pseudomonas
aeruginosa, and Proteus mirabilis) bacteria and the yeast C. albicans
CECT 1039.
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3 μg/mL). Furthermore, the presence of a butyl group at
position 2 and 6 (5c and 5ad, respectively) broadens the
activity to the genus Staphylococcus.
■ CONCLUSIONS
The EAP protocol has emerged as an efficient tool for the
transformation of β,γ-unsaturated N-acyl oxazolidin-2-ones
into 2,3,4,5,6-pentasubstituted THPs. These oxacycles were
obtained in an unprecedented bicyclic form because of the
rearrangement suffered in the reaction medium by the auxiliary
borne by the starting material. Two variants of the EAP
protocol have been developed, a two-step sequence and a
simpler one-pot variant, both exhibiting high tolerance to
various functional groups and allowing the introduction of
aromatic and aliphatic moieties at positions 2, 5, and 6 of the
THPs. The one-pot version permitted the introduction of five
adjacent stereocenters with diastereoisomeric ratios generally
greater than 95:5, as well as the generation of three C−O and
two C−C bonds with average yields of ≤90%. The two-step
strategy allowed the production of both racemic and chiral
THPs, and the modulation of the stereochemistry of the
starting unsaturated aldol allowed the fine-tuning of the
stereochemical pattern shown in the final THP, enabling thus
access to different cores of several natural products. Computa-
tional studies were consistent with those stereochemical essays
and with the observed rearrangement of the oxazolidin-2-one
motif. It was also revealed that the presence of the oxazolidin-
2-one ring in the starting materials was absolutely necessary to
guarantee, on one hand, the diastereoselectivity of the process
and to deactivate, on the other, the competing 2-oxonia-Cope
rearrangement usually concomitant with Prins cyclization. The
meticulous screening of the reaction conditions led us to
establish as optimal the employment of DCM as the solvent
and 2.5 equiv of BF3·OEt2 as the promoter, although its
combination with TMSCl permitted the direct synthesis of
chlorinated derivatives. Other Lewis acids such as FeBr3,
TMSBr, and TMSI were also able to yield halogenated bicycles
or even 4-halo-2,3,4,5,6-pentasubstituted THPs, but these
reaction conditions have not yet been optimized. Direct
halogenation of the bicyclic THPs was also achieved, and it
was found that these compounds constitute a versatile platform
for accessing a considerable diversity of simpler nonbicyclic
THPs bearing amines, amides, carbamates, carboxylic acids,
and hydroxy groups. Bioassays showed that some of the
synthesized THPs were active against Gram-positive bacteria,
yielding the best values of the MIC50 for B. subtilis. We expect
that this complete study detailed herein will lay the foundation
for expanding the range of synthetic applications of the EAP
protocol.
■ EXPERIMENTAL SECTION
General Experimental Methods. Atoms of all the compounds
were numbered according to the IUPAC name. All reagents were
commercially available and used as received without further
purification, unless noted otherwise. A 3.3 M solution of acetaldehyde
in DCM was prepared by diluting 23 mL of commercial and volatile
acetaldehyde in 100 mL of dry DCM. The molarity of the solution
was checked by 1H NMR spectroscopy. The solution was stored at 2−
8 °C under Ar, being stable for at least 12 months. BF3·OEt2 (bp 129
°C) was distilled and stored at −18 °C under Ar. All solvents were
dried and distilled under Ar immediately prior to use or stored
appropriately. THF was refluxed over sodium and benzophenone.
DCM was distilled from CaH2. Reactions were monitored by thin-
layer chromatography (TLC) analysis employing UV light (365 nm),
a phosphomolybdic acid solution 10 wt % in methanol, or a vanillin
solution (6 g of vanillin, 450 mL of ethanol, 40 mL of AcOH, and 30
mL of H2SO4). TLC was run on silica gel 60 F254 aluminum sheets.
Flash chromatography was performed with silica gel (230−400 mesh)
as the stationary phase and mixtures of n-hexane and EtOAc, in
different proportions given in each case, as the mobile phase. Melting
points were determined on a Büchi B-540 model. Optical rotations
were determined on a PerkinElmer 343 polarimeter using a sodium
lamp operating at 589 nm. 1H NMR (400, 500, or 600 MHz) and 13C
NMR (100, 125, or 150 MHz) spectra were recorded at room
temperature; chemical shifts (δ) are reported in parts per million, and
coupling constants (J) are given in hertz. 1H NMR spectra are
referenced to the resonance from residual CHCl3 at 7.26 ppm;
multiplicity is expressed by the abbreviations m (multiplet), br (broad
signal), s (singlet), d (doublet), t (triplet), q (quartet), and
combinations thereof for more highly coupled systems. 13C NMR
spectra are referenced to the central peak of the signal from CDCl3 at
77.16 ppm; multiplicity was assigned from DEPT135 and DEPT90
experiments and is expressed by the abbreviations s (C), d (CH), t
(CH2), and q (CH3). Structures were elucidated according to
literature precedents or using two-dimensional NMR techniques such
as COSY, HSQC, edited HSQC, and/or HMBC; spatial elucidation
was performed via NMR according to the GOESY technique. Mass
spectra were recorded by using electronic impact (EI-TOF 70 eV) or
by using electrospray ionization (ESI+-TOF), as specified in each case.
Antimicrobial Assay. The strains used to determine antimicrobial
activity included S. aureus ATCC 6538, S. aureus methicillin-resistant
(MRSA ULL1, clinical isolate, University of La Laguna), S. epidermidis
ATCC 14990, B. subtillis ATCC 6051, B. cereus ATCC 21772, E. coli
ATCC 9637, P. mirabilis CECT 170 (from the Coleccioń Española de
Cultivos Tipo), P. aeruginosa AK958 (from the Department of
Microbiology collection from the University of British Columbia,
Vancouver, BC), and C. albicans CECT1032. The MIC50 was
determined for each compound in triplicate, by the microdilution
method (range of 0.08−40 μg/mL) in 96-well microtiter plates.74
Wells with the same proportion of DMSO were used as controls, and
the level never exceeded 1% (v/v). The starting microorganism
density was approximately 1 × 105 to 5 × 105 colony forming units
(CFU) per milliliter, and growth was monitored by measuring the
increase in the optical density at 550 nm with a microplate reader
(Tecan Group Ltd., Mannedorf, Switzerland). All wells with no visible
growth were subcultured by transferring them in duplicate (100 μL)
to agar plates. After overnight incubation, colony counts were
performed and the MIC50 was defined as the lowest concentration of
compound affecting a 50% decrease in growth at the end of the
incubation period relative to untreated controls.
General Procedure for the Synthesis of the β,γ-Unsaturated
Carboxylic Acids 4. A mixture of the aldehyde, malonic acid (1.1
equiv), and NMM (1.1 equiv), prepared under Ar, was heated at 95
°C until the reaction was complete (2−8 h approximately). After that,
the mixture was cooled to 0 °C, treated with a 2 M aqueous solution
of H2SO4 (1.1 equiv), and extracted three times with DCM. The
combined organic layers were washed with water, dried over
anhydrous MgSO4, filtered, concentrated, and purified by flash
chromatography to yield acids 4.75 Acids 4a−4c are commercially
available and were used as received without further purification. Acids
4d−4f were described in our previous publication30 and were stable
for at least 12 months stored under Ar at −18 °C.
General Procedure for the Synthesis of the N-Acyl
Oxazolidin-2-ones 3. All the subsequent operations were performed
under an Ar atmosphere. To a solution of the carboxylic acid in dry
THF (0.16 M) was added, at 0 °C, TEA (1.1 equiv). After 5 min,
pivaloyl chloride (1.3 equiv) was also added at 0 °C, producing a
suspension of the mixed acid anhydride that was stirred for 1 h at rt.
Meanwhile, in another flask, a solution of the oxazolidin-2-one (1.3
equiv) in dry THF (0.3 M) was cooled to −78 °C, treated dropwise
with a 2.5 M solution of n-butyllithium in hexanes (1.2 equiv), and
kept at that temperature until it was poured (a slow addition is not
required) into the −78 °C cooled suspension of the anhydride. After
that, the mixture was allowed to warm to rt, and after 15 h, the
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reaction was stopped with a saturated NH4Cl aqueous solution. Then,
it was extracted three times with EtOAc, and the combined organic
layers were dried over anhydrous MgSO4, filtered, concentrated, and
purified by flash chromatography to yield desired compound 3. The
N-acyl oxazolidin-2-ones are usually slightly more apolar than the
starting carboxylic acid. Compounds with the structure of 3 are stable
for 6 months if they are properly stored under Ar at −18 °C, although
they begin to decompose thereafter. N-Acyl oxazolidin-2-ones 3a−3f
were described in our previous publication.30
(R,E)-4-Benzyl-3-(hex-3-enoyl)oxazolidin-2-one (3g). Acid 4a (1
mL, 8.18 mmol) was subjected to the general procedure for the
synthesis of N-acyl oxazolidin-2-ones 3. Purification by flash
chromatography (11 cm of height of silica gel, n-hexane/EtOAc
75:25) provided the title compound together with the rest of the
pivaloyl chloride. To remove that contaminant, the mixture was
solved in Et2O (30 mL) and washed with H2O (10 × 30 mL). The
organic layer was dried over anhydrous MgSO4, filtered, and
concentrated to yield product 3g (2.00 g, 90%) as a yellowish oil:
Rf = 0.44 (n-hexane/EtOAc 70:30), 0.85 (n-hexane/EtOAc 20:80);
[α]25D −64.7 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.02 (t,
J = 7.5 Hz, 3H, H6′), 2.06−2.13 (m, 2H, H5′), 2.78 (dd, J = 13.5, 9.8
Hz, 1H, 1 × PhCH2C4), 3.30 (dd, J = 13.4, 3.2 Hz, 1H, 1 ×
PhCH2C4), 3.61−3.73 (m, 2H, H2′), 4.16−4.23 (m, 2H, H5), 4.67
(ddt, J = 9.6, 7.5, 3.2 Hz, 1H, H4), 5.61 (dtt, J = 15.6, 6.6, 1.3 Hz, 1H,
H3′), 5.70 (dtt, J = 15.6, 6.1, 1.3 Hz, 1H, H4′), 7.19−7.22 (m, 2H),
7.27−7.30 (m, 1H), 7.31−7.35 (m, 2H); 13C NMR (125 MHz,
CDCl3) δ 13.6 (q, C6′), 25.8 (t, C5′), 38.0 (t, C2′ or PhCH2C4), 39.3
(t, C2′ or PhCH2C4), 55.4 (d, C4), 66.4 (t, C5), 120.1 (d, C3′), 127.5
(d, Ph), 129.1 (d, 2C, Ph), 129.6 (d, 2C, Ph), 135.4 (s, Ph), 137.3 (d,
C4′), 153.5 (s, C2), 172.1 (s, C1′); MS (EI) m/z (relative intensity)
273 (M)+ (55), 178 (28), 97 (M − oxazolidin-2-one)+ (55), 96
(100); HRMS calcd for C16H19NO3 [(M)
+] 273.1365, found
273.1362.
(S,E)-3-(Hex-3-enoyl)-4-isopropyloxazolidin-2-one (3h). Acid 4a
(0.5 mL, 4.09 mmol) and (S)-4-isopropyloxazolidin-2-one (641 mg,
4.91 mmol, 1.2 equiv) were subjected to the general procedure for the
synthesis of N-acyl oxazolidin-2-ones 3 and yielded, after purification
by flash chromatography (32 cm of height of silica gel, n-hexane/
EtOAc 95:5), compound 3h (765 mg, 83%) as a thick colorless oil: Rf
= 0.32 (n-hexane/EtOAc 80:20), 0.55 (n-hexane/EtOAc 80:20, three
times); [α]25D +75.1 (c 1.0, CHCl3);
1H NMR (500 MHz, CDCl3) δ
0.86 (dd, J = 6.8, 0.9 Hz, 3H, (CH3)2CHC4), 0.90 (dd, J = 7.0, 1.2
Hz, 3H, 1 × (CH3)2CHC4), 0.98 (td, J = 7.6, 1.2 Hz, 3H, H6′), 2.02−
2.09 (m, 2H, H5′), 2.34−2.41 (m, 1H, (CH3)2CHC4), 3.59 (dd, J =
16.7, 6.6 Hz, 1H, H2′), 3.70 (dd, J = 17.0, 6.7 Hz, 1H, H2′), 4.20 (ddd,
J = 9.1, 3.0, 0.9 Hz, 1H, H5), 4.25−4.28 (m, 1H, H5), 4.40−4.44 (m,
1H, H4), 5.53−5.60 (m, 1H, H3′), 5.63−5.70 (m, 1H, H4′); 13C NMR
(125 MHz, CDCl3) δ 13.6 (q, C6′), 14.8 (q, (CH3)2CHC4), 18.1 (q,
(CH3)2CHC4), 25.7 (t, C5′), 28.5 (d, (CH3)2CHC4), 39.3 (t, C2′),
58.6 (d, C4), 63.5 (t, C5), 120.3 (d, C3′), 137.1 (d, C4′), 154.1 (s, C2),
172.0 (s, C1′); MS (EI) m/z (relative intensity) 225 (M)
+ (19), 210
(M − Me)+ (1), 130 (42), 96 (M − H − oxazolidin-2-one)+ (100);
HRMS calcd for C12H19NO3 [(M)
+] 225.1365, found 225.1376.
(4R,5S)-3-[(E)-Hex-3-enoyl]-4-methyl-5-phenyloxazolidin-2-one
(3i). Acid 4a (0.3 mL, 2.46 mmol) and (4R,5S)-4-methyl-5-
phenyloxazolidin-2-one (523 mg, 2.95 mmol, 1.2 equiv) were
subjected to the general procedure for the synthesis of N-acyl
oxazolidin-2-ones 3 and yielded, after purification by flash
chromatography (32 cm of height of silica gel, n-hexane/EtOAc
90:10), compound 3i (581 mg, 87%) as a colorless oil: Rf = 0.19 (n-
hexane/EtOAc 80:20), 0.62 (n-hexane/EtOAc 60:40); [α]25D +29.8
(c 1.1, CHCl3);
1H NMR (600 MHz, CDCl3) δ 0.89 (d, J = 6.7 Hz,
3H, CH3C4), 1.00 (t, J = 7.4 Hz, 3H, H6′), 2.04−2.10 (m, 2H, H5′),
3.63−3.71 (m, 2H, H2′), 4.75 (dq, J = 6.7, 6.7 Hz, 1H, H4), 5.57−5.61
(m, 1H, H5), 5.65−5.70 (m, 2H, H3′, H4′), 7.29−7.30 (m, 2H, Ph),
7.35−7.38 (m, 1H, Ph), 7.40−7.42 (m, 2H, Ph); 13C NMR (150
MHz, CDCl3) δ 13.6 (q, C6′), 14.7 (q, CH3C4), 25.7 (t, C5′), 39.4 (t,
C2′), 54.9 (d, C4), 79.1 (d, C5), 120.1 (d, C3′), 125.8 (d, 2C, Ph),
128.8 (d, 2C, Ph), 128.9 (d, Ph), 133.4 (s, Ph), 137.1 (d, C4′), 153.1
(s, C2), 171.8 (s, C1′); HRMS calcd for C16H19NO3Na [(M + Na)
+]
296.1263, found 296.1261.
General Procedure for the Synthesis of syn-Aldols 2. All the
subsequent operations were performed under an Ar atmosphere. A
solution of the N-acyl oxazolidin-2-ones in dry DCM (1 M) was
cooled to −78 °C. TEA (1.3 equiv) and a 1 M solution of n-Bu2BOTf
in DCM (1.2 equiv) were dropped sequentially, and then the mixture
was stirred at that temperature for 30 min. After that, it was warmed
to 0 °C, and after 20 min, it was recooled to −78 °C, the aldehyde
R2CHO (1.5 equiv) was added, and the mixture was allowed to warm
to rt. After 15 h, the mixture was cooled to 0 °C and subjected to an
oxidative workup. To it were sequentially added a pH 7 buffer
solution (1.1 mL/mmol of N-acyl oxazolidin-2-ones), MeOH (2.6
mL/mmol of N-acyl oxazolidin-2-ones), and a 35 wt % solution of
H2O2 in water (1.1 mL/mmol of N-acyl oxazolidin-2-ones). The
layers were then separated, and the aqueous layer was extracted three
times with DCM. The combined organic layers were dried over
anhydrous MgSO4, filtered, and concentrated. A non-aqueous
simplified workup is also valid. A small amount of silica gel 60
(35−70 mesh) was added; the solvent was removed in the rotavap,
and the silica-supported crude was purified. The crude was purified by
flash chromatography (the homoallylic alcohol is usually slightly more
polar than the starting N-acyl oxazolidin-2-ones) to yield desired
compounds. Stored under Ar at −18 °C, aldols were stable for at least
12 months. Except for anti-aldol 2a, all the syn-aldols 2 were prepared
as described above. anti-Aldol 2a and syn-aldols 2a−2g were
described in our previous publication.30
3-{(R*,E)-2-[(R*)-(4-Bromophenyl)(hydroxy)methyl]hex-3-enoyl}-
oxazolidin-2-one (2h). N-Acyl oxazolidin-2-one 3a (994 mg, 5.43
mmol) was subjected to the general procedure for the synthesis of
syn-aldols 2 and yielded, after purification by flash chromatography
(17 cm of height of silica gel, n-hexane/EtOAc 70:30), compound 2h
(1.18 g, 59%) as a white solid: Rf = 0.41 (n-hexane/EtOAc 60:40, two
times); mp 60−64 °C (from DCM/n-hexane); 1H NMR (500 MHz,
CDCl3) δ 0.94 (t, J = 7.5 Hz, 3H, H6′), 2.00−2.06 (m, 2H, H5′), 3.09
(br s, 1H, OH), 3.85−3.91 (m, 1H, H4), 3.93−3.99 (m, 1H, H4),
4.26−4.31 (m, 1H, H5), 4.32−4.39 (m, 1H, H5), 4.74 (dd, J = 9.1, 5.7
Hz, 1H, H2′), 4.99 (d, J = 5.7 Hz, 1H, H1″), 5.52 (dd, J = 15.5, 9.1 Hz,
1H, H3′), 5.69 (dt, J = 15.5, 6.1 Hz, 1H, H4′), 7.24 (d, J = 8.5 Hz, 2H,
Ar), 7.44 (d, J = 8.5 Hz, 2H, Ar); 13C NMR (150 MHz, CDCl3) δ
13.4 (q, C6′), 25.9 (t, C5′), 42.7 (t, C4), 53.8 (d, C2′), 62.0 (t, C5),
73.9 (d, C1″), 121.3 (d, C3′), 121.7 (s, Ar), 128.7 (d, 2C, Ar), 131.3
(d, 2C, Ar), 139.8 (s, Ar), 140.7 (d, C4′), 153.0 (s, C2), 173.7 (s, C1′);
HRMS calcd for C16H18




oxazolidin-2-one (2i). N-Acyl oxazolidin-2-one 3g (643 mg, 2.35
mmol) was subjected to the general procedure for the synthesis of
syn-aldols 2 and yielded, after purification by flash chromatography
(18 cm of height of silica gel, n-hexane/EtOAc 70:30), compound 2i
(559 mg, 75%) as a colorless oil: Rf = 0.42 (n-hexane/EtOAc 60:40);
[α]25D 0 (c 1.0, CHCl3), −22.0 (c 1.7, Et2O); 1H NMR (500 MHz,
CDCl3) δ 1.04 (t, J = 7.5 Hz, 3H, H6′), 1.19 (d, J = 6.4 Hz, 3H, H2″),
2.11−2.17 (m, 2H, H5′), 2.79 (dd, J = 13.4, 9.2 Hz, 1H, CH2Ph), 2.99
(br s, 1H, OH), 3.19 (dd, J = 13.5, 2.9 Hz, 1H, CH2Ph), 4.13−4.19
(m, 2H, 1 × H5, H1″), 4.20−4.25 (m, 1H, 1 × H5), 4.44 (dd, J = 9.2,
3.9 Hz, 1H, H2′), 4.70−4.76 (m, 1H, H4), 5.60 (dd, J = 15.3, 9.3 Hz,
1H, H3′), 5.90 (dt, J = 15.4, 6.9 Hz, 1H, H4′), 7.17−7.21 (m, 2H, Ph),
7.27−7.29 (m, 1H, Ph), 7.30−7.34 (m, 2H, Ph); 13C NMR (125
MHz, CDCl3) δ 13.7 (q, C6′), 20.0 (q, C2″), 26.0 (t, C5′), 37.7 (t,
CH2Ph), 52.5 (d, C2′), 55.1 (d, C4), 66.0 (t, C5), 68.2 (d, C1″), 121.6
(d, C3′), 127.6 (d, Ph), 129.1 (d, 2C, Ph), 129.6 (d, 2C, Ph), 135.1 (s,
Ph), 140.2 (d, C4′), 153.1 (s, C2), 174.8 (s, C1′); HRMS calcd for
C18H23NO4Na [(M + Na)
+] 340.1525, found 340.1520.
(R)-4-Benzyl-3-{(R,E)-2-[(S)-1-hydroxy-3-phenylpropyl]hex-3-
enoyl}oxazolidin-2-one (2j). N-Acyl oxazolidine-2-one 3g (600 mg,
2.19 mmol) was subjected to the general procedure for the synthesis
of syn-aldols 2 and yielded, after purification by flash chromatography
(30 cm of height of silica gel, n-hexane/EtOAc 80:20), compound 2j
(533 mg, 60%) as a yellow oil: Rf = 0.39 (n-hexane/EtOAc 70:30);
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[α]25D −13.2 (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.03 (t,
J = 7.5 Hz, 3H, H6′), 1.63 (br s, 1H, OH), 1.68−1.75 (m, 1H, H2″),
1.82−1.90 (m, 1H, H2″), 2.10−2.16 (m, 2H, H5′), 2.66−2.72 (m, 1H,
H3″), 2.78 (d, J = 13.5, 9.0 Hz, 1H, C4CH2Ph), 2.81−2.87 (m, 1H,
H3″), 3.20 (dd, J = 13.5, 3.5 Hz, 1H, C4CH2Ph), 3.97 (dt, J = 9.1, 3.6
Hz, 1H, H1″), 4.14−4.22 (m, 2H, H5), 4.50 (dd, J = 9.3, 3.9 Hz, 1H,
H2′), 4.68−4.73 (m, 1H, H4), 5.61 (ddt, J = 15.4, 9.2, 1.4 Hz, 1H,
H3′), 5.92 (dt, J = 15.4, 6.4 Hz, 1H, H4′), 7.17−7.22 (m, 5H, Ph),
7.27−7.34 (m, 5H, Ph); 13C NMR (150 MHz, CDCl3) δ 13.7 (q,
C6′), 26.1 (t, C5′), 32.0 (t, C3″), 35.8 (t, C2″), 37.7 (t, C4CH2Ph), 51.2
(d, C2′), 55.1 (d, C4), 66.0 (t, C5), 71.1 (d, C1″), 121.3 (d, C3′), 125.9
(d, Ph), 127.6 (d, Ph), 128.5 (d, 2C, Ph), 128.7 (d, 2C, Ph), 129.1 (d,
2C, Ph), 129.6 (d, 2C, Ph), 135.1 (s, Ph), 140.3 (d, C4′), 142.1 (s,
Ph), 153.0 (s, C2), 175.0 (s, C1′); HRMS calcd for C25H29NO4Na
[(M + Na)+] 430.1994, found 430.1998.
(S)-3-{(S,E)-2-[(R)-1-Hydroxyethyl]hex-3-enoyl}-4-isopropyloxa-
zolidin-2-one (2k). N-Acyl oxazolidin-2-one 3h (276 mg, 1.23 mmol)
was subjected to the general procedure for the synthesis of syn-aldols
2 and yielded, after purification by flash chromatography (25 cm of
height of silica gel, n-hexane/EtOAc 70:30), compound 2k (283 mg,
86%) as a thick colorless oil: Rf = 0.21 (n-hexane/EtOAc 70:30);
[α]25D −27.8 (c 1.1, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.81 (d,
J = 6.9 Hz, 3H, (CH3)2CHC4), 0.88 (d, J = 6.9 Hz, 3H,
(CH3)2CHC4), 0.96 (t, J = 7.5 Hz, 3H, H6′), 1.14 (d, J = 6.4 Hz,
3H, H2″), 2.03−2.08 (m, 2H, H5′), 2.25−2.34 (m, 1H,
(CH3)2CHC4), 3.10 (br s, 1H, OH), 4.09−4.14 (m, 1H, H1″), 4.17
(dd, J = 9.1, 3.3 Hz, 1H, H5), 4.25 (dd, J = 8.9, 8.9 Hz, 1H, H5),
4.43−4.48 (m, 2H, H4, H2′), 5.52 (ddq, J = 15.6, 9.2, 1.3 Hz, 1H,
H3′), 5.87 (dt, J = 15.0, 6.5 Hz, 1H, H4′);
13C NMR (125 MHz,
CDCl3) δ 13.6 (q, C6′), 14.6 (q, (CH3)2CHC4), 17.9 (q,
(CH3)2CHC4), 19.9 (q, C2″), 25.9 (t, C5′), 28.3 (d, (CH3)2CHC4),
52.2 (d, C2′), 58.2 (d, C4), 63.2 (t, C5), 67.8 (d, C1″), 121.7 (d, C3′),
140.1 (d, C4′), 153.6 (s, C2), 175.1 (s, C1′); MS (EI) m/z (relative
intensity) 225 (M − H − i-Pr)+ (1), 141 (M − oxazolidin-2-one)+
(1), 128 (oxazolidin-2-one)+ (100), 113 (M − N-acyl oxazolidin-2-
one)+ (38); HRMS calcd for C11H15NO4 [(M − H − i-Pr)+]
225.1001, found 225.1007.
(S)-3-{(S,E)-2-[(R)-1-Hydroxy-3-phenylpropyl]hex-3-enoyl}-4-iso-
propyloxazolidin-2-one (2l). N-Acyl oxazolidin-2-one 3h (194 mg,
0.86 mmol) was subjected to the general procedure for the synthesis
of syn-aldols 2 and yielded, after purification by flash chromatography
(25 cm of height of silica gel, n-hexane/EtOAc 80:20), compound 2l
(215 mg, 69%) as an amorphous white solid: Rf = 0.33 (n-hexane/
EtOAc 70:30); [α]25D −23.8 (c 1.1, CHCl3); 1H NMR (500 MHz,
CDCl3) δ 0.80 (d, J = 7.0 Hz, 3H, (CH3)2CHC4), 0.87 (d, J = 7.0 Hz,
3H, (CH3)2CHC4), 0.95 (t, J = 7.5 Hz, 3H, H6′), 1.63−1.70 (m, 1H,
H2″), 1.78−1.86 (m, 1H, H2″), 2.02−2.08 (m, 2H, H5′), 2.25−2.34
(m, 1H, (CH3)2CHC4), 2.63−2.69 (m, 1H, H3″), 2.77−2.83 (m, 1H,
H3″), 3.21 (br s, 1H, OH), 3.91−3.95 (m, 1H, H1″), 4.16 (dd, J = 9.2,
3.2 Hz, 1H, H5), 4.23 (dd, J = 8.7, 8.7 Hz, 1H, H5), 4.43 (dt, J = 8.3,
3.4 Hz, 1H, H4), 4.52 (dd, J = 9.2, 3.4 Hz, 1H, H2′), 5.54 (ddt, J =
15.6, 9.2, 1.5 Hz, 1H, H3′), 5.88 (dt, J = 15.4, 6.5 Hz, 1H, H4′);
13C
NMR (125 MHz, CDCl3) δ 13.7 (q, C6′), 14.7 (q, (CH3)2CHC4),
18.0 (q, (CH3)2CHC4), 26.0 (t, C5′), 28.3 (d, (CH3)2CHC4), 32.0 (t,
C3″), 35.8 (t, C2″), 50.9 (d, C2′), 58.2 (d, C4), 63.2 (t, C5), 70.7 (d,
C1″), 121.5 (d, C3′), 125.9 (d, Ph), 128.5 (d, 2C, Ph), 128.7 (d, 2C,
Ph), 140.2 (d, C4′), 142.1 (s, Ph), 153.5 (s, C2), 175.4 (s, C1′); MS
(EI) m/z (relative intensity) 359 (M)+ (1), 316 (M − i-Pr)+ (1), 225
(M + 1 − Me − Ph − i-Pr)+ (47), 128 (oxazolidin-2-one)+ (128);
HRMS calcd for C21H29NO4 [(M)
+] 359.2097, found 359.2111.
(4R,5S)-3-{(2R,3S)-2-[(E)-But-1-en-1-yl]3-hydroxyheptanoyl}-4-
methyl-5-phenyloxazolidin-2-one (2m). N-Acyl oxazolidin-2-one 3i
(207 mg, 0.76 mmol) was subjected to the general procedure for the
synthesis of syn-aldols 2 and yielded, after purification by flash
chromatography (21 cm of height of silica gel, n-hexane/EtOAc
85:15), compound 2m (175 mg, 64%) as a thick colorless oil: Rf =
0.33 (n-hexane/EtOAc 80:20); [α]25D +75.3 (c 1.0, CHCl3);
1H
NMR (500 MHz, CDCl3) δ 0.84−0.88 (br m, 3H, CH3C4), 0.89−
0.94 (br m, 3H, H5″), 0.97−1.03 (br m, 3H, H6′), 1.29−1.39 (br m,
3H, 3 × C1″(CH2)3CH3), 1.42−1.55 (br m, 3H, 3 × C1″(CH2)3CH3),
2.03−2.13 (br m, 2H, H5′), 3.01 (br s, 1H, OH), 3.96 (br m, 1H,
H1″), 4.45−4.51 (br m, 1H, H2′), 4.77−4.85 (br m, 1H, H4), 5.53−
5.61 (br m, 1H, H3′), 5.65−5.69 (br m, 1H, H5), 5.82−5.89 (br m,
1H, H4′), 7.27−7.32 (m, 2H, Ph), 7.35−7.44 (m, 3H, Ph); 13C NMR
(125 MHz, CDCl3) δ 13.7 (q, C6′), 14.1 (q, C5″), 14.4 (q, CH3C4),
22.7 (t, C4″), 26.0 (t, C5′), 28.0 (t, C3″), 33.9 (t, C2″), 51.3 (d, C2′),
54.8 (d, C4), 72.0 (d, C1″), 78.9 (d, C5), 121.4 (d, C3′), 125.8 (d, 2C,
Ph), 128.9 (d, 2C, Ph), 129.0 (d, Ph), 133.4 (s, Ph), 139.6 (d, C4′),
152.7 (s, C2), 174.9 (s, C1′); HRMS calcd for C21H29NO4Na [(M +
Na)+] 382.1994, found 382.1995.
General Procedure for the Synthesis of Bicycles 5. With
aldols 2 as a starting point (two-step EAP), to a solution of the
homoallylic alcohol and the aldehyde R3CHO (1.5 equiv) in dry
DCM (0.1 M) was added, under an Ar atmosphere, BF3·OEt2 (2.5
equiv). Once TLC analysis showed full conversion (<30 min), the
reaction was quenched with H2O. The layers were separated, and the
aqueous layer was extracted three times with DCM. The combined
organic layers were dried over anhydrous MgSO4, filtered, and
concentrated.76 The crude was purified by flash chromatography (the
bicycle is usually slightly more apolar than the starting homoallylic
alcohol) to yield the desired product. With N-acyl oxazolidin-2-ones 3
as a starting point (one-pot EAP), a solution of the N-acyl oxazolidin-
2-one in dry DCM (1 M) was cooled to −78 °C. TEA (1.3 equiv)
and a 1 M solution of n-Bu2BOTf in DCM (1.2 equiv) were added
under an Ar atmosphere sequentially, and the mixture was stirred at
that temperature for 30 min. Then, it was warmed to 0 °C, and after
20 min, it was recooled to −78 °C, the aldehyde R2CHO (1 equiv)
was added, and the mixture was allowed to warm to rt. After 15 h, the
aldehyde R3CHO (1.5 equiv) and BF3·OEt2 (2.5 equiv) were
sequentially added under an Ar atmosphere. Once TLC analysis
revealed full conversion (<30 min), the reaction was quenched and
the mixture purified as described above. Traces of an UV−vis polar
byproduct, the 2-oxonia-Cope rearranged isomer 6, could be
punctually detected. Bicycles 5 are highly stable and can be stored
without an Ar atmosphere at rt without decomposition. Except for
products 5c-Ac, 5l, 5r, 5u, and 5ag−5ai, the rest of bicycles 5 were
described in our previous publication (see the Supporting Information




Aldol 2c (38.7 mg, 0.14 mmol) was subjectted to the general
procedure for the synthesis of bicycles 5 (two-step EAP) using acetic
acid (1.4 mL, 0.1M) as the solvent to yield, after purification by flash
chromatography (20 cm of height of silica gel, n-hexane/EtOAc
80:20), title compound 5c-Ac (41 mg, 71%, >95:5 dr) as an
amorphous white solid. Rf = 0.4 (n-hexane/EtOAc 60:40);
1H NMR
(600 MHz, CDCl3) δ 0.87−0.97 (m, 9H, H2″′, H4′, H4″), 1.26−1.79
(m, 14H, H8, 1 × H1′, 6 × CH2), 2.01 (s, 3H, OCOCH3), 2.28 (br s,
1H, H1′), 2.38 (dd, J = 11.1, 11.1 Hz, 1H, H4a), 3.10 (dd, J = 8.4, 8.4
Hz, 1H, H7), 3.41 (t, J = 8.7 Hz, 1H, H5), 3.92−4.00 (m, 1H,
NCH2CH2OCOCH3), 4.07−4.13 (m, 1H, NCH2CH2OCOCH3),
4.17 (t, J = 11.1 Hz, 1H, H8a), 4.27 (br s, 2H, NCH2CH2OCOCH3);
13C NMR (150 MHz, CDCl3) δ 9.5 (q, C2″′), 14.2 (q, C4′ or C4″),
14.2 (q, C4′ or C4″), 18.6 (t, C1″′), 20.91 (q, NCH2CH2OCOCH3),
22.6 (t, C3′ or C3″), 22.6 (t, C2′ or C2″), 27.6 (t, C2′ or C2″), 32.1 (t,
C1″), 34.0 (t, C1′), 41.5 (t, NCH2CH2OCOCH3), 45.2 (d, C8), 47.5
(d, C4a), 61.6 (t, NCH2CH2OCOCH3), 74.7 (d, C5), 76.7 (d, C8a),
76.9 (d, C7), 152.5 (s, C2), 169.5 (s, C4), 171.2 (s, OCOCH3);





2′,4′(3′H)-dione (5l). Aldol 2b (30 mg, 0.13 mmol) and cyclo-
hexanone (0.03 mL, 0.29 mmol, 2.2 equiv) were subjected to the
general procedure for the Prins cyclization and yielded, after
purification by flash chromatography (21 cm of height of silica gel,
n-hexane/EtOAc 75:25), THF 8l (7.8 mg, 19%, 80:20 dr), title
compound 5l (10 mg, 23%, >95:5 dr), and previously described
bicycle 5b (8 mg, 45%, >95:5 dr). 5l was isolated as a colorless oil,
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and its description is given here: Rf = 0.44 (n-hexane/EtOAc 60:40,
two times); 1H NMR (500 MHz, CDCl3) δ 1.11 (t, J = 7.3 Hz, 3H,
H2″′), 1.11−1.17 (m, 1H, CH2 from cyclohexane), 1.21−1.26 (m, 1H,
CH2 from cyclohexane), 1.31−1.39 (m, 1H, CH2 from cyclohexane),
1.41−1.50 (m, 6H, H8, 3 × CH2 from cyclohexane, 2 × H1″′), 1.52 (d,
J = 6.0 Hz, 3H, H1′), 1.65−1.70 (m, 2H, CH2 from cyclohexane),
1.71−1.77 (m, 2H, CH2 from cyclohexane), 1.97 (br s, 1H, OH), 2.34
(dd, J = 12.3, 9.9 Hz, 1H, H4a), 3.74 (dq, J = 9.8, 6.0 Hz, 1H, H5),
3.77−3.85 (br m, 2H, NCH2CH2OH), 3.89 (ddd, J = 14.1, 6.0, 4.2
Hz, 1H, NCH2CH2OH), 4.09 (ddd, J = 14.1, 6.0, 4.2 Hz, 1H,
NCH2CH2OH), 4.31 (dd, J = 12.1, 10.5 Hz, 1H, H8a);
13C NMR
(125 MHz, CDCl3) δ 15.2 (q, C2″′), 20.4 (t, CH2 from cyclohexane),
21.3 (t, CH2 from cyclohexane), 21.4 (q, C1′), 21.7 (t, C1″′), 25.7 (t,
CH2 from cyclohexane), 26.0 (t, CH2 from cyclohexane), 36.4 (t,
CH2 from cyclohexane), 44.4 (t, NCH2CH2OH), 50.0 (d, C4a), 51.6
(d, C8), 61.2 (t, NCH2CH2OH), 63.4 (d, C5), 76.8 (s, C7), 78.3 (d,
C8a), 152.7 (s, C2), 169.7 (s, C4); HRMS calcd for C17H27NO5Na
[(M + Na)+] 348.1787, found 348.1792.
(4aS*,5S*,7S*,8S*,8aS*)-8-Ethyl-3-(2-hydroxyethyl)-7-(2-me-
thoxyphenyl)-5-methyltetrahydro-2H,5H-pyrano[3,4-e][1,3]-
oxazine-2,4(3H)-dione (5r). Aldol 2b (54 mg, 0.24 mmol) was
subjected to the general procedure for the Prins cyclization and
yielded, after purification by flash chromatography (25 cm of height of
silica gel, n-hexane/EtOAc 70:30), THF 8r (16 mg, 20%, 80:20 dr),
title compound 5r (17 mg, 20%, >95:5 dr), and previously described
bicycle 5b (3 mg, 10%, >95:5 dr). 5r was isolated as a thick colorless
oil, and its description is given here: Rf = 0.28 (n-hexane/EtOAc
60:40, two times); 1H NMR (500 MHz, CDCl3) δ 0.73 (t, J = 7.7 Hz,
3H, H2″′), 1.28−1.34 (m, 1H, H1″′), 1.47−1.53 (m, 1H, H1″′), 1.58
(d, J = 6.1 Hz, 3H, H1′), 1.89−2.14 (m, 2H, H8, OH), 2.56 (dd, J =
12.1, 9.6 Hz, 1H, H4a), 3.77−3.86 (m, 3H, H5, NCH2CH2OH), 3.81
(s, 3H, MeO), 3.93 (ddd, J = 14.0, 6.8, 4.3 Hz, 1H, NCH2CH2OH),
4.13 (ddd, J = 14.0, 5.8, 4.3 Hz, 1H, NCH2CH2OH), 4.39 (dd, J =
11.6, 10.9 Hz, 1H, H8a), 4.79 (br s, 1H, H7), 6.88−6.89 (m, 1H, Ar),
6.99−7.02 (m, 1H, Ar), 7.27−7.30 (m, 1H, Ar), 7.37−7.41 (m, 1H,
Ar); 13C NMR (150 MHz, CDCl3) δ 10.3 (q, C2″′), 19.3 (t, C1″′),
21.1 (q, C1′), 44.5 (t, NCH2CH2OH), 47.1 (d, C8), 49.2 (d, C4a),
55.6 (q, MeO), 61.1 (t, NCH2CH2OH), 71.9 (d, C5), 72.7 (d, C7),
77.8 (d, C8a), 110.9 (d, C3″), 121.3 (d, C5″), 127.6 (s, C1″), 128.1 (d,
C6″), 129.5 (d, C4″), 152.4 (s, C2), 156.8 (s, C2″), 169.4 (s, C4);





2,4(3H)-dione (5u). Aldol 2h (72 mg, 0.20 mmol) and acetaldehyde
(0.09 mL of a 3.3 M solution in DCM, 0.30 mmol, 1.5 equiv) were
subjected to the general procedure for the synthesis of bicycles 5
(two-step EAP) and yielded, after purification by flash chromatog-
raphy (25 cm of height of silica gel, n-hexane/EtOAc 70:30),
compound 5u (36 mg, 43%, >95:5 dr) and previously described
bicycle 5b (3 mg, 6%, >95:5 dr). Alternatively, N-acyl oxazolidin-2-
one 3a (320 mg, 1.75 mmol) was subjected to the general procedure
for the synthesis of bicycles 5 (one-pot EAP) and yielded, after
purification by flash chromatography (25 cm of height of silica gel, n-
hexane/EtOAc 70:30), title compound 5u (155 mg, 22%, >95:5 dr)
and a small amount of 5b (19 mg, 5%, >95:5 dr). 5u was isolated as a
white solid, and its description is given here: Rf = 0.36 (n-hexane/
EtOAc 60:40, two times); mp 72−77 °C (from DCM/n-hexane); 1H
NMR (600 MHz, CDCl3) δ 0.98 (t, J = 7.5 Hz, 3H, H2″′), 1.31 (d, J =
6.2 Hz, 3H, H1″), 1.63−1.70 (m, 1H, H1″′), 1.73−1.84 (m, 2H, H8,
H1″′), 1.89 (br s, 1H, OH), 2.94 (dd, J = 11.9, 10.0 Hz, 1H, H4a), 3.50
(dq, J = 9.7, 6.1 Hz, 1H, H7), 3.67−3.77 (m, 2H, NCH2CH2OH),
3.78−3.83 (m, 1H, NCH2CH2OH), 3.94−4.00 (m, 1H,
NCH2CH2OH), 4.38 (dd, J = 11.2, 11.2 Hz, 1H, H8a), 4.47 (d, J =
10.0 Hz, 1H, H5), 7.30 (d, J = 8.4 Hz, 2H, 2 × H2′), 7.50 (d, J = 8.4
Hz, 2H, 2 × H3′); 13C NMR (150 MHz, CDCl3) δ 9.6 (q, C2″′), 18.9
(t, C1″′), 19.1 (q, C1″), 44.4 (t, NCH2CH2OH), 46.9 (d, C8), 48.3 (d,
C4a), 60.8 (t, NCH2CH2OH), 74.9 (d, C7), 76.4 (d, C8a), 76.8 (d,
C5), 122.7 (s, C4′), 129.7 (d, 2C, 2 × C2′), 131.6 (d, 2C, 2 × C3′),
138.5 (s, C1′), 152.0 (s, C2), 168.4 (s, C4); HRMS calcd for
C18H22
79BrNO5Na [(
79M + Na)+] 434.0579, found 434.0584.
(4aS,5S,7R,8R,8aS)-8-Ethyl-3-[(R)-1-hydroxy-3-phenylpropan-2-
yl]-5,7-dimethyltetrahydropyrano[3,4-e][1,3]oxazine-2,4(3H,7H)-
dione (5ag). Aldol 2i (26 mg, 83 μmol) and acetaldehyde (37 μL of a
3.3 M solution in DCM, 125 mmol, 1.5 equiv) were subjected to the
general procedure for the synthesis of bicycles 5 (two-step EAP) and
yielded, after purification by flash chromatography (18 cm of height of
silica gel, n-hexane/EtOAc 70:30), 3-(N-acyl-oxazolidin-2-one)-THP
21a (3 mg, 9%, >95:5 dr) and title bicycle 5ag (19 mg, 62%, >95:5
dr). 5ag: yellowish oil; Rf = 0.31 (n-hexane/EtOAc 60:40); [α]
25
D
−54.5 (c 1.0, CHCl3); 1H NMR (600 MHz, CDCl3) δ 0.80 (t, J = 7.5
Hz, 3H, H2″′), 1.19 (d, J = 6.2 Hz, 3H, H1″), 1.40−1.47 (m, 2H, H8,
H1″′), 1.44 (d, J = 6.0 Hz, 3H, H1′), 1.58−1.62 (m, 1H, H1″′), 2.14
(dd, J = 12.1, 9.2 Hz, 1H, H4a), 2.81 (br s, 1H, OH), 3.05 (dd, J =
13.8, 6.0 Hz, 1H, 1 × CH2Ph), 3.08 (br s, 1H, H7), 3.13 (br s, 1H,
H8a), 3.19 (dd, J = 14.0, 11.4 Hz, 1H, 1 × CH2Ph), 3.26 (br s, 1H,
H5), 3.91 (dd, J = 11.7, 3.5 Hz, 1H, CH2OH), 4.06−4.12 (br m, 1H,
CH2OH), 5.13−5.20 (br m, 1H, NCH(CH2Ph)CH2OH), 7.16−7.19
(m, 2H, Ph), 7.19−7.22 (m, 1H, Ph), 7.25−7.29 (m, 2H, Ph); 1H
NMR (600 MHz, C6D6, 320 K) δ 0.64 (t, J = 7.6 Hz, 3H, H2″′), 0.96
(d, J = 6.2 Hz, 3H, H1″), 1.09−1.19 (m, 2H, H8, H1″′), 1.31−1.41 (m,
1H, H1″′), 1.49 (d, J = 6.0 Hz, 3H, H1′), 1.65 (dd, J = 12.0, 9.6 Hz,
1H, H4a), 2.18 (br s, 1H, OH), 2.65 (dq, J = 9.8, 6.2 Hz, 1H, H7),
2.84 (dd, J = 13.9, 6.1 Hz, 1H, 1 × CH2Ph), 3.03−3.10 (m, 2H, H5,
H8a), 3.21 (dd, J = 14.0, 11.2 Hz, 1H, 1 × CH2Ph), 3.71 (dd, J = 11.4,
4.4 Hz, 1H, CH2OH), 4.06 (dd, J = 11.4, 7.4 Hz, 1H, CH2OH),
5.12−5.16 (br m, 1H, NCH(CH2Ph)CH2OH), 6.97−7.00 (m, 1H,
Ph), 7.06−7.09 (m, 1H, Ph), 7.11−7.13 (m, 2H, Ph); 13C NMR (150
MHz, CDCl3) δ 9.2 (q, C2″′), 18.7 (t, C1″′), 18.9 (q, C1″), 20.9 (q,
C1′), 33.3 (t, CH2Ph), 46.4 (d, C8), 48.8 (d, C4a), 55.5 (d,
NCH(CH2Ph)CH2OH),
77 63.5 (t, CH2OH), 71.0 (d, C5), 73.6 (d,
C7), 76.2 (d, C8a),
78 126.9 (d, Ph), 128.7 (d, 2C, Ph), 129.2 (d, 2C,
Ph), 137.5 (s, Ph), 151.9 (s, C2), 169.4 (s, C4);
13C NMR (150 MHz,
C6D6, 320 K) δ 9.7 (q, C2″′), 19.0 (q, C1″), 19.2 (t, C1″′), 21.0 (q,
C1′), 33.9 (t, CH2Ph), 46.9 (d, C8), 49.0 (d, C4a), 56.4 (d,
NCH(CH2Ph)CH2OH),
79 63.8 (t, CH2OH), 71.1 (d, C5), 73.6 (d,
C7), 76.4 (d, C8a), 126.8 (d, Ph), 128.7 (d, 2C, Ph), 129.6 (d, 2C,
Ph), 138.4 (s, Ph), 151.5 (s, C2), 169.5 (s, C4); MS (EI) m/z (relative
intensity) 361 (M)+ (1), 343 (M − H2O)+ (2), 228 (M + 2 −
CH(Bn)CH2OH)
+ (83), 185 (10), 184 (M − N(CO)CH(Bn)-
CH2OH)
+ (78), 91 (100); HRMS calcd for C20H27NO5 [(M)
+]
361.1889, found 361.1884; HRMS calcd for C20H27NO5Na [(M +
Na)+] 384.1787, found 384.1785.
(4aR,5R,7S,8S,8aR)-8-Ethyl-3-[(S)-1-hydroxy-3-methylbutan-2-
yl]-5,7-dimethyltetrahydro-2H,5H-pyrano[3,4-e][1,3]oxazine-
2,4(3H)-dione (5ah). Aldol 2k (58 mg, 0.22 mmol) and acetaldehyde
(0.1 mL of a 3.3 M solution in DCM, 0.33 mmol, 1.5 equiv) were
subjected to the general procedure for the synthesis of bicycles 5
(two-step EAP) and yielded, after purification by flash chromatog-
raphy (28 cm of height of silica gel, n-hexane/EtOAc 85:15), 3-(N-
acyl-oxazolidin-2-one)-THP 21b (11 mg, 16%, >95:5 dr) and title
bicycle 5ah (29 mg, 43%, 92:8 dr). 5ah: colorless oil; Rf = 0.33 (n-
hexane/EtOAc 60:40); [α]25D +104.4 (c 1.0, CHCl3);
1H NMR (500
MHz, CDCl3) δ 0.84 (d, J = 6.6 Hz, 3H, 1 × (CH3)2CH), 0.92 (t, J =
7.6 Hz, 3H, H2″′), 1.04 (d, J = 6.4 Hz, 3H, 1 × (CH3)2CH), 1.27 (d, J
= 6.1 Hz, 3H, H1″), 1.52 (d, J = 6.1 Hz, 3H, H1′), 1.55−1.63 (m, 2H,
H8, 1 × H1″′), 1.69−1.76 (m, 1H, H1″′), 2.36 (dd, J = 12.2, 9.8 Hz,
1H, H4a), 2.35−2.45 (m, 1H, (CH3)2CH), 2.89 (br s, 1H, OH), 3.31
(dq, J = 9.7, 6.2 Hz, 1H, H7), 3.61 (dq, J = 9.5, 6.0 Hz, 1H, H5), 3.79
(dd, J = 12.1, 2.7 Hz, 1H, 1 × CH2OH), 4.01−4.08 (m, 1H, 1 ×
CH2OH), 4.11 (dd, J = 12.1, 10.4 Hz, 1H, H8a), 4.34−4.40 (m, 1H,
NCH(CH2OH)CH(CH3)2);
13C NMR (125 MHz, CDCl3) δ 9.7 (q,
C2″′), 19.0 (t, C1″′), 19.1 (q, C1″), 20.0 (q, 1 × (CH3)2CH), 20.2 (q, 1
× (CH3)2CH), 21.0 (q, C1′), 25.4 (d, (CH3)2CH), 47.0 (d, C8), 49.3
(d, C4a), 62.3 (d, NCH(CH2OH)CH(CH3)2),
80 62.7 (t, CH2OH),
71.2 (d, C5), 73.9 (d, C7), 76.6 (d, C8a), 152.3 (s, C2), 169.8 (s, C4);
MS (EI) m/z (relative intensity) 314 (M + H)+ (2), 284 (M − Et)+
or (M − 2 Me)+ (11), 283 (M − Et − H)+ or (M + 1 − CH2OH)+
(66), 282 (M − CH2OH)+ (18),81 240 (M + 1 − Et − i-Pr)+ (2), 238
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(M − 1 − 5Me)+ (100), 228 (M + H − Et − Me − i-Pr)+ or (M + 2
− CH(i-Pr)CH2OH)+ (94),81 226 (M − CH(i-Pr)CH2OH)+ (2),
184 (M + 1 − Et − CH(i-Pr)CH2OH − Me)+ (92);
81 HRMS calcd
for C16H28NO5 [(M + H)
+] 314.1967, found 314.1974.
(4aR,5R,7S,8S,8aR)-8-Ethyl-3-[(S)-1-hydroxy-3-methylbutan-2-
yl]-7-methyl-5-phenethyltetrahydro-2H,5H-pyrano[3,4-e][1,3]-
oxazine-2,4(3H)-dione (5ai). Aldol 2l (43 mg, 0.12 mmol) and
acetaldehyde (0.05 mL of a 3.3 M solution in DCM, 0.18 mmol, 1.5
equiv) were subjected to the general procedure for the synthesis of
bicycles 5 (two-step EAP) and yielded, after purification by flash
chromatography (28 cm of height of silica gel, n-hexane/EtOAc
90:10), 3-(N-acyl-oxazolidin-2-one)-THP 21c (6 mg, 12%, >95:5 dr)
and title bicycle 5ai (22 mg, 45%, >95:5 dr). 5ai: colorless oil; Rf =
0.60 (n-hexane/EtOAc 70:30, three times); [α]25D +97.7 (c 0.9,
CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.82 (d, J = 6.7 Hz, 3H,
(CH3)2CH), 0.92 (t, J = 7.5 Hz, 3H, H2″′), 1.04 (d, J = 6.7 Hz, 3H,
(CH3)2CH), 1.32 (d, J = 6.1 Hz, 3H, H1″), 1.55−1.63 (m, 2H, H8,
H1″′), 1.68−1.76 (m, 1H, H1″′), 1.81−1.88 (m, 1H, H1′), 2.35−2.45
(m, (CH3)2CH), 2.43 (dd, J = 12.0, 9.8 Hz, 1H, H4a), 2.59−2.66 (m,
1H, H1′), 2.71−2.77 (m, 1H, H2′), 2.85−2.91 (m, 1H, H2′), 3.25 (dq,
J = 9.8, 6.3 Hz, 1H, H7), 3.47 (td, J = 9.5, 2.2 Hz, 1H, H5), 3.78 (dd, J
= 12.2, 2.8 Hz, 1H, CH2OH), 4.03 (dd, J = 12.2, 7.5 Hz, 1H,
CH2OH), 4.10 (dd, J = 11.9, 10.4 Hz, 1H, H8a), 4.32−4.38 (m, 1H,
NCH(i-Pr)CH2OH), 7.16−7.20 (m, 1H, Ph), 7.21−7.24 (m, 2H,
Ph), 7.26−7.30 (m, 2H, Ph); 13C NMR (125 MHz, CDCl3) δ 9.7 (q,
C2″′), 19.0 (t, C1″′), 19.1 (q, C1″), 20.0 (q, (CH3)2CH), 20.2 (q,
(CH3)2CH), 25.3 (d, (CH3)2CH), 31.5 (t, C2′), 35.7 (t, C1′), 47.1 (d,
C8), 47.6 (d, C4a),
82 62.7 (t, CH2OH), 73.7 (d, C5), 73.9 (d, C7), 76.7
(d, C8a), 125.9 (d, Ph), 128.5 (d, 2C, Ph), 128.8 (d, 2C, Ph), 141.9 (s,
Ph), 152.3 (s, C2), 169.8 (s, C4); MS (EI) m/z (relative intensity)
403 (M)+ (13), 385 (M − H2O)+ (2),83 283 (M − CH2OH)+ (1),
359 (M + H − i-Pr)+ (2), 316 (M − CH(i-Pr)CH2OH)+ (4), 298 (M
− CH2CH2Ph)+ (22), 256 (M + H − CH2CH2Ph − i-Pr)+ (18);83
HRMS calcd for C23H33NO5 [(M)
+] 403.2359, found 403.2385.
Synthesis of 2-Oxonia-Cope Rearranged Isomers 6. These
byproducts could be punctually detected during the synthesis of
bicycles 5. 6a and 6c were described in our previous publication,30
and 6b, 6x, and 6y were never isolated.
Synthesis of Halogenated 2,3,4,5,6-Pentasubstituted THPs
1 and 7. (4aS*,5S*,7R*,8R*,8aS*)-3-(2-Chloroethyl)-8-ethyl-5,7-
diisobutyltetrahydro-2H,5H-pyrano[3,4-e][1,3]oxazine-2,4(3H)-
dione (7a-Cl). To a suspension of bicycle 5a (86 mg, 0.24 mmol) in
H2O (2.4 mL, 0.1 M) was added a 37% HCl aqueous solution (2.4
mL, 29 mmol, 121 equiv), and the mixture was heated at 100 °C.
After 4 h, the mixture was allowed to cool to rt, saturated with NaCl,
and extracted with EtOAc (5 × 5 mL). The combined organic layers
were dried over MgSO4, filtered, concentrated, and purified by flash
chromatography (21 cm of height of silica gel, n-hexane/EtOAc 93:7)
to yield title compound 7a-Cl (51 mg, 57%) as a colorless oil: Rf =
0.31 (n-hexane/EtOAc 90:10); 1H NMR (500 MHz, CDCl3) δ 0.85−
0.94 (m, 15H, 2 × (CH3)2CHCH2, H2″′), 1.30−1.36 (m, 1H,
(CH3)2CHCH2), 1.41−1.52 (m, 1H, (CH3)2CHCH2), 1.53−1.67
(m, 2H, H8, H1″′), 1.68−1.78 (m, 1H, H1″′), 1.85−1.97 (m, 2H, 2 ×
(CH3)2CHCH2), 2.07−2.13 (m, 1H, (CH3)2CHCH2), 2.38 (dd, J =
12.0, 9.6 Hz, 1H, H4a), 3.19 (td, J = 10.3, 2.1 Hz, 1H, H7), 3.53 (td, J
= 10.1, 1.9 Hz, 1H, H5), 3.69 (t, J = 6.3 Hz, NCH2CH2Cl), 4.01−4.07
(m, 1H, NCH2CH2Cl), 4.13−4.18 (m, 1H, NCH2CH2Cl), 4.21 (dd, J
= 11.7, 10.4 Hz, 1H, H8a);
1H NMR (500 MHz, C6D6) δ 0.69 (t, J =
7.5 Hz, 3H, H2″′), 0.81 (d, J = 6.6 Hz, 3H, (CH3)2CHCH2), 0.87 (d, J
= 6.8 Hz, 3H, (CH3)2CHCH2), 0.98 (d, J = 6.7 Hz, 3H,
(CH3)2CHCH2), 1.00 (d, J = 6.6 Hz, 3H, (CH3)2CHCH2), 1.09
(ddd, J = 13.5, 10.5, 2.3 Hz, 1H, H1″), 1.20−1.35 (m, 3H, H8, H1″,
H1″′), 1.36−1.54 (m, 2H, H1′, H1″′), 1.70 (dd, J = 12.0, 9.6 Hz, 1H,
H4a), 1.89−1.99 (m, 1H, H2″), 2.00−2.09 (m, 1H, H2′), 2.22 (ddd, J =
13.6, 10.4, 1.9 Hz, 1H, H1′), 2.72 (td, J = 10.5, 1.5 Hz, 1H, H7), 3.20
(td, J = 9.8, 1.9 Hz, 1H, H5), 3.37−3.48 (m, 2H, NCH2CH2Cl), 3.64
(dd, J = 11.9, 10.4 Hz, 1H, H8a), 3.81 (dt, J = 13.9, 6.1 Hz, 1H,
NCH2CH2Cl), 3.97 (dt, J = 13.9, 6.7 Hz, 1H, NCH2CH2Cl);
13C
NMR (125 MHz, CDCl3) δ 9.3 (q, C2″′), 18.5 (t, C1″′), 21.0 (q,
(CH3)2CHCH2) , 21 .1 (q , (CH3)2CHCH2) , 23 .9 (q ,
(CH3)2CHCH2) , 24 .0 (q , (CH3)2CHCH2) , 24 .1 (d ,
(CH3)2CHCH2), 24.3 (d, (CH3)2CHCH2), 40.7 (t, NCH2CH2Cl),
41.5 (t, (CH3)2CHCH2), 42.9 (t, NCH2CH2Cl), 43.4 (t,
(CH3)2CHCH2), 45.6 (d, C8), 48.1 (d, C4a), 72.8 (d, C5), 75.1 (d,
C7), 76.8 (d, C8a), 151.4 (s, C2), 168.7 (s, C4);
13C NMR (125 MHz,
C6D6) δ 10.0 (q, C2″′), 19.1 (t, C1″′), 21.3 (q, (CH3)2CHCH2), 21.6
(q, (CH3)2CHCH2), 24.0 (q, 2C, 2 × (CH3)2CHCH2), 24.4 (d, C2″),
24.9 (d, C2′), 41.0 (t, NCH2CH2Cl), 42.0 (t, C1″), 42.9 (t,
NCH2CH2Cl), 43.9 (t, C1′), 46.1 (d, C8), 47.9 (d, C4a), 72.9 (d,
C5), 75.3 (d, C7), 76.9 (d, C8a), 150.8 (s, C2), 168.6 (s, C4); MS (EI)
m/z (relative intensity) 375 (37Cl − M)+ (1), 373 (35Cl − M)+ (3),
316 (M − i-Bu)+ (100), 287 (M − i-Bu − Et)+ (9), 259 (M − 2 i-
Bu)+ (17); HRMS calcd for C19H32NO4Cl [(M)
+] 373.2020, found
373.2014; HRMS calcd for C19H32NO4Na




a suspension of bicycle 5a (1.55 g, 4.3 mmol) in H2O (4.3 mL, 0.1 M)
was added a 48% HBr aqueous solution (58.5 mL, 520 mmol, 121
equiv), and the mixture was heated at 100 °C. After 24 h, the mixture
was allowed to cool to rt, saturated with NaCl, and extracted with
DCM (3 × 15 mL). The combined organic layers were dried over
MgSO4, filtered, concentrated, and purified by flash chromatography
(6 cm of height of silica gel, n-hexane/EtOAc 60:40) to yield title
compound 7a-Br (1.45 g, 81%) as a thick brown oil: Rf = 0.3 (n-
hexane/EtOAc 60:40); 1H NMR (500 MHz, CDCl3) δ 0.84−0.88
(m, 3H, H2″′), 0.90−0.97 (m, 12H, 4 × (CH3)2CH), 1.30−1.37 (m,
1H, H1″), 1.40−1.50 (m, 2H, H1′, H1″), 1.52−1.65 (m, 2H, H8, H1″′),
1.70−1.76 (m, 1H, H1″′), 1.85−1.96 (m, 2H, H2′, H2″), 2.06−2.14
(m, 1H, H1′), 2.34−2.40 (m, 1H, H4a), 3.16−3.23 (m, 1H, H7), 3.49−
3.56 (m, 3H, H5, NCH2CH2Br), 4.05−4.14 (m, 1H, NCH2CH2Br),
4.15−4.26 (m, 2H, H8a, NCH2CH2Br); 13C NMR (125 MHz,
CDCl3) δ 9.3 (q, C2″′), 18.5 (t, C1″′), 21.0 (q, (CH3)2CHCH2), 21.2
(q, (CH3)2CHCH2), 23.9 (q, (CH3)2CHCH2), 24.0 (q,
(CH3)2CHCH2) , 24 .1 (d , (CH3)2CHCH2) , 24 .4 (d ,
(CH3)2CHCH2), 28.3 (t, NCH2CH2Br), 41.6 (t, (CH3)2CHCH2),
42.8 (t, NCH2CH2Br), 43.4 (t, (CH3)2CHCH2), 45.6 (d, C8), 48.1
(d, C4a), 72.9 (d, C5), 75.2 (d, C8a), 76.8 (d, C7), 151.3 (s, C2), 168.6





(7b-Cl). To a solution of aldol 2b (37 mg, 0.16 mmol) in DCM (1.6
mL, 0.1 M) were sequentially added acetaldehyde (73 μL of a 3.3 M
solution in DCM, 0.24 mmol, 1.5 equiv), TMSCl (0.05 mL, 0.40
mmol, 2.5 equiv), and BF3·OEt2 (0.01 mL, 0.08 mmol, 0.5 equiv;
smaller amounts led to longer reaction times and worse yields of the
bicycle). After 2 h, the reaction was quenched by adding H2O (2 mL),
the layers were separated, and the aqueous layer was extracted with
DCM (3 × 2 mL). The combined organic layers were dried over
MgSO4, filtered, concentrated, and purified by flash chromatography
(16 cm of height of silica gel, n-hexane/EtOAc 70:30) to yield title
compound 7b-Cl (31 mg, 67%, >95:5 dr) and rearranged byproduct
6b (2 mg, 6%). 7b-Cl was isolated as a white solid, and its description
is given here: Rf = 0.60 (n-hexane/EtOAc 60:40); mp 53−57 °C
(from DCM/n-hexane); 1H NMR (500 MHz, CDCl3) δ 0.93 (t, J =
7.5 Hz, 3H, H2″′), 1.28 (d, J = 6.1 Hz, 3H, H1″), 1.55 (d, J = 6.0 Hz,
3H, H1′), 1.57−1.64 (m, 2H, H8, H1″′), 1.70−1.77 (m, 1H, H1″′), 2.38
(dd, J = 12.1, 9.6 Hz, 1H, H4a), 3.33 (dq, J = 9.8, 6.1 Hz, 1H, H7),
3.62 (dq, J = 9.6, 6.0 Hz, 1H, H5), 3.71 (t, J = 6.4 Hz, 2H,
NCH2CH2Cl), 4.08 (dt, J = 13.8, 6.3 Hz, 1H, NCH2CH2Cl), 4.17
(dt, J = 13.9, 6.6 Hz, 1H, NCH2CH2Cl), 4.19 (dd, J = 12.2, 10.3 Hz,
1H, H8a);
13C NMR (125 MHz, CDCl3) δ 9.6 (q, C2″′), 18.9 (t, C1″′),
19.1 (q, C1″), 21.0 (q, C1′), 40.7 (t, NCH2CH2Cl), 42.9 (t,
NCH2CH2Cl), 46.9 (d, C8), 49.1 (d, C4a), 71.1 (d, C5), 73.9 (d,
C7), 76.5 (d, C8a), 151.4 (s, C4), 168.5 (s, C2); MS (EI) m/z (relative
intensity) 289 (M)+ (4), 274 (M − Me)+ (16), 246 (M − Et − Me)+
(3), 230 (M − 1 − Et − 2Me)+ (4); HRMS calcd for
C13H20NO4Na
35Cl [(M + Na)+] 312.0979, found 312.0970; HRMS
calcd for C13H20NO4
35Cl [(M)+] 289.1081, found 289.1089.
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a solution of aldol 2b (50 mg, 0.22 mmol) and acetaldehyde (0.1 mL
of a 3.3 M solution in DCM, 0.33 mmol, 1.5 equiv) in DCM (2.2 mL,
0.1 M) was added TMSBr (0.08 mL, 0.55 mmol, 2.5 equiv). After 3 h,
the reaction was stopped by the addition of H2O (3 mL) and the
aqueous layer was extracted with DCM (3 × 3 mL). The combined
organic layers were dried over MgSO4, filtered, and concentrated.
1H
NMR analysis of the crude revealed a 1.5:1 mixture of isomers 7b-Br
and 1b-Br. Purification by flash chromatography (16 cm of height of
silica gel, n-hexane/EtOAc 90:10) allowed their separation, yielding
bicycle 7b-Br (34 mg, 46%, >95:5 dr) and 3-(N-acyl-oxazolidin-2-
one)-THP 1b-Br (22 mg, 30%, >95:5 dr). 7b-Br: yellowish oil; Rf =
0.53 (n-hexane/EtOAc 80:20); 1H NMR (500 MHz, CDCl3) δ 0.92
(t, J = 7.5 Hz, 3H, H2″′), 1.27 (d, J = 6.2 Hz, 3H, H1″), 1.54 (d, J = 6.0
Hz, 3H, H1′), 1.56−1.63 (m, 2H, H8, H1″′), 1.69−1.77 (m, 1H, H1″′),
2.36 (dd, J = 12.1, 9.8 Hz, 1H, H4a), 3.32 (dq, J = 9.8, 6.1 Hz, 1H,
H7), 3.54 (t, J = 6.7 Hz, 2H, NCH2CH2Br), 3.62 (dq, J = 9.7, 6.1 Hz,
1H, H5), 4.09−4.14 (m, 1H, NCH2CH2Br), 4.17−4.23 (m, 2H, H8a, 1
× NCH2CH2Br);
13C NMR (150 MHz, CDCl3) δ 9.5 (q, C2″′), 18.9
(t, C1″′), 19.1 (q, C1″), 20.9 (q, C1′), 28.3 (t, NCH2CH2Br), 42.7 (t,
NCH2CH2Br), 46.8 (d, C8), 49.1 (d, C4a), 71.0 (d, C5), 73.9 (d, C7),
76.5 (d, C8a), 151.2 (s, C2), 168.4 (s, C4); MS (EI) m/z (relative
intensity) 335 (81M)+ (4), 333 (79M)+ (3), 319 (81M − Me)+ (13),
317 (79M − Me)+ (13), 69 (100); HRMS calcd for C13H2081BrNO4
[(81M)+] 335.0555, found 335.0544. 1b-Br: thick colorless oil; Rf =
0.25 (n-hexane/EtOAc 80:20), 0.58 (n-hexane/EtOAc 60:40); 1H
NMR (500 MHz, CDCl3) δ 0.87 (t, J = 7.6 Hz, 3H, C5′CH2CH3),
1.21 (d, J = 6.1 Hz, 3H, C2′CH3), 1.28 (d, J = 6.1 Hz, 3H, C6′CH3),
1.59−1.66 (m, 1H, C5′CH2CH3), 1.68−1.73 (m, 1H, H5′), 1.76−1.84
(m, 1H, C5′CH2CH3), 3.47 (dq, J = 9.7, 6.2 Hz, 1H, H6′), 3.60 (dq, J
= 9.4, 6.2 Hz, 1H, H2′), 4.04 (dt, J = 11.1, 8.3 Hz, 1H, H4), 4.12 (dt, J
= 11.1, 7.9 Hz, 1H, H4), 4.38 (dd, J = 11.1, 11.1 Hz, 1H, H4′), 4.43 (t,
J = 8.2 Hz, 2H, H5), 4.63 (dd, J = 10.2, 10.2 Hz, 1H, H3′);
13C NMR
(125 MHz, CDCl3) δ 8.8 (q, C5′CH2CH3), 21.9 (t, C5′CH2CH3),
19.6 (q, C2′CH3), 20.0 (q, C6′CH3), 42.9 (t, C4), 49.7 (d, C5′), 55.7
(d, C3′), 56.1 (d, C4′), 61.9 (t, C5), 76.1 (d, C2′), 76.2 (d, C6′), 153.1
(s, C2), 172.5 (s, C3′C(O)N); MS (EI) m/z (relative intensity) 254
(M − Br)+ (26), 210 (M − 1 − Br − Et − Me)+ (100), 168 (M − Br
− oxazolidin-2-one)+ (3), 140 (M − Br − N-acyl oxazolidin-2-one)+
(1); HRMS calcd for C13H20
79BrNO4Na [(





dro-2H-pyran-3-carbonyl)oxazolidin-2-one (1b-I). To a solution of
aldol 2b (50 mg, 0.22 mmol) and acetaldehyde (0.1 mL of a 3.3 M
solution in DCM, 0.33 mmol, 1.5 equiv) in DCM (2.2 mL, 0.1 M)
was added TMSI (0.08 mL, 0.55 mmol, 2.5 equiv). TLC analysis
showed that the reaction was completed at 12 min, and H2O (3 mL)
was added. The aqueous layer was extracted with DCM (3 × 3 mL),
and the combined organic layers were dried over MgSO4, filtered, and
concentrated. 1H NMR analysis of the crude revealed a 3.4:1 mixture
of isomers 7b-I and 1b-I. Purification by flash chromatography (16
cm of height of silica gel, n-hexane/EtOAc 90:10) allowed their
separation, yielding bicycle 7b-I (50 mg, 58%, >95:5 dr) and 3-(N-
acyl oxazolidin-2-one)-THP 1b-I (14 mg, 17%, >95:5 dr). 7b-I:
yellow oil; Rf = 0.22 (n-hexane/EtOAc 90:10), 0.63 (n-hexane/EtOAc
60:40); 1H NMR (600 MHz, CDCl3) δ 0.94 (t, J = 7.5 Hz, 3H, H2″′),
1.27 (d, J = 6.2 Hz, 3H, H1″), 1.54 (d, J = 6.0 Hz, 3H, H1′), 1.56−1.65
(m, 2H, H8, H1″′), 1.69−1.76 (m, 1H, H1″′), 2.34 (dd, J = 12.1, 9.6
Hz, 1H, H4a), 3.29−3.37 (m, 3H, H7, 2 × NCH2CH2I), 3.61 (dq, J =
9.7, 6.0 Hz, 1H, H5), 4.03−4.08 (m, 1H, NCH2CH2I), 4.11−4.16 (m,
1H, NCH2CH2I), 4.20 (dd, J = 11.8, 10.7 Hz, 1H, H8a);
13C NMR
(150 MHz, CDCl3) δ 0.3 (t, NCH2CH2I), 9.7 (q, C2″′), 19.11 (t,
C1″′), 19.13 (q, C1″), 21.0 (q, C1′), 43.5 (t, NCH2CH2I), 47.1 (d, C8),
49.4 (d, C4a), 71.2 (d, C5), 74.1 (d, C7), 76.8 (d, C8a), 151.1 (s, C2),
168.3 (s, C4); MS (EI) m/z (relative intensity) 267 (3), 254 (M − I)+
(5), 228 (M + 2 − CH2CH2I)+ (1), 210 (M − CH2CH2I − Me)+ or
(M − Et − I − Me)+ (56), 184 (M − CH2CH2I − Et − Me)+ (1),
140, 91 (100); HRMS calcd for C13H20NO4 [(M − I)+] 254.1392,
found 254.1384. 1b-I: yellow oil; Rf = 0.07 (n-hexane/EtOAc 90:10),
0.44 (n-hexane/EtOAc 60:40); 1H NMR (500 MHz, CDCl3) δ 0.83
(t, J = 7.5 Hz, 3H, C5′CH2CH3), 1.20 (d, J = 6.2 Hz, 3H, C2′CH3),
1.28 (d, J = 6.2 Hz, 3H, C6′CH3), 1.62−1.68 (m, 1H, 1 ×
C5′CH2CH3), 1.70−1.79 (m, 2H, H5′, 1 × C5′CH2CH3), 3.49 (dq, J =
9.4, 6.1 Hz, 1H, H6′), 3.58 (dq, J = 9.4, 6.1 Hz, 1H, H2′), 4.01−4.07
(m, 1H, H4), 4.09−4.14 (m, 1H, H4), 4.40−4.47 (m, 3H, 2 × H5,
H4′), 4.77 (dd, J = 11.0, 10.1 Hz, 1H, H3′);
13C NMR (150 MHz,
CDCl3) δ 8.5 (q, C5′CH2CH3), 19.7 (q, C2′CH3), 20.3 (q, C6′CH3),
24.8 (t, C5′CH2CH3), 36.6 (d, C4′), 42.9 (t, C4), 50.0 (d, C5′), 57.0
(d, C3′), 61.9 (t, C5), 76.1 (d, C6′), 77.0 (d, C2′), 153.0 (s, C2), 173.2
(s, C3′CO); MS (EI) m/z (relative intensity) 295 (M − oxazolidin-2-
one)+ (1), 267 (M − N-acyl oxazolidin-2-one)+ (1), 254 (M − I)+
(33), 210 (M − CH2CH2I − Me)+ or (M − Et − I − Me)+ (100),
168 (M − I − oxazolidin-2-one)+ (2), 140 (M − I − N-acyl
oxazolidin-2-one)+ (1); HRMS calcd for C13H20NO4 [(M − I)+]
254.1392, found 254.1389.
Synthesis of 2,3,4,5-Tetrasubstituted THFs 8. These by-
products were punctually obtained during the synthesis of
corresponding bicycles 5.
3-{(2S*,3R*,4R*)-2-Methyl-4-[(E)-prop-1-en-1-yl]-1-oxaspiro-
[4.5]decane-3-carbonyl}oxazolidin-2-one (8l). For the detailed
synthetic procedure, see the synthesis of bicycle 5l. THF 8l (7.8
mg, 19%, 80:20 dr) was isolated as a white solid (probably
crystalline): Rf = 0.43 (n-hexane/EtOAc 80:20, four times);
1H
NMR (600 MHz, CDCl3) δ 1.09−1.14 (m, 1H, CH2 from
cyclohexane), 1.23−1.26 (m, 1H, CH2 from cyclohexane), 1.28 (d,
J = 6.1 Hz, 3H, C2′Me), 1.39−1.45 (m, 1H, CH2 from cyclohexane),
1.50−1.55 (m, 2H, CH2 from cyclohexane), 1.56−1.62 (m, 5H, CH2
from cyclohexane), 1.62 (dd, J = 6.0, 1.0 Hz, 3H, C4′CHCHMe),
2.79 (dd, J = 11.1, 8.9 Hz, 1H, H4′), 4.02 (t, J = 8.0 Hz, 2H, H4), 4.20
(dq, J = 9.3, 6.1 Hz, 1H, H2′), 4.33−4.41 (m, 3H, 2 × H5, H3′), 5.36−
5.48 (m, 2H, C4′CHCHMe); 13C NMR (150 MHz, CDCl3) δ 18.2
(q, C4′CHCHMe), 21.0 (q, C2′Me), 21.8 (t, CH2 from cyclo-
hexane), 23.3 (t, CH2 from cyclohexane), 25.8 (t, CH2 from
cyclohexane), 34.5 (t, CH2 from cyclohexane), 36.7 (t, CH2 from
cyclohexane), 43.1 (t, C4), 53.7 (d, C3′), 60.9 (d, C4′), 61.8 (t, C5),
77.1 (d, C2′), 84.2 (s, C5′), 128.1 (d, CH), 128.4 (d, CH), 153.4
(s, NC(O)O), 173.6 (s, C3′C(O)N); HRMS calcd for C17H25NO4Na
[(M + Na)+] 330.1681, found 330.1671.
3-{(2S*,3R*,4R*,5R*)-2-Methyl-5-phenyl-4-[(E)-prop-1-en-1-yl]-
tetrahydrofuran-3-carbonyl}oxazolidin-2-one (8m). Aldol 2b (110
mg, 0.48 mmol) was subjected to the general procedure for the
synthesis of bicycles 5 (two-step EAP) and yielded, after purification
by flash chromatography (28 cm of height of silica gel, n-hexane/
EtOAc 60:40), title compound 8m (6 mg, 4%, 80:20 dr) and bicycle
5i (117 mg, 72%, >95:5 dr). THF 8m was isolated as a thick colorless
oil, and its description is given here. Rf = 0.42 (n-hexane/EtOAc
60:40); 1H NMR (500 MHz, CDCl3) δ 1.42 (dd, J = 6.5, 1.6 Hz, 3H,
C4′CHCHCH3), 1.49 (d, J = 5.7 Hz, 3H, C2′CH3), 3.46−3.50 (m,
1H, H4′), 4.02−4.07 (m, 2H, H4), 4.27−4.33 (m, 1H, H3′), 4.36−4.47
(m, 3H, H5, H2′), 4.77−4.87 (m, 1H, C4′CHCHCH3), 5.21 (d, J =
8.3 Hz, 1H, H5′), 5.29−5.37 (m, 1H, C4′CHCHCH3), 7.20−7.25
(m, 3H, Ar), 7.29−7.33 (m, 2H, Ar); 13C NMR (150 MHz, CDCl3) δ
17.8 (q, C4′CHCHCH3), 19.7 (q, C2′CH3), 43.1 (t, C4), 53.8 (d,
C4′), 54.8 (d, C3′), 61.9 (t, C5), 79.2 (d, C2′), 83.8 (d, C5′), 127.0 (d,
2C, Ar), 127.3 (d, Ar), 127.7 (d, C4′CHCHCH3), 128.1 (d, 2C,
Ar), 129.0 (d, C4′CHCHCH3), 139.7 (s, Ar), 153.3 (s, C2), 173.5




1-yl]tetrahydrofuran-3-carbonyl}oxazolidin-2-one (8n). Aldol 2b
(56 mg, 0.25 mmol) was subjected to the general procedure for the
synthesis of bicycles 5 (two-step EAP) and yielded, after purification
by flash chromatography (28 cm of height of silica gel, n-hexane/
EtOAc 70:30), title compound 8n (7 mg, 8%, 85:15 dr) and bicycle
5n (56 mg, 64%, >95:5 dr). THF 8n was isolated as a thick colorless
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oil, and its description is given here: Rf = 0.19 and 0.29 (n-hexane/
EtOAc 60:40); 1H NMR (500 MHz, CDCl3) δ 1.44 (dd, J = 6.5, 1.7
Hz, 3H, C4′CHCHCH3), 1.49 (d, J = 5.9 Hz, 3H, C2′CH3), 3.44−
3.50 (m, 1H, H4′), 4.05 (t, J = 8.0 Hz, 2H, H4), 4.21−4.48 (m, 4H, 2
× H5, H2′, H3′), 4.78−4.86 (m, 1H, C4′CHCHCH3), 5.19 (d, J =
8.0 Hz, 1H, H5′), 5.30−5.38 (m, 1H, C4′CHCHCH3), 6.90−7.03
(m, 4H, Ar), 7.10−7.15 (m, 1H, Ar) (once the 1H NMR spectrum
was recorded, the solvent was evaporated and the product was stored
at −18 °C under an Ar atmosphere; twelve months later, the NMR
analysis showed that the product had suffered decomposition; thus, a
well-resolved 13C NMR spectrum could not be obtained); HRMS
calcd for C18H20NO4FNa [(M + Na)
+] 356.1274, found 356.1281.
3-{(2S*,3R*,4R*,5S*)-5-(2-Chlorophenyl)-2-methyl-4-[(E)-prop-
1-en-1-yl]tetrahydrofuran-3-carbonyl}oxazolidin-2-one (8o). Aldol
2b (102 mg, 0.45 mmol) was subjected to the general procedure for
the synthesis of bicycles 5 (two-step EAP) and yielded, after
purification by flash chromatography (21 cm of height of silica gel, n-
hexane/EtOAc 70:30), title compound 8o (25 mg, 16%, 80:20 dr),
bicycle 5o (100 mg, 60%, >95:5 dr), and bicycle 5b (1 mg, 1%, >95:5
dr). THF 8o was isolated as a thick yellowish oil, and its description is
given here: Rf = 0.37 (n-hexane/EtOAc 60:40);
1H NMR (500 MHz,
CDCl3) δ 1.37 (dd, J = 6.5, 1.6 Hz, 3H, C4′CHCHCH3), 1.50 (d, J
= 6.0 Hz, 3H, C2′CH3), 3.62 (dt, J = 9.7, 7.3 Hz, 1H, H4′), 4.07 (t, J =
7.9 Hz, 2H, H4), 4.24 (dd, J = 7.9, 6.6 Hz, 1H, H3′), 4.30 (dq, J = 8.1,
6.0 Hz, 1H, H2′), 4.37−4.44 (m, 2H, H5), 4.87 (ddq, J = 15.1, 9.8, 1.6
Hz, 1H, C4′CHCHCH3), 5.34 (dq, J = 14.9, 6.3 Hz, 1H, C4′CH
CHCH3), 5.51 (d, J = 7.6 Hz, 1H, H5′), 7.15−7.19 (m, 1H, Ar),
7.25−7.29 (m, 2H, Ar), 7.54−57 (m, 2H); 1H NMR (500 MHz,
C6D6) δ 1.26 (dd, J = 6.5, 1.6 Hz, 3H, C4′CHCHCH3), 1.61 (d, J =
6.1 Hz, 3H, C2′CH3), 2.90−3.00 (m, 4H, 2 × H4, 2 × H5), 3.99 (ddd,
J = 9.6, 6.9, 6.9 Hz, 1H, H4′), 4.44 (dd, J = 7.7, 6.1 Hz, 1H, H2′), 4.62
(dd, J = 7.7, 6.4 Hz, 1H, H3′), 5.18 (ddd, J = 15.2, 10.0, 1.6 Hz, 1H,
C4′CHCHCH3), 5.49 (dq, J = 15.2, 6.5 Hz, 1H, C4′CH
CHCH3), 5.81 (d, J = 7.6 Hz, 1H, H5′), 6.79 (td, J = 7.7, 1.6 Hz, 1H,
Ar), 6.99 (td, J = 7.6, 1.0 Hz, 1H, Ar), 7.12 (dd, J = 7.9, 1.1 Hz, 1H,
Ar), 7.81 (dd, J = 7.8, 1.4 Hz, 1H, Ar); 13C NMR (125 MHz, CDCl3)
δ 17.7 (q, C4′CHCHCH3), 19.8 (q, C2′CH3), 43.1 (t, C4), 52.8 (d,
C4′), 54.8 (d, C3′), 61.9 (t, C5), 79.0 (d, C2′), 80.8 (d, C5′), 126.6 (d,
Ar), 127.6 (d, C4′CHCHCH3), 127.9 (d, Ar), 128.3 (d, Ar), 128.6
(d, C4′CHCHCH3), 129.0 (d, Ar), 131.8 (s, Ar), 137.3 (s, Ar),
153.3 (s, C2), 173.6 (s, C3′C(O)N); MS (EI) m/z (relative intensity)
350 (M + 1)+ (1), 349 (M)+ (1), 308 (M − CH3CHCH)+ (1), 262
(M − 1-oxazolidin-2-one)+ (2), 235 (M − N-acyl oxazolidin-2-one)+
(1), 193 (M − 1 − CH3CHCH − N-acyl oxazolidin-2-one)+ (24),
122 (M − 2 − Ar − N-acyl oxazolidin-2-one)+ (100); HRMS calcd
for C18H20NO4Cl [(M)
+] 349.1081, found 349.1097.
3-{(2S,3R,4R,5S)-5-(4-Methoxyphenyl)-2-methyl-4-[(E)-prop-1-
en-1-yl]tetrahydrofuran-3-carbonyl}oxazolidin-2-one (8q). Aldol
2b (119 mg, 0.53 mmol) was subjected to the general procedure
for the synthesis of bicycles 5 (two-step EAP) and yielded, after
purification by flash chromatography (28 cm of height of silica gel, n-
hexane/EtOAc 60:40), title compound 8q (18 mg, 10%, 80:20 dr),
bicycle 5q (119 mg, 63%, >95:5 dr), and bicycle 5b (8 mg, 12%,
>95:5 dr). THF 8q was isolated as a thick yellowish oil, and its
description is given here: Rf = 0.51 (n-hexane/EtOAc 60:40, two
times); 1H NMR (500 MHz, CDCl3) δ 1.40 (d, J = 6.2 Hz, 3H,
C4′CHCHCH3), 1.59 (d, J = 6.3 Hz, 3H, C2′CH3), 3.15−3.20 (m,
1H, H4′), 3.80 (s, 3H, MeO), 4.05 (t, J = 8.0 Hz, 2H, H4), 4.10−4.14
(m, 1H, H2′), 4.39−4.47 (m, 3H, H5, H3′), 4.72 (d, J = 9.4 Hz, 1H,
H5′), 5.28−5.34 (m, 1H, C4′CHCHMe), 5.40−5.45 (m, 1H,
C4′CHCHMe), 6.86 (d, J = 8.8 Hz, 2H, Ar), 7.28 (d, J = 8.8 Hz,
2H, Ar); 13C NMR (125 MHz, CDCl3) δ 18.1 (q, C4′CHCHCH3),
20.6 (q, C2′CH3), 43.1 (t, C4), 55.4 (q, MeO), 55.6 (d, C3′), 58.6 (d,
C4′), 62.0 (t, C5), 80.9 (d, C2′), 85.2 (d, C5′), 113.8 (d, 2C, Ar),
127.87 (d, 2C, Ar), 127.93 (d, C4′CHCHMe), 129.1 (d, C4′CH
CHMe), 131.2 (s, Ar), 153.4 (s, C2), 159.3 (s, Ar), 172.9 (s,





For the detailed synthetic procedure, see the synthesis of bicycle 5r.
THF 8r (3 mg, 10%, >95:5 dr) was isolated as a thick colorless oil,
and its description is given here: Rf = 0.41 (n-hexane/EtOAc 60:40,
two times); 1H NMR (500 MHz, CDCl3) δ 1.37 (dd, J = 6.5, 1.7 Hz,
3H, C4′CHCHMe), 1.48 (d, J = 5.8 Hz, 3H, C2′Me), 3.49−3.54
(m, 1H, H4′), 3.75 (s, 3H, MeO), 4.03−4.07 (m, 2H, H4), 4.22−4.29
(m, 1H, H3′), 4.34−4.43 (m, 3H, H5, H2′), 4.89 (ddq, J = 15.1, 9.6,
1.8 Hz, 1H, C4′CHCHMe), 5.21−5.31 (m, 1H, C4′CHCHMe),
5.46 (d, J = 7.8 Hz, 1H, H5′), 6.77−6.79 (m, 1H, Ar), 6.93−6.96 (m,
1H, Ar), 7.18−7.22 (m, 1H, Ar), 7.41−7.43 (m, 1H, Ar); 13C NMR
(150 MHz, CDCl3) δ 17.7 (q, C4′CHCHCH3), 19.7 (q, C2′CH3),
43.1 (t, C4), 53.3 (d, C4′), 54.6 (d, C3′), 55.2 (q, MeO), 61.8 (t, C5),
78.8 (d, C2′), 79.3 (d, C5′), 109.8 (d, Ar), 120.4 (d, Ar), 126.4 (d,
C4′CHCHCH3), 127.0 (d, Ar), 128.1 (d, Ar), 128.2 (s, Ar), 130.0
(d, C4′CHCHCH3), 153.2 (s, C2), 156.0 (s, Ar), 174.0 (s,
C3′C(O)N); MS (EI) m/z (relative intensity) (M)
+ (1), 303 (M − 1
− CH3CHCH)+ (1), 259 (M − oxazolidin-2-one)+ (1), 197 (M −
Ar − CH3CHCH)+ (1), 122 (M − 2 − Ar − N-acyl oxazolidin-2-




(syn-9a) and Ethyl (S*,E)-2-[(S*)-1-Hydroxy-3-methylbutyl]-
hex-3-enoate (anti-9a). All the subsequent operations were
performed under an Ar atmosphere. To an ice-cooled solution of i-
Pr2NH (1.44 mL, 10.27 mmol, 1.2 equiv) in THF (43 mL, 0.2 M with
regard to the ester) was added a 2.5 M solution of n-butyllithium in
hexanes (3.8 mL, 9.5 mmol, 1.1 equiv). The mixture was stirred at rt
for 15 min and then cooled to −78 °C. A solution of commercial ethyl
(E)-hex-3-enoate (1.4 mL, 8.56 mmol) in THF (43 mL, 0.2 M) was
added dropwise, and the mixture was kept at that temperature for 30
min. After that, a solution of i-BuCHO (1.1 mL, 10.27 mmol, 1.2
equiv) in THF (43 mL, 0.2 M with regard to the ester) was added
dropwise, and the mixture was allowed to warm to rt. After 12 h, a
saturated NH4Cl aqueous solution (150 mL) was added and the
mixture was poured into a separatory funnel where the layers were
separated. The aqueous layer was extracted with EtOAc (3 × 150
mL), and the combined organic layers were dried over anhydrous
MgSO4, filtered, and concentrated to provide a 2.2:1 syn/anti aldol
mixture (69:31 dr). Purification by flash chromatography (28 cm of
height of silica gel, n-hexane/EtOAc 95:5) allowed the isolation of
aldols syn-9a (1.06 g, 57%) and anti-9a (482 mg, 26%), both as
yellowish oils. syn-9a: Rf = 0.61 (n-hexane/EtOAc 80:20);
1H NMR
(400 MHz, CDCl3) δ 0.88 (d, J = 6.8 Hz, 3H, C3′(CH3)2), 0.90 (d, J
= 6.8 Hz, 3H, C3′(CH3)2), 0.99 (t, J = 7.5 Hz, 3H), 1.10 (ddd, J =
13.9, 8.9, 3.5 Hz, 1H, H2′), 1.25 (t, J = 7.2 Hz, 3H, CO2CH2CH3),
1.41 (ddd, J = 14.0, 9.5, 5.1 Hz, 1H, H2′), 1.73−1.84 (m, 1H, H3′),
2.04−2.11 (m, 2H, H5), 2.60 (br s, 1H, OH), 2.92 (dd, J = 9.1, 4.7
Hz, 1H, H2), 3.90−3.94 (m, 1H, H1′), 4.15 (q, J = 7.2 Hz, 2H,
CO2CH2CH3), 5.51 (dd, J = 15.7, 9.3 Hz, 1H, H3), 5.67 (dt, J = 15.5,
6.5 Hz, 1H, H4);
13C NMR (100 MHz, CDCl3) δ 13.6 (q, C6), 14.3
(q, CO2CH2CH3), 21.9 (q, C3′(CH3)2), 23.6 (q, C3′(CH3)2), 24.5 (d,
C3′), 25.8 (t, C5), 43.3 (t, C2′), 55.4 (d, C2), 60.9 (t, CO2CH2CH3),
66.7 (d, C1′), 122.3 (d, C3), 138.6 (d, C4), 174.1 (s, C1); MS (EI) m/
z (relative intensity) 211 (M − OH)+ (1), 171 (M − i-Bu)+ (1), 155
(M − CO2Et)+ (2), 142 (M + 1 − CH(OH)CH2CH(CH3)2)+ (100);
HRMS calcd for C8H14O2 [(M + 1 − CH(OH)CH2CH(CH3)2)+]
142.0994, found 142.0990. anti-9a: Rf = 0.49 (n-hexane/EtOAc
80:20); 1H NMR (400 MHz, CDCl3) δ 0.89 (d, J = 6.8 Hz, 3H,
C3′(CH3)2), 0.91 (d, J = 6.8 Hz, 3H, C3′(CH3)2), 0.98 (t, J = 7.5 Hz,
3H), 1.22−1.35 (m, 2H, H2′), 1.26 (t, J = 7.2 Hz, 3H, CO2CH2CH3),
1.79−1.89 (m, 1H, H3′), 2.01−2.09 (m, 2H, H5), 2.40 (br s, 1H,
OH), 2.98 (dd, J = 8.9, 7.4 Hz, 1H, H2), 3.82−3.88 (br m, 1H, H1′),
4.13−4.20 (m, 2H, CO2CH2CH3), 5.42 (ddt, J = 15.4, 9.0, 1.5 Hz,
1H, H3), 5.67 (dt, J = 15.4, 6.4 Hz, 1H, H4);
13C NMR (100 MHz,
CDCl3) δ 13.6 (q, C6), 14.3 (q, CO2CH2CH3), 21.7 (q, C3′(CH3)2),
23.8 (q, C3′(CH3)2), 24.6 (d, C3′), 25.7 (t, C5), 44.0 (t, C2′), 56.4 (d,
C2), 60.8 (t, CO2CH2CH3), 71.1 (d, C1′), 123.6 (d, C3), 137.4 (d,
C4), 174.0 (s, C1); MS (EI) m/z (relative intensity) 211 (M − OH)+
(1), 171 (M − i-Bu)+ (2), 155 (M − CO2Et)+ (2), 142 (M + 1 −
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CH(OH)CH2CH(CH3)2)
+ (100); HRMS calcd for C8H14O2 [(M +
1 − CH(OH)CH2CH(CH3)2)+] 142.0994, found 142.0989.
Methyl (R*,E)-2-[(S*)-1-Hydroxyethyl]hex-3-enoate (syn-
9b). To a solution of aldol 2b (29 mg, 0.13 mmol) in DCM (1.3
mL, 0.1 M) were sequentially added, under an Ar atmosphere, MeOH
(0.11 mL, 2.60 mmol, 20 equiv) and FeCl3 (52.7 mg, 0.33 mmol, 2.5
equiv). The reaction mixture was stirred for 16 h, and then H2O was
added. The mixture was poured into a separatory funnel where the
layers were separated. The aqueous layer was extracted three times
with DCM, and the combined organic layers were dried over
anhydrous MgSO4, filtered, concentrated, and purified by flash
chromatography (16 cm of height of silica gel, n-hexane/EtOAc
70:30) to yield aldol syn-9b (15 mg, 70%) as a colorless oil: Rf = 0.43
(n-hexane/EtOAc 60:40, two times); 1H NMR (500 MHz, CDCl3) δ
1.00 (t, J = 7.4 Hz, 3H, H6), 1.15 (d, J = 6.4 Hz, 3H, H2′), 2.06−2.12
(m, 2H, H5), 2.59 (br s, 1H, OH), 2.94 (dd, J = 9.2, 5.2 Hz, 1H, H2),
3.70 (s, 3H, CO2Me), 4.00−4.05 (m, 1H, H1′), 5.51 (dd, J = 15.2, 9.4
Hz, 1H, H3), 5.70 (dt, J = 15.2, 6.4 Hz, 1H, H4);
13C NMR (125
MHz, CDCl3) δ 13.6 (q, C6), 20.1 (q, C2′), 25.8 (t, C5), 52.0 (q,
CO2Me), 56.4 (d, C2), 67.9 (d, C1′), 122.3 (d, C3), 139.0 (d, C4),
174.3 (s, C1); HRMS calcd for C9H16O3Na [(M + Na)
+] 195.0997,
found 195.0997.
General Procedure for the Synthesis of 4-Halo-2,3,4,5,6-
pentasubstituted THPs 10. To a solution of the aldol and the
aldehyde R3CHO (1.5 equiv) in DCM (0.1 M) were sequentially
added, under an Ar atmosphere, TMSCl (1 equiv) and Fe(acac)3 (0.1
equiv). Once TLC analysis revealed full conversion of the starting
material (<30 min), the reaction was quenched by adding H2O and
the mixture was poured into a separatory funnel where the layers were
separated. The aqueous layer was extracted three times with DCM,
and the combined organic layers were dried over anhydrous MgSO4,
filtered, concentrated, and purified by flash chromatography.
Ethyl (2S*,3R*,4S*,5R*,6R*)-4-Chloro-5-ethyl-2,6-diisobutylte-
trahydro-2H-pyran-3-carboxylate (10a). syn-Aldol 9a (109 mg,
0.48 mmol) was subjected to the general procedure for the synthesis
of 4-halo-2,3,4,5,6-pentasubstituted THPs 10 and yielded, after
purification by flash chromatography (28 cm of height of silica gel,
n-hexane/EtOAc 98/:2), THP 10a (111 mg, 70%, >95:5 dr).
Alternatively, a solution of syn-aldol 9a (150 mg, 0.66 mmol) and i-
BuCHO (0.11 mL, 0.99 mmol, 1.5 equiv) in DCM (6.6 mL, 0.1 M)
was treated with FeCl3 (110 mg, 0.66 mmol, 1 equiv) and stirred for
30 min. Then, H2O (10 mL) was added, and the aqueous layer was
extracted with DCM (3 × 10 mL). The combined organic layers were
dried over MgSO4, filtered, concentrated, and purified as described
above to yield title compound 10a (103 mg, 47%, >95:5 dr) and
undesired rearranged byproduct 11 (11 mg, 7%). 4-Chloro-THP 10a
was isolated as a white solid, and its description is given here: Rf =
0.51 (n-hexane/EtOAc 98:2); mp 56−60 °C (from DCM/n-hexane);
1H NMR (400 MHz, CDCl3) δ 0.81−0.91 (m, 15H, 5 × CH3), 0.98−
1.04 (m, 1H, H1′), 1.27 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 1.31−1.42
(m, 2H, H1″′), 1.44−1.62 (m, 3H, H5, 1 × H1′, 1 × H1″), 1.72−1.92
(m, 3H, 1 × H1″, H2′, H2″′), 2.56 (dd, J = 10.3, 10.3 Hz, 1H, H3), 3.28
(td, J = 10.2, 2.4 Hz, 1H, H6), 3.41 (td, J = 10.1, 1.9 Hz, 1H, H2),
4.13−4.27 (m, 3H, H4, CO2CH2CH3); 13C NMR (150 MHz, CDCl3)
δ 8.7 (q, C2″), 14.4 (q, CO2CH2CH3), 20.0 (t, C1″), 21.0 (q,
CH(CH3)2), 21.1 (q, CH(CH3)2), 23.8 (q, CH(CH3)2), 24.1 (q,
CH(CH3)2), 24.17 (d, CH(CH3)2), 24.22 (d, CH(CH3)2), 42.2 (t,
C1″′), 43.0 (t, C1′), 48.6 (d, C5), 59.4 (d, C3), 61.1 (t, CO2CH2CH3),
62.4 (d, C4), 76.3 (d, C2), 77.1 (d, C6), 171.7 (s, CO2CH2CH3);




trahydro-2H-pyran-3-carboxylate (10b). anti-9a (98 mg, 0.43
mmol) was subjected to the general procedure for the synthesis of
4-halo-2,3,4,5,6-pentasubstituted THPs 10 and yielded, after a
reaction time of 21 h and purification by flash chromatography (28
cm of height of silica gel, n-hexane/EtOAc 99:1), title compound 10b
(28 mg, 20%, >95:5 dr) and undesired lactone 12 (48 mg, 62%) as
result of the 2-oxonia-Cope rearrangement. 4-Chloro-THP 10b was
isolated as a white solid, and its description is given here: Rf = 0.71 (n-
hexane/EtOAc 90:10); mp 38−44 °C (from DCM/n-hexane); 1H
NMR (500 MHz, CDCl3) δ 0.83−0.92 (m, 15H, 5 × CH3), 1.19−
1.25 (m, 1H, H1′), 1.28 (t, J = 7.0 Hz, 3H, CO2CH2CH3), 1.30−1.35
(m, 1H, H1″′), 1.43−1.48 (m, 1H, 1 × H1′), 1.53−1.59 (m, 2H, 1 ×
H1″, 1 × H1″′), 1.67−1.73 (m, 1H, 1 × H1″), 1.79−1.86 (m, 1H, H2′),
1.89−1.96 (m, 1H, H2″′), 2.42 (ddt, J = 11.2, 11.2, 3.7 Hz, 1H, H5),
2.97 (dd, J = 5.3, 2.7 Hz, 1H, H3), 3.20 (td, J = 10.3, 1.9 Hz, 1H, H6),
3.49 (dt, J = 9.9, 3.3 Hz, 1H, H2), 4.09 (dd, J = 11.5, 5.5 Hz, 1H, H4),
4.15−4.26 (m, 2H, CO2CH2CH3); 13C NMR (150 MHz, CDCl3) δ
8.7 (q, C2″), 14.5 (q, CO2CH2CH3), 20.2 (t, C1″), 21.1 (q,
CH(CH3)2), 21.7 (q, CH(CH3)2), 23.4 (q, CH(CH3)2), 24.0 (q,
CH(CH3)2), 24.1 (d, CH(CH3)2), 24.5 (d, CH(CH3)2), 42.1 (t,
C1″′), 42.5 (t, C1′), 43.4 (d, C5), 53.1 (d, C3), 61.5 (t, CO2CH2CH3),
61.4 (d, C4), 75.5 (d, C2), 78.2 (d, C6), 169.9 (s, CO2CH2CH3);




yltetrahydro-2H-pyran-3-carboxylate (10c) and Methyl
(2S*,3R*,4S*,5R*,6R*)-2,6-Dibutyl-4-chloro-5-ethyltetrahydro-2H-
pyran-3-carboxylate (10d). syn-Aldol 9b (53 mg, 0.31 mmol) was
subjected to the general procedure for the synthesis of 4-halo-
2,3,4,5,6-pentasubstituted THPs 10 and yielded, after purification by
flash chromatography (28 cm of height of silica gel, n-hexane/EtOAc
98:2), undesired THP 10d (6 mg, 16%, >95:5 dr) and expected THP
10c (17 mg, 20%, >95:5 dr), both as colorless oils. 10c: Rf = 0.29 (n-
hexane/EtOAc 95:5); 1H NMR (600 MHz, CDCl3) δ 0.87 (t, J = 7.5
Hz, 3H, H2″), 0.90 (t, J = 7.0 Hz, 3H, H4″′), 1.18 (d, J = 6.1 Hz, 3H,
H1′), 1.25−1.36 (m, 3H, 1 × H2″′, H3″′), 1.38−1.44 (m, 1H, H1″′),
1.45−1.50 (m, 1H, H2″′), 1.53−1.57 (m, 1H, H5), 1.57−1.62 (m, 1H,
H1″), 1.63−1.68 (m, 1H, H1″′), 1.76−1.83 (m, 1H, H1″), 2.58 (dd, J =
10.1, 10.1 Hz, 1H, H3), 3.25−3.28 (m, 1H, H6), 3.49 (dq, J = 9.8, 6.2
Hz, 1H, H2), 3.75 (s, 3H, CO2Me), 4.20 (dd, J = 11.0, 11.0 Hz, 1H,
H4);
13C NMR (150 MHz, CDCl3) δ 8.9 (q, C2″), 14.2 (q, C4″′),
20.02 (q, C1′), 20.07 (t, C1″), 22.8 (t, C3″′), 27.6 (t, C2″′), 32.7 (t,
C1″′), 47.6 (d, C5), 52.2 (q, CO2Me), 60.1 (d, C3), 62.1 (d, C4), 74.4
(d, C2), 79.1 (d, C6), 172.2 (s, CO2Me); HRMS calcd for
C14H25O3Na
37Cl [(M + Na)+] 301.1360, found 301.1362. 10d: Rf
= 0.34 (n-hexane/EtOAc 95:5); 1H NMR (600 MHz, CDCl3) δ 0.871
(t, J = 7.6 Hz, 3H, H2″), 0.874 (t, J = 7.2 Hz, 3H, H4′ or H4″′), 0.91 (t,
J = 7.1 Hz, 3H, H4′ or H4″′), 1.25−1.37 (m, 7H, 1 × H2′, 2 × H3′, 2 ×
H2″′, 2 × H3″′), 1.38−1.44 (m, 1H, H1″′), 1.45−1.52 (m, 3H, 2 × H1′,
1 × H2′), 1.52−1.55 (m, 1H, H5), 1.58−1.62 (m, 1H, H1″), 1.64−1.69
(m, 1H, H1″′), 1.75−1.82 (m, 1H, H1″), 2.63 (dd, J = 10.2, 10.2 Hz,
1H, H3), 3.22 (td, J = 9.6, 2.5 Hz, 1H, H6), 3.33 (td, J = 9.4, 2.6 Hz,
1H, H2), 3.75 (s, 3H, CO2Me), 4.21 (dd, J = 11.0, 11.0 Hz, 1H, H4);
13C NMR (150 MHz, CDCl3) δ 8.9 (q, C2″), 14.1 (q, C4′ or C4″′),
14.2 (q, C4′ or C4″′), 20.1 (t, C1″), 22.5 (t, C3′ or C3″′), 22.6 (t, C3′ or
C3″′), 27.5 (t, C2′ or C2″′), 27.7 (t, C2′ or C2″′), 32.7 (t, C1″′), 33.8 (t,
C1′), 48.2 (d, C5), 52.2 (q, CO2Me), 59.0 (d, C3), 62.5 (d, C4), 78.0
(d, C2), 79.0 (d, C6), 172.4 (s, CO2Me); HRMS calcd for
C17H31O3Na
35Cl [(M + Na)+] 341.1859, found 341.1865.
Ethyl (4S*,5R*,E)-4-Ethyl-5-hydroxy-7-methyloct-2-enoate
(11). This undesired byproduct was obtained during the FeCl3-
mediated synthesis of previously described 4-chloro-THP 10a (see
the synthetic procedure in its section). 11 (11 mg, 7%) was obtained
as a colorless oil, and its description is given here: Rf = 0.17 (n-
hexane/EtOAc 90:10); 1H NMR (400 MHz, CDCl3) δ 0.88 (t, J =
7.7 Hz, 3H, H2′), 0.91 (d, J = 6.5 Hz, 3H, CH(CH3)2), 0.92 (d, J =
6.6 Hz, 3H, CH(CH3)2), 1.17−1.25 (m, 1H, H6), 1.30 (t, J = 7.1 Hz,
3H, CO2CH2CH3), 1.34−1.40 (m, 1H, H6), 1.43−1.53 (m, 1H, H1′),
1.56−1.66 (m, 1H, H1′), 1.71−1.82 (m, 1H, H7), 2.02−2.09 (m, 1H,
H4), 3.70−3.74 (m, 1H, H5), 4.20 (q, J = 7.1 Hz, 2H, CO2CH2CH3),
5.85 (d, J = 15.8 Hz, 1H, H2), 6.85 (d, J = 15.7, 9.7 Hz, 1H, H3);
13C
NMR (100 MHz, CDCl3) δ 12.1 (q, C2′), 14.4 (q, CO2CH2CH3),
22.0 (q, CH(CH3)2), 23.7 (q, CH(CH3)2), 23.9 (t, C1′), 24.7 (d, C7),
44.6 (t, C6), 51.1 (d, C4), 60.5 (t, CO2CH2CH3), 71.7 (d, C5), 123.9
(d, C2), 149.0 (d, C3), 166.5 (s, CO2CH2CH3); HRMS calcd for
C13H24O3Na [(M + Na)
+] 251.1623, found 251.1624.
(5R*,6S*)-5-Ethyl-6-isobutyl-5,6-dihydro-2H-pyran-2-one
(12). This undesired byproduct was obtained during the synthesis of
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previously described 4-chloro-THP 10b (see the synthetic procedure
in its section). 12 (48 mg, 62%) was obtained as a colorless oil, and its
description is given here: Rf = 0.27 (n-hexane/EtOAc 90:10);
1H
NMR (400 MHz, CDCl3) δ 0.90 (d, J = 6.4 Hz, 3H, CH2CH(CH3)2),
0.91 (d, J = 6.6 Hz, 3H, CH2CH(CH3)2), 0.96 (t, J = 7.4 Hz, 3H,
CH2CH3), 1.32−1.39 (m, 1H, CH2CH(CH3)2), 1.41−1.50 (m, 1H,
CH2CH3), 1.57−1.65 (m, 1H, CH2CH3), 1.67−1.75 (m, 1H,
CH2CH(CH3)2), 1.86−1.97 (m, 1H, CH2CH(CH3)2), 2.16−2.22
(m, 1H, H5), 4.28 (ddd, J = 10.3, 7.4, 4.4 Hz, 1H, H6), 5.95 (dd, J =
9.9, 1.9 Hz, 1H, H3), 6.75 (dd, J = 9.8, 3.5 Hz, 1H, H4);
13C NMR
(100 MHz, CDCl3) δ 10.6 (q, CH2CH3), 21.6 (q, CH2CH(CH3)2),
23.5 (q, CH2CH(CH3)2), 24.1 (d, CH2CH(CH3)2), 24.3 (t,
CH2CH3), 39.9 (d, C5), 42.5 (t, CH2CH(CH3)2), 79.8 (d, C6),
120.6 (d, C3), 149.1 (d, C4), 163.9 (s, C2); MS (EI) m/z (relative
intensity) 182 (M)+ (1), 168 (M + 1 − Me)+ (1), 125 (M − i-Bu)+




tetrahydro-2H-pyran-3-carboxylate (13). syn-Aldol 9b (37 mg,
0.22 mmol) was subjected to the general procedure for the synthesis
of bicycles 5 (two-step EAP). Once the reaction had reached
completion, 1H NMR analysis of the crude revealed a 1:1 mixture of
the epimers at C4 of THP 13. After purification by flash
chromatography (21 cm of height of silica gel, n-hexane/EtOAc
95:5), that inseparable mixture of the isomers of 13 (6 mg, 12%,
50:50 dr) was isolated. The mixture decomposed after 1 month, in
spite of being stored under Ar at −18 °C. 13: colorless oil; Rf = 0.49
(n-hexane/EtOAc 60:40); 1H NMR (400 MHz, CDCl3) δ 0.94 (t, J =
7.6 Hz, 3H, H2″), 1.20 (d, J = 6.1 Hz, 3H, H1′), 1.26 (d, J = 5.8 Hz,
3H, H1″′), 1.40−1.55 (m, 2H, H5, H1″), 1.61−1.71 (m, 1H, H1″),
2.46−2.53 (m, 1H, H3), 3.31−3.38 (m, 1H, H6), 3.49−3.57 (m, 1H,
H2), 3.75 (s, 3H, CO2Me), 4.67 (dd, J = 10.3 Hz, 0.5H, H4), 4.80 (dd,
J = 10.2 Hz, 0.5H, H4);
13C NMR (125 MHz, CDCl3) δ 10.0 (q, C2″),
19.2 (q, C1″′), 19.79 (t, C1″), 19.83 (q, C1′), 47.7 and 47.8 (d, C5),
52.2 (q, CO2Me), 56.5 and 56.7 (d, C3), 72.6 and 72.7 (d, C2), 74.4
and 74.5 (d, C6), 92.4 and 93.9 (d, C4), 172.3 (s, CO2Me); HRMS
calcd for C11H20O4Na [(M + Na)
+] 239.1259, found 239.1257.
(2S*,5S*,6R*)-5-Ethyl-N-(2-hydroxyethyl)-2,6-diisobutyl-
5,6-dihydro-2H-pyran-3-carboxamide (14). A 1 M solution of
KHMDS in THF (0.76 mL, 0.76 mmol, 1.5 equiv) was added, at −78
°C and under an Ar atmosphere, dropwise to a stirred solution of
bicycle 5a (179 mg, 0.50 mmol) in THF (2.8 mL, 0.2 M). The
reaction mixture was stirred at −78 °C for 2 h, until TLC analysis
revealed full conversion of the starting material. Then, the cold bath
was removed, the reaction quenched with a saturated NH4Cl aqueous
solution (5 mL), and the mixture poured into a separatory funnel with
5 mL of DCM. The layers were separated; the aqueous layer was
extracted with DCM (3 × 5 mL), and the combined organic layers
were dried over MgSO4, filtered, concentrated, and purified by flash
chromatography (21 cm of height of silica gel, n-hexane/EtOAc
30:70) to yield title compound 14 (73 mg, 47%) as a colorless oil.
Product 14 was revealed properly with oleum and with a
phosphomolybdic acid, although it was not revealed with ninhydrin,
vanillin, or anisaldehyde: Rf = 0.35 (n-hexane/EtOAc 20:80);
1H
NMR (500 MHz, CDCl3) δ 0.85−0.94 (m, 15H, 2 × (CH3)2CHCH2,
3 × H2″), 1.12−1.23 (m, 1H, H1″), 1.29−1.43 (m, 4H, 2
×(CH3)2CHCH2), 1.44−1.55 (m, 1H, H1″), 1.84−1.97 (m, 3H, H5,
2 × (CH3)2CHCH2), 2.95 (br s, 1H, OH), 3.17 (td, J = 9.4, 3.0 Hz,
1H, H6), 3.46 (t, J = 5.6 Hz, 2H, NCH2CH2OH), 3.74 (t, J = 4.9 Hz,
2H, NCH2CH2OH), 4.39−4.44 (m, 1H, H2), 6.16 (br s, 1H, H4),
6.24 (t, J = 5.2 Hz, 1H, NH); 13C NMR (125 MHz, CDCl3) δ 10.4
(q, C2″), 21.0 (q, (CH3)2CHCH2), 21.4 (q, (CH3)2CHCH2), 23.4 (t,
C1″), 23.9 (q, 2C, 2 × (CH3)2CHCH2), 24.4 (d, (CH3)2CHCH2),
24.6 (d, (CH3)2CHCH2), 41.5 (d, C5), 42.0 (t, (CH3)2CHCH2), 42.2
(t, (CH3)2CHCH2), 42.3 (t, NCH2CH2OH), 62.1 (t,
NCH2CH2OH), 72.7 (d, C2), 75.1 (d, C6), 132.6 (d, C4), 139.7 (s,
C3), 170.3 (s, C3C(O)N); MS (EI) m/z (relative intensity) 312 (M +
1)+ (8), 311 (M)+ (23), 294 (M − OH)+ (5), 282 (M − Et)+ (7),
266 (M − CH2CH2OH)+ (4), 254 (M − i-Bu)+ (28), 236 (M − i-Bu
− H2O)+ (8), 225 (M − Et − i-Bu)+ (30), 197 (M − 2 i-Bu)+ (2),
182 (M + 1 − i-Bu − Me − NHCH2CH2OH)+ (100), 168 (M − 2i-




a solution of bicycle 5a (162 mg, 0.46 mmol) in MeOH (3.3 mL, 0.14
M) was added MeSO3H (0.02 mL, 0.32 mmol, 0.7 equiv), and the
mixture was heated at 60 °C for 8 h. After that, it was allowed to warm
to rt and Ba(OH)2·8H2O (432 mg, 1.37 mmol, 3 equiv) was added.
Then, the mixture was heated again at 60 °C for an extra 2 h and then
cooled to rt. A 1 M aqueous solution of HCl (5 mL) was added; the
aqueous layer was extracted with Et2O (3 × 5 mL), and the combined
organic layers were washed with brine (15 mL), dried over MgSO4,
filtered, concentrated, and purified by flash chromatography (21 cm of
height of silica gel, EtOAc) to yield title compound 15 (89 mg, 60%)
as an amorphous white solid: Rf = 0.33 (DCM/MeOH 90:10), 0.51
(EtOAc/HOAc 95:5); 1H NMR (500 MHz, CDCl3) δ 0.85−0.93 (m,
15H, 5 × Me), 1.10−1.16 (m, 1H, (CH3)2CHCH2), 1.21−1.27 (m,
2H, H5, (CH3)2CHCH2), 1.29−1.39 (m, 1H, (CH3)2CHCH2), 1.37−
1.46 (m, 1H, (CH3)2CHCH2), 1.49−1.56 (m, 1H, H1″), 1.61−1.70
(m, 1H, H1″), 1.83−1.93 (m, 2H, 2 × (CH3)2CHCH2), 1.98 (dd, J =
9.6 Hz, 1H, H3), 3.15−3.22 (m, 1H, NCH2CH2OH), 3.27 (td, J =
10.2, 1.9 Hz, 1H, H6), 3.40−3.56 (m, 2H, 2 × OH), 3.52 (td, J = 10.1,
1.8 Hz, 1H, H2), 3.60−3.74 (m, 2H, 1 × NCH2CH2OH, 1 ×
NCH2CH2OH), 3.76−3.82 (m, 1 × NCH2CH2OH), 3.89 (dd, J =
10.1, 10.1 Hz, 1H, H4), 6.29 (br s, 1H, NH);
13C NMR (125 MHz,
CDCl3) δ 9.5 (q, C2″), 19.0 (t, C1″), 21.1 (q, 2 × (CH3)2CHCH2),
23.9 (q, (CH3)2CHCH2), 24.1 (q, (CH3)2CHCH2), 24.2 (d,
(CH3)2CHCH2), 24.3 (d, (CH3)2CHCH2), 42.1 (t, NCH2CH2OH),
42.3 (t, (CH3)2CHCH2), 42.9 (t, (CH3)2CHCH2), 48.3 (d, C5), 59.5
(d, C3), 61.4 (t, NCH2CH2OH), 71.7 (d, C4), 74.7 (d, C2), 76.0 (d,
C6), 174.1 (s, C3CONH); MS (EI) m/z (relative intensity) 330 (M +
2)+ (1), 328 (M)+ (1), 312 (M − OH)+ (1), 311 (M − H2O)+ (2),
298 (M − CH2OH)+ (1), 272 (M − i-Bu)+ (8), 227 (M − i-Bu −
CH2CH2OH)
+ (2), 216 (M + 1 − 2i-Bu)+ (100), 188 (M + 2 − 2i-Bu
− Et)+ (16); HRMS calcd for C18H34NO4 [(M)+] 328.2488, found
328.2497.
(2S* ,3S* ,4S* ,5R* ,6R*)-5-Ethyl-4-{[(2-hydroxyethyl)-
carbamoyl]oxy}-2,6-diisobutyltetrahydro-2H-pyran-3-carbox-
ylic Acid (16). To an ice-cooled solution of bicycle 5a (1.19 g, 3.36
mmol) in a 3:1 THF/H2O mixture (60 mL, 0.05 M) was added a 35%
(w/w) aqueous solution of H2O2 (1.8 mL, 20.2 mmol, 6 equiv) and
LiOH·H2O (287 mg, 6.72 mmol, 2 equiv). The mixture was allowed
to warm to rt and stirred for 21 h, and then an aliquot was taken,
diluted with a small amount of EtOAc, and treated with a few drops of
a 5% HCl aqueous solution. TLC analysis of the treated aliquot
revealed full conversion of the starting material. After that, the
reaction mixture was cooled to 0 °C and the reaction was quenched
with a 1.5 M aqueous solution of Na2SO3 (60 mL). Then, the THF
was evaporated in the rotavap, and the remaining solution was diluted
with H2O (40 mL), washed with DCM (100 mL), acidified to pH 1
with a 5% HCl aqueous solution, and extracted with EtOAc (3 × 150
mL). The combined organic layers were washed with brine (500 mL),
dried over MgSO4, filtered, and concentrated. One-tenth of the crude
was separated and purified by flash chromatography (9 cm of height
of silica gel, 100 mL of EtOAc and then EtOAc/MeOH 80:20) to
yield title compound 16 (98 mg, which mathematically means a total
yield of 79%) as an amorphous white solid. The nonpurified crude
was consumed in the synthesis of THP 17: Rf = 0.24 (EtOAc), 0.38
(EtOAc/HOAc 95:5), 0.39 (EtOAc/MeOH 90:10), 0.54 (EtOAc/
MeOH 80:20), 0.75 (DCM/MeOH 80:20); 1H NMR (500 MHz,
CDCl3) δ 0.85−0.93 (m, 15H, 5 × CH3), 1.16−1.25 (m, 1H, 1 ×
(CH3)2CHCH2), 1.26−1.35 (m, 1H, 1 × (CH3)2CHCH2), 1.37−
1.55 (m, 5H, H5, 1 × H1′, 2 × H1″, 1 × H1″′), 1.83−1.95 (m, 2H, 2 ×
(CH3)2CHCH2), 2.35 (dd, J = 10.2, 10.2 Hz, 1H, H3), 3.08−3.16 (m,
1H, NCH2CH2OH), 3.30−3.36 (m, 1H, H6), 3.43−3.67 (m, 3H, H2,
1 × NCH2CH2OH, 1 × NCH2CH2OH), 3.72−3.82 (m, 1H,
NCH2CH2OH), 5.15 (dd, J = 10.5, 10.5 Hz, 1H, H4), 5.23−5.32
(m, 1H, NH); 1H NMR (500 MHz, (D3C)2CO) δ 0.85−0.94 (m,
15H, 5 × CH3), 1.13−1.21 (m, 1H, H1′), 1.29−1.34 (m, 1H, H5),
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1.35−1.40 (m, 2H, H1″′), 1.42−1.52 (m, 3H, 1 × H1′, 2 × H1″), 1.85−
1.97 (m, 2H, 2 × (CH3)2CHCH2), 2.25 (dd, J = 10.1, 10.1 Hz, 1H,
H3), 3.17−3.24 (m, 2H, NCH2CH2OH), 3.39 (td, J = 9.7, 4.0 Hz,
1H, H6), 3.50−3.60 (m, 3H, H2, NCH2CH2OH), 5.16 (dd, J = 10.5,
10.5 Hz, 1H, H4), 6.19 (br s, 1H, NH);
13C NMR (125 MHz,
CDCl3) δ 9.7 (q, C2″), 19.4 (t, C1″), 21.3 (q, 2C, 2 ×
(CH3)2CHCH2) , 23 .8 (q , (CH3)2CHCH2) , 24 .1 (q ,
(CH3)2CHCH2) , 24 .4 (d , (CH3)2CHCH2) , 24 .5 (d ,
(CH3)2CHCH2), 42.1 (t, (CH3)2CHCH2), 43.2 (t, (CH3)2CHCH2),
43.6 (t, NCH2CH2OH), 46.4 (d, C5), 56.2 (d, C3), 61.7 (t,
NCH2CH2OH), 75.1 (d, C4), 76.4 (d, C6), 76.6 (d, C2), 157.7 (s,
OC(O)NH), 175.5 (s, CO2H);
13C NMR (125 MHz, (D3C)2CO) δ
9.5 (q, C2″), 19.5 (t, C1″), 21.4 (q, (CH3)2CHCH2), 21.5 (q,
(CH3)2CHCH2) , 24 .1 (q , (CH3)2CHCH2) , 24 .3 (q ,
(CH3)2CHCH2), 24.90 (d, (CH3)2CHCH2), 25.01 (d,
(CH3)2CHCH2), 42.7 (t, C1″′), 43.9 (t, C1′), 44.3 (t, NCH2CH2OH),
47.5 (d, C5), 56.5 (d, C3), 61.9 (t, NCH2CH2OH), 74.0 (d, C4), 75.3
(d, C2), 76.4 (d, C6), 157.2 (s, OC(O)NH), 173.2 (s, CO2H); MS
(EI) m/z (relative intensity) 344 (M − Et)+ (1), 343 (M − 1 − Et)+
(4), 316 (M − i-Bu)+ (4), 287 (M − i-Bu − Et)+ (4), 269 (M −
carbamate)+ (34), 229 (M − 1 − 2i-Bu − Et)+ (13), 223 (M − 1 −
carbamate − CO2H)+ (20), 211 (M − 1 − i-Bu − carbamate)+ (100),
155 (M − carbamate − 2i-Bu)+ (27), 126 (M − 2i-Bu − carbamate −
2Et)+ (28), 110 (M − 2i-Bu − carbamate − CO2H)+ (17); HRMS
calcd for C17H29NO6 [(M − 1 − Et)+] 343.1995, found 343.1987;
HRMS calcd for C12H19O3 [(M + 1 − i-Bu − carbamate)+] 211.1334,
found 211.1339.
(2S*,3R*,4S*,5S*,6R*)-5-Ethyl-4-hydroxy-2,6-diisobutylte-
trahydro-2H-pyran-3-carboxylic Acid (17). THP 16 (95 mg, 0.26
mmol) was dissolved in a 3:1:1 THF/MeOH/H2O mixture (3.5 mL,
0.07 M), and LiOH·H2O (164 mg, 3.83 mmol, 15 equiv) was added.
The reaction mixture was heated at 80 °C for 24 h. After that, an
aliquot was taken, diluted with a small amount of EtOAc, and treated
with a few drops of a 5% HCl aqueous solution. TLC analysis of the
treated aliquot revealed full conversion of the starting material. The
organic solvents were removed in the rotavap, and then the aqueous
mixture was extracted with EtOAc (3 × 5 mL). The combined
organic layers were washed with brine (15 mL), and when the huge
amount of emulsion disappeared, the organic layer was separated,
dried over MgSO4, filtered, concentrated, and purified by flash
chromatography (14 cm of height of silica gel, 60 mL of a 98:2
EtOAc/MeOH mixture followed by 60 mL of a 90:10 EtOAc/MeOH
mixture and 60 mL of an 80:20 EtOAc/MeOH mixture) to yield title
compound 17 (52 mg, 70%) as an amorphous white solid. A similar
yield was obtained when the reaction was performed with nonpurified
THP 16 as the starting material. THP 17 shows decreasing solubility
in deuterated solvents according to the order DMSO-d6 ≫ acetone-d6
> MeOD ≫ CDCl3 > C6D6 ≫ D2O (totally insoluble): Rf = 0.28
(EtOAc), 0.46 (EtOAc/MeOH 95:5), 0.53 (EtOAc/HOAc 97.5:2.5),
0.69 (EtOAc/HOAc 95:5); 1H NMR (500 MHz, (D3C)2CO) δ
0.84−0.93 (m, 15H, 5 × CH3), 1.12−1.21 (m, 2H, H5, 1 ×
(CH3)2CHCH2), 1.34−1.39 (m, 2H, (CH3)2CHCH2), 1.44−1.49
(m, 1H, (CH3)2CHCH2), 1.49−1.56 (m, 1H, H1″), 1.69−1.79 (m,
1H, H1″), 1.84−1.96 (m, 2H, (CH3)2CHCH2), 2.17 (dd, J = 10.0,
10.0 Hz, 1H, H3), 3.25−3.31 (m, 1H, H6), 3.42 (td, J = 10.2, 2.0 Hz,
1H, H2), 3.79 (dd, J = 10.2, 10.2 Hz, 1H, H4);
13C NMR (125 MHz,
(D3C)2CO) δ 9.8 (q, C2″), 19.4 (t, C1″), 21.4 (q, (CH3)2CHCH2),
21.5 (q, (CH3)2CHCH2), 24.2 (q, (CH3)2CHCH2), 24.4 (q,
(CH3)2CHCH2), 24.92 (d, (CH3)2CHCH2), 24.94 (d,
(CH3)2CHCH2), 43.0 (t, (CH3)2CHCH2), 44.1 (t, (CH3)2CHCH2),
49.4 (d, C5), 59.1 (d, C3), 72.4 (d, C4), 75.5 (d, C2), 76.7 (d, C6),
174.7 (s, CO2H); MS (EI) m/z (relative intensity) 268 (M − H2O)+
(18), 240 (M − 1 − CO2H)+ (2), 229 (M − i-Bu)+ (49), 211 (M − i-
Bu − H2O)+ (28), 182 (M − 2 − i-Bu − CO2H)+ (13), 173 (M + 1




To an ice-cooled 1 M solution of DIBAL-H in hexanes (4 mL, 4
mmol, 9 equiv) was added dropwise, under an Ar atmosphere and for
7 min, a solution of bicycle 5a (159 mg, 0.45 mmol) in Et2O (4.5 mL,
0.1 M). Five minutes after the addition, TLC analysis revealed that
the reaction was completed. At 20 min, the mixture was diluted with
Et2O (20 mL) and a saturated Rochelle salt aqueous solution (5 mL)
was added. The mixture was vigorously stirred for 1 h, until two clear
phases were observed when the stirring was stopped. The layers were
separated in a separatory funnel; the aqueous layer was extracted with
Et2O (3 × 20 mL), and the combined organic layers were dried over
MgSO4, filtered, concentrated, and purified by flash chromatography
(16 cm of height of silica gel, DCM/MeOH 95:5) to yield title
compound 18 (97 mg, 66%) as a yellowish oil: Rf = 0.24 (DCM/
MeOH 95:5); 1H NMR (500 MHz, CDCl3) δ 0.79−0.90 (m, 15H, 5
× (CH3)), 1.15−1.20 (m, 1H, H1″′), 1.25−1.32 (m, 2H, H3, H1′),
1.35−1.42 (m, 2H, H1′, H1″′), 1.43−1.49 (m, 1H, H1″), 1.52−1.60
(m, 1H, H5), 1.58−1.65 (m, 1H, H1″), 1.80−1.92 (m, 2H, H2′, H2″′),
2.31 (s, 3H, CH3N), 2.40−2.47 (m, 2H, 1 × C5CH2N, 1 ×
NCH2CH2OH), 2.47 (dd, J = 12.6, 2.9 Hz, 1H, C5CH2N), 2.67−2.72
(m, 1H, NCH2CH2OH), 2.97 (td, J = 9.5, 1.8 Hz, 1H, H6), 3.17 (td, J
= 10.4, 1.9 Hz, 1H, H2), 3.56 (dd, J = 9.7, 9.7 Hz, 1H, H4), 3.64−3.74
(m, 2H, NCH2CH2OH);
13C NMR (125 MHz, CDCl3) δ 9.3 (q,
C2″), 18.5 (t, C1″), 21.05 (q, (CH3)2CHCH2), 21.06 (q,
(CH3)2CHCH2), 24.0 (q, (CH3)2CHCH2), 24.1 (d, 2C, 2 ×
(CH3)2CHCH2), 24.2 (q, (CH3)2CHCH2), 42.1 (t, C1′), 42.5 (t,
C1″′), 43.2 (q, CH3N), 45.2 (d, C5), 48.4 (d, C3), 59.6 (t,
NCH2CH2OH), 60.4 (t, NCH2CH2OH), 61.2 (t, C5CH2N), 74.6
(d, C6), 75.9 (d, C2), 77.2 (d, C4); MS (EI) m/z (relative intensity)
330 (M + 1)+ (1), 329 (M)+ (1), 314 (M − Me)+ (1), 298 (M −
CH2OH)
+ (14), 272 (M − t-Bu)+ (1), 216 (M + 1 − 2t-Bu)+ (6),
186 (M − 2t-Bu − Et)+ (1), 88 (100); HRMS calcd for C19H39NO3
[(M)+] 329.2930, found 329.2922.
(2R*,3S*,4S*,5R*,6S*)-3-Ethyl-5-(hydroxymethyl)-2,6-diiso-
butyltetrahydro-2H-pyran-4-ol (19). To a solution of bicycle 5a
(285 mg, 0.73 mmol) in THF (7 mL, 0.1 M) was added dropwise, at
rt and under an Ar atmosphere, a 1 M solution of DIBAL-H in
hexanes (8 mL, 8 mmol, 11 equiv). Then, the reaction mixture was
heated at 66 °C for 19 h. Once TLC analysis revealed that the
reaction was completed, the mixture was cooled to rt and diluted with
Et2O (50 mL) and the reaction was quenched with a saturated
Rochelle salt aqueous solution (10 mL). The mixture was vigorously
stirred for 1 h and then was poured into a separatory funnel together
with H2O (40 mL). The layers were separated; the aqueous layer was
extracted with Et2O (3 × 50 mL), and the combined organic layers
were dried over MgSO4, filtered, concentrated, and purified by flash
chromatography (35 cm of height of silica gel, n-hexane/EtOAc
75:25) to yield diol 19 (71 mg, 36%). Alternatively, carbamate 20 (65
mg, 0.18 mmol) was dissolved in a 1:1:1 THF/MeOH/H2O mixture
(2.6 mL, 0.07 M), and LiOH·H2O (78 mg, 1.85 mmol, 10 equiv) was
added. The mixture was heated at 80 °C with a saturated NH4Cl
aqueous solution (5 mL), and the aqueous mixture was extracted with
DCM (3 × 10 mL). The combined organic layers were dried over
MgSO4, filtered, concentrated, and purified by flash chromatography
(14 cm of height of silica gel, n-hexane/EtOAc 60:40) to yield diol 19
(38 mg, 80%): amorphous white solid; Rf = 0.25 (n-hexane/EtOAc
50:50), 0.40 (n-hexane/EtOAc 20:80); 1H NMR (500 MHz, CDCl3)
δ 0.84 (d, J = 6.6 Hz, 3H, (CH3)2CHCH2), 0.86 (d, J = 6.4 Hz, 3H,
(CH3)2CHCH2), 0.89 (t, J = 7.5 Hz, 3H, H2″), 0.91 (d, J = 7.0 Hz,
3H, (CH3)2CHCH2), 0.92 (d, J = 7.0 Hz, 3H, (CH3)2CHCH2),
1.20−1.25 (m, 1H, (CH3)2CHCH2), 1.28−1.33 (m, 2H, H3, 1 ×
(CH3)2CHCH2), 1.39−1.56 (m, 4H, H5, 1 × H1″, 2 ×
(CH3)2CHCH2), 1.62−1.70 (m, 1H, H1″), 1.86−1.96 (m, 2H, 2 ×
(CH3)2CHCH2), 2.50 (br s, 1H, OH), 2.84 (br s, 1H, OH), 3.11 (td,
J = 10.4, 2.8 Hz, 1H, H6), 3.18 (td, J = 10.4, 2.5 Hz, 1H, H2), 3.64
(dd, J = 10.6, 8.1 Hz, 1H, 1 × CH2OH), 3.70 (dd, J = 9.9, 9.9 Hz, 1H,
H4), 3.96 (dd, J = 10.6, 3.4 Hz, 1H, 1 × CH2OH);
1H NMR (600
MHz, C6D6) δ 0.88−0.95 (m, 15H, 3 × H2″, 4 × (CH3)2CHCH2),
1.09−1.15 (m, 1H, H1″′), 1.27−1.35 (m, 2H, H3, H1″′), 1.39−1.51
(m, 4H, H5, 2 × H1′, 1 × H2′), 1.60 (br s, 1H, CH2OH), 1.69−1.76
(m, 1H, H1″), 2.02−2.14 (m, 2H, H2′, H2″′), 2.66 (br s, 1H, C4OH),
2.95−3.01 (m, 1H, H6), 3.07−3.12 (m, 1H, H2), 3.27−3.32 (m, 1H, 1
× C5CH2OH), 3.51−3.56 (m, 1H, H4), 3.60−3.65 (m, 1H, 1 ×
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C5CH2OH);
13C NMR (125 MHz, CDCl3) δ 9.4 (q, C2″), 18.8 (t,
C1″), 21.1 (q, 2C, (CH3)2CHCH2), 24.1 (d, (CH3)2CHCH2), 24.15
(q, 2C, (CH3)2CHCH2), 24.19 (d, (CH3)2CHCH2), 42.2 (t,
(CH3)2CHCH2), 42.7 (t, (CH3)2CHCH2), 49.1 (d, C3), 50.6 (d,
C5), 63.9 (t, CH2OH), 74.0 (d, C6), 74.5 (d, C4), 75.8 (d, C2);





(20). Bicycle 5a (175 mg, 0.49 mmol) was dissolved in a 4:1 THF/
H2O mixture (5 mL, 0.1 M); the solution was cooled to 0 °C, and
NaBH4 (75 mg, 1.96 mmol, 4 equiv) was added. Then, the reaction
mixture was allowed to warm to rt and stirred for 16 h. After that, the
reaction was quenched with a saturated Rochelle salt aqueous solution
(5 mL). The mixture was vigorously stirred for 16 h and then poured
into a separatory funnel together with EtOAc (10 mL). The layers
were separated; the aqueous layer was extracted with EtOAc (3 × 10
mL), and the combined organic layers were washed with brine (50
mL), dried over MgSO4, filtered, concentrated, and purified by flash
chromatography (12 cm of height of silica gel, n-hexane/EtOAc
30:70) to yield compound 20 (128 mg, 70%) as an amorphous white
solid:84 Rf = 0.29 (EtOAc/MeOH 80:20);
1H NMR (500 MHz,
CDCl3) δ 0.85 (t, J = 7.5 Hz, 3H, H2″), 0.87 (d, J = 6.6 Hz, 3H,
(CH3)2CHCH2), 0.89 (d, J = 6.5 Hz, 3H, (CH3)2CHCH2), 0.92 (d, J
= 6.8 Hz, 6H, (CH3)2CHCH2), 1.27−1.34 (m, 2H, H5, H1″′), 1.38−
1.52 (m, 6H, H3, 2 × H1′, 2 × H1″, H1″′), 1.87−1.98 (m, 2H,
(CH3)2CHCH2), 3.26 (td, J = 10.2, 2.1 Hz, 1H, H2), 3.33−3.44 (m,
2H, NCH2CH2OH), 3.51 (td, J = 10.0, 2.9 Hz, 1H, H6), 3.54 (dd, J =
12.9, 2.5 Hz, 1H, C5CH2OH), 3.61−3.65 (m, 1H, C5CH2OH), 3.74
(t, J = 5.0 Hz, 2H, NCH2CH2OH), 4.92 (dd, J = 10.5, 10.5 Hz, 1H,
H4), 5.25 (t, J = 5.7 Hz, 1H, NH);
13C NMR (125 MHz, CDCl3) δ
9.4 (q, C2″), 19.7 (t, C1″), 21.05 (q, (CH3)2CHCH2), 21.08 (q,
(CH3)2CHCH2), 24.1 (q, (CH3)2CHCH2), 24.16 (d,
(CH3)2CHCH2), 24.17 (q, (CH3)2CHCH2), 24.3 (d,
(CH3)2CHCH2), 41.9 (t, (CH3)2CHCH2), 42.2 (t, (CH3)2CHCH2),
43.6 (t, NCH2CH2OH), 46.8 (d, C3), 50.6 (d, C5), 58.1 (t,
C5CH2OH), 62.3 (t, NCH2CH2OH), 73.1 (d, C4), 73.8 (d, C6), 75.7
(d, C2), 158.8 (s, OC(O)N); MS (EI) m/z (relative intensity) 302
(M − i-Bu)+ (3), 254 (M − 1 − OC(O)NHCH2CH2OH)+ (5), 223
(M − 1 − carbamate − CH2OH)+ (31), 197 (M − 1 − i-Bu −
carbamate)+ (100), 168 (M + 1 − i-Bu − carbamate − CH2OH)+
(41), 141 (M − 2i-Bu − carbamate)+ (9), 111 (M + 1 − 2i-Bu −
carbamate − CH2OH)+ (12); HRMS calcd for C15H28NO5 [(M − i-
Bu)+] 302.1967, found 302.1961.
Synthesis of 3-(N-Acyl oxazolidin-2-one)-THPs 21. (R)-4-
Benzyl-3-[(2S,3R,4S,5S,6R)-5-ethyl-4-hydroxy-2,6-dimethyltetrahy-
dro-2H-pyran-3-carbonyl]oxazolidin-2-one (21a). Aldol 2i (26 mg,
83 μmol) and acetaldehyde (37 μL of a 3.3 M solution in DCM, 125
μmol, 1.5 equiv) were subjected to the general procedure for the
synthesis of bicycles 5 (two-step EAP) and yielded, after purification
by flash chromatography (18 cm of height of silica gel, n-hexane/
EtOAc 70:30), title compound 21a (3 mg, 9%, >95:5 dr) and
previously described 5ag (19 mg, 62%, >95:5 dr). 21a: thick colorless
oil; Rf = 0.43 (n-hexane/EtOAc 60:40); [α]
25
D −66.0 (c 0.6, CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.93 (t, J = 7.6 Hz, 3H, C5′CH2CH3),
1.18 (d, J = 5.9 Hz, 3H, C2′CH3), 1.26 (d, J = 6.2 Hz, 3H, C6′CH3),
1.29−1.35 (m, 1H, H5′), 1.54−1.61 (m, 1H, C5′CH2CH3), 1.70−1.77
(m, 1H, C5′CH2CH3), 2.16 (d, J = 9.9 Hz, 1H, OH), 2.82 (dd, J =
13.7, 9.5 Hz, 1H, C4CH2), 3.34 (dd, J = 13.7, 3.5 Hz, 1H, C4CH2),
3.43 (dq, J = 10.0, 6.2 Hz, 1H, H6′), 3.76 (dq, J = 8.9, 6.0 Hz, 1H,
H2′), 3.80−3.83 (m, 1H, H3′), 3.84 (ddd, J = 9.8, 9.8, 9.8 Hz, 1H,
H4′), 4.16−4.23 (m, 2H, H5), 4.68−4.72 (m, 1H, H4), 7.25−7.27 (m,
2H, H3″, H5″), 7.28−7.29 (m, 1H, H4″), 7.32−7.35 (m, 2H, H2″, H6″);
13C NMR (125 MHz, CDCl3) δ 9.8 (q, C5′CH2CH3), 19.2 (t,
C5′CH2CH3), 19.5 (q, C6′CH3), 19.8 (q, C2′CH3), 37.8 (t, C4CH2),
50.9 (d, C5′), 55.3 (d, C3′), 56.1 (d, C4), 66.3 (t, C5), 73.6 (d, C2′),
74.4 (d, C4′), 75.0 (d, C6′), 127.5 (d, C4″), 129.1 (d, 2C, C2″, C6″),
129.7 (d, 2C, C3″, C5″), 135.3 (s, C1″), 154.5 (s, C2), 174.2 (s,
C3′C(O)N); MS (EI) m/z (relative intensity) 361 (M)
+ (4), 344 (M
− OH)+ (5), 343 (M − H2O)+ (24), 228 (9), 185 (M − oxazolidin-2-
one)+ (13), 184 (12), 157 (M − N-acyl oxazolidin-2-one)+ (3), 91





Aldol 2k (58 mg, 0.22 mmol) and acetaldehyde (0.1 mL of a 3.3
M solution in DCM, 0.33 mmol, 1.5 equiv) were subjected to the
general procedure for the synthesis of bicycles 5 (two-step EAP) and
yielded, after purification by flash chromatography (28 cm of height of
silica gel, n-hexane/EtOAc 85:15), title compound 21b (11 mg, 16%,
>95:5 dr) and previously described bicycle 5ah (29 mg, 43%, 92:8
dr). 21b: thick colorless oil; Rf = 0.37 (n-hexane/EtOAc 60:40);
[α]25D +97.9 (c 0.9, CHCl3);
1H NMR (500 MHz, CDCl3) δ 0.91 (t,
J = 7.6 Hz, 3H, CH3CH2C5′), 0.93 (t, J = 7.3 Hz, 6H, 2 ×
(CH3)2CHC3), 1.16 (d, J = 5.8 Hz, 3H, CH3C2′), 1.25 (d, J = 6.2 Hz,
3H, CH3C6′), 1.26−1.30 (m, 1H, H5′), 1.51−1.57 (m, 1H, 1 ×
CH3CH2C5′), 1.66−1.74 (m, 1H, 1 × CH3CH2C5′), 2.16 (d, J = 10.4
Hz, 1H, OH),85 2.43−2.49 (m, 1H, (CH3)2CHC3), 3.39 (dq, J =
10.0, 6.0 Hz, 1H, H6′), 3.72 (dq, J = 9.2, 6.1 Hz, 1H, H2′), 3.75 (dd, J
= 10.0, 9.4 Hz, 1H, H4′), 3.82 (dd, J = 9.3, 9.3 Hz, 1H, H3′), 4.24 (dd,
J = 9.2, 2.8 Hz, 1H, H5), 4.29 (dd, J = 9.2, 7.7 Hz, 1H, H5), 4.46 (ddd,
J = 7.9, 3.7, 2.6 Hz, 1H, H4);
13C NMR (125 MHz, CDCl3) δ 9.9 (q,
CH3CH2C5′), 14.8 (q, 1 × (CH3)2CHC3), 18.1 (q, 1 ×
(CH3)2CHC3), 19.3 (t, CH3CH2C5′), 19.5 (q, CH3C6′), 19.8 (q,
CH3C2′), 28.7 (d, (CH3)2CHC3), 51.1 (d, C5′), 55.1 (d, C3′), 59.4 (d,
C4), 63.7 (t, C5), 73.5 (d, C2′), 74.5 (d, C4′), 75.0 (d, C6′), 155.2 (s,
C2), 174.0 (s, C3′C(O)N); MS (EI) m/z (relative intensity) 297 (M
− H − Me)+ (1), 295 (M − H2O)+ (26), 283 (M − Et − H)+ (1),86
271 (M + 1 − i-Pr)+ (1), 228 (M + H − Et − Me − i-Pr)+ (2),87 185
(M − oxazolidin-2-one)+ (4), 157 (M − N-acyl oxazolidin-2-one)+
(1),88 156 (N-acyl oxazolidin-2-one)+ (5);88 HRMS calcd for
C16H25NO4 [(M − H2O)+] 295.1784, found 295.1782.
(S)-3-[(2R,3S,4R,5R,6S)-5-Ethyl-4-hydroxy-6-methyl-2-phenethyl-
tetrahydro-2H-pyran-3-carbonyl]-4-isopropyloxazolidin-2-one
(21c). Aldol 2l (43 mg, 0.12 mmol) and acetaldehyde (0.05 mL of a
3.3 M solution in DCM, 0.18 mmol, 1.5 equiv) were subjected to the
general procedure for the synthesis of bicycles 5 (two-step EAP) and
yielded, after purification by flash chromatography (28 cm of height of
silica gel, n-hexane/EtOAc 90:10), title compound 21c (6 mg, 12%,
>95:5 dr) and previously described bicycle 5ai (22 mg, 45%, >95:5
dr). 21c: white solid (probably crystalline); Rf = 0.63 (n-hexane/
EtOAc 70:30, three times); [α]25D +61.9 (c 0.3, CHCl3);
1H NMR
(500 MHz, CDCl3) δ 0.89−0.92 (m, 9H, 2 × (CH3)2CH, CH3CH2),
1.27−1.32 (m, 1H, H5′), 1.29 (d, J = 6.0 Hz, 3H, CH3C6′), 1.56−1.61
(m, 1H, CH3CH2), 1.62−1.78 (m, 3H, CH2CH2Ph, CH3CH2), 2.15
(d, J = 10.7 Hz, 1H, OH), 2.40−2.48 (m, 1H, (CH3)2CH), 2.57−2.63
(m, 1H, CH2CH2Ph), 2.85−2.91 (m, 1H, CH2CH2Ph), 3.36 (dq, J =
10.0, 6.0 Hz, 1H, H6′), 3.61 (td, J = 9.5, 2.4 Hz, 1H, H2′), 3.73 (ddd, J
= 10.4, 10.4, 10.4 Hz, 1H, H4′), 3.89 (dd, J = 9.9, 9.9 Hz, 1H, H3′),
4.19−4.26 (m, 2H, H5), 4.39−4.42 (m, 1H, H4), 7.16−7.19 (m, 3H,
Ph), 7.24−7.28 (m, 2H, Ph); 13C NMR (125 MHz, CDCl3) δ 9.9 (q,
CH3CH2), 14.8 (q, (CH3)2CH), 18.1 (q, (CH3)2CH), 19.3 (t,
CH3CH2), 19.5 (q, CH3C6′), 28.6 (d, (CH3)2CH), 32.1 (t,
CH2CH2Ph), 35.8 (t, CH2CH2Ph), 51.5 (d, C5′), 53.8 (d, C3′),
59.4 (d, C4), 63.6 (t, C5), 74.9 (d, C4′), 75.1 (d, C6′), 76.7 (d, C2′),
126.0 (d, Ph), 128.5 (d, 2C, Ph), 128.6 (d, 2C, Ph), 142.3 (s, Ph),
155.2 (s, C2), 174.0 (s, C3′C(O)N); MS (EI) m/z (relative intensity)
403 (M)+ (4), 388 (M −Me)+ (6), 385 (M − H2O)+ (12), 316 (M −
H − Et − Me − i-Pr)+ (3), 298 (M − CH2CH2Ph)+ (4), 275 (M −
oxazolidin-2-one)+ (2), 256 (M − H − H2O − oxazolidin-2-one)
(59), 248 (M + H − N-acyl oxazolidin-2-one)+ (6),89 158 (N-acyl
oxazolidin-2-one + 2)+ (9),89 130 (oxazolidin-2-one + 2)+ (74);89
HRMS calcd for C23H33NO5 [(M)
+] 403.2359, found 403.2353.
(4R,5S)-3-[(2S,3R,4S,5S,6R)-2,6-Dibutyl-5-ethyl-4-hydroxytetra-
hydro-2H-pyran-3-carbonyl]-4-methyl-5-phenyloxazolidin-2-one
(21d). Aldol 2m (22 mg, 60 mmol) was subjected to the general
procedure for the synthesis of bicycles 5 (two-step EAP) and yielded,
after purification by flash chromatography (18 cm of height of silica
gel, 600 mL of n-hexane/EtOAc 90:10 to remove nonpolar
impurities90 and then 200 mL of EtOAc), title compound 21d (2.7
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mg, 10%, >95:5 dr) as a colorless oil: Rf = 0.69 (EtOAc); [α]
25
D
−13.9 (c 0.3, CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.81 (t, J = 7.2
Hz, 3H, CH3CH2CH2CH2), 0.85−0.94 (m, 6H, CH3CH2C5′ and
CH3CH2CH2CH2), 1.14−1.55 (m, 13H, H5′, 12H from CH2), 1.63−
1.68 (m, 1H, 1H from CH2), 1.69−1.75 (m, 1H, 1 × CH3CH2C5′),
2.01 (d, J = 9.2 Hz, 1H, OH), 3.20 (td, J = 9.7, 2.1 Hz, 1H, H6′), 3.46
(td, J = 9.4, 2.6 Hz, 1H, H2′), 3.77−3.85 (m, 1H, H4′), 3.85−3.88 (m,
1H, H3′), 4.47 (qd, J = 6.3, 2.8 Hz, 1H, H4), 5.11 (d, J = 2.5 Hz, 1H,
H5), 7.27−7.28 (m, 1H, Ph), 7.30−7.36 (m, 1H, Ph), 7.38−7.43 (m,
3H); 13C NMR (150 MHz, CDCl3) δ 9.8 (q, CH3CH2C5′), 14.1 (q,
CH3CH2CH2CH2C2′), 14.3 (q, CH3CH2CH2CH2C2′), 19.0 (t,
CH3CH2C5′), 19.8 (q, CH3C4), 22.6 (t, CH3CH2CH2CH2C2′), 22.7
(t, CH3CH2CH2CH2C2′), 27.75 (t, CH3CH2CH2CH2C2′), 27.82 (t,
CH3CH2CH2CH2C2′), 32.5 (t, CH3CH2CH2CH2C2′), 33.6 (t,
CH3CH2CH2CH2C2′), 49.2 (d, C5′), 54.4 (d, C3′), 58.7 (d, C4),
74.7 (d, C4′), 77.4 (d, C2′), 78.3 (d, C6′), 81.8 (d, C5), 125.1 (d, 2C,
Ph), 129.3 (d, 2C, Ph), 129.5 (d, Ph), 137.6 (s, Ph), 154.1 (s, C2),
174.3 (s, C3′C(O)N); MS (EI) m/z (relative intensity) 445 (M)
+ (1),
428 (M − OH)+ (18), 427 (M − H2O)+ (61), 388 (M − Bu)+ (22),
373 (M − Bu − Me)+ (2), 359 (M − Bu − Et)+ (1), 339 (M − Et −
Ph)+ (21), 302 (M − 2Bu − Et)+ (1), 250 (M − Et − Bu − H2O −
Me − Ph)+ (100), 240 (M + 1 − N-acyl oxazolidin-2-one)+ (3), 204
(N-acyl oxazolidin-2-one)+ (4), 178 (oxazolidin-2-one +2)+ (49);91




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.joc.8b01182.
Molecule index that correlates the numbering of the
molecules discussed herein with those revealed in our
previous report;30 list of the products subjected to
biological evaluation; NMR analysis of the minor
diastereoisomer obtained during the synthesis of bicycle
5a; comparison of representative signals of 1b-Br, 5b,
and 7b-Br in NMR spectra; NMR analysis of bicycle 5e
and its minor diastereoisomers, as well as a mechanistic
proposal for their production; mechanistic proposal and
NMR evolution of the conversion of anti-aldol 9a into
products 10b and 12; helpful information for the
identification of bicycles 5 and THPs-Xc 21; chiral
HPLC chromatograms; screening of Lewis acids for the
enantiomeric version of Prins cyclization; DFT calcu-
lation results; copies of 1H and 13C NMR spectra for
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(49) Gueŕinot, A.; Reymond, S.; Cossy, J. Ritter Reaction: Recent
Catalytic Developments. Eur. J. Org. Chem. 2012, 2012, 19−28.
(50) Hu, Y.; Skalitzky, D. J.; Rychnovsky, S. D. Prins Cyclization of
4-Allyl-1,3-dioxanes Prepared from 1,3-Diol Synthons. A Rapid Entry
into Functionalized Tetrahydropyrans. Tetrahedron Lett. 1996, 37,
8679−8682.
(51) Other practical aspects of the reaction were evaluated. It was
compatible with a non-inert atmosphere, and it showed robustness
against the moisture: from aldol 2b and acetaldehyde, 5b was
obtained as a sole product in 78% yield in the presence of 1 equiv of
H2O; when 10 equiv of H2O was added, 5b (60%) was obtained
together with rearranged alcohol 6b (12%). Thorough monitoring
revealed that the reaction time was <1 min, although a reaction time
of 30 min was customarily selected. With aldol 2a and
isovaleraldehyde as the starting point, no reaction was observed at
−78 °C; when that reaction was performed at −18 or 0 °C, 5a was
successfully obtained (75%, >95:5 dr). These temperatures are
recommended in those cases in which a worse diastereoselectivity is
achieved at rt.
(52) Kishi, Y.; Inagi, S.; Fuchigami, T. Prins Cyclization in Ionic
Liquid Hydrogen Fluoride Salts: Facile and Highly Efficient Synthesis
of 4-Fluorinated Tetrahydropyrans, Thiacyclohexanes, and Piper-
idines. Eur. J. Org. Chem. 2009, 2009, 103−109.
(53) Byproducts probably obtained due to an isomerization of anti-
2a or some of its intermediates in the reaction medium. See the
Supporting Information for a mechanistic proposal and a detailed
analysis of the NMR spectra.
(54) Kocsis, L. S.; Benedetti, E.; Brummond, K. M. A Thermal
Dehydrogenative Diels−Alder Reaction of Styrenes for the Concise
Synthesis of Functionalized Naphthalenes. Org. Lett. 2012, 14, 4430−
4433.
(55) Poulter, D. C.; Winstein, S. J. Solvolysis and Degenerate
Cyclopropylcarbinyl-Cyclopropylcarbinyl Rearrangement of a Hex-
amethylcyclopropylcarbinyl System. J. Am. Chem. Soc. 1969, 91,
3650−3652.
(56) Reddy, B. V. S.; Yarlagadda, S.; Reddy, C. R.; Reddy, M. R.;
Sridhar, B.; Satyanarayana, D.; Jagadeesh, B. Tandem Prins Strategy
for the Synthesis of Spiropyrrolidine and Spiropiperidine Derivatives.
Eur. J. Org. Chem. 2015, 2015, 3076−3085.
(57) Xie, Y.; Cheng, G.-J.; Lee, S.; Kaib, P. S. J.; Thiel, W.; List, B.
Catalytic Asymmetric Vinylogous Prins Cyclization: A Highly
Diastereo- and Enantioselective Entry to Tetrahydrofurans. J. Am.
Chem. Soc. 2016, 138, 14538−14541.
(58) We speculate that BF3·OEt2 forms a chelate with both the
oxocarbenium ion and the MeO group, leading to a six-membered
ring in the transition state that might alter the evolution of the
cyclization to the bicyclic products.
(59) (a) Hinkle, R. J.; Chen, Y.; Nofi, C. P.; Lewis, S. E. Electronic
Effects on a One-pot Aromatization Cascade Involving Alkynyl-Prins
Cyclization, Friedel−Crafts Alkylation and Dehydration to Tricyclic
Benzo[f ]isochromenes. Org. Biomol. Chem. 2017, 15, 7584−7593.
(b) Barry, C. S.; Bushby, N.; Harding, J. R.; Hughes, R. A.; Parker, G.
D.; Roe, R.; Willis, C. L. Probing the Mechanism of Prins Cyclisations
and Application to the Synthesis of 4-Hydroxytetrahydropyrans.
Chem. Commun. 2005, 29, 3727−3729.
(60) Jasti, R.; Anderson, C. D.; Rychnovsky, S. D. Utilization of an
Oxonia-Cope Rearrangement as a Mechanistic Probe for Prins
Cyclizations. J. Am. Chem. Soc. 2005, 127, 9939−9945.
(61) Crosby, S. R.; Harding, J. R.; King, C. D.; Parker, G. D.; Willis,
C. L. Oxonia-Cope Rearrangement and Side-Chain Exchange in the
Prins Cyclization. Org. Lett. 2002, 4, 577−580.
(62) During the synthesis of 5w, we unsuccessfully tried to avoid the
undesired production of 6c by repeating the reaction at different
concentrations (1 and 0.01 M) and temperatures (−78 °C), but a
similar proportion was always obtained. Gratifyingly, we finally were
able to improve the low yield by changing DCM to n-hexanes as the
solvent (50% of 5w and 30% of 6c). As product 6c is a homoallylic
alcohol susceptible to suffering a Prins cyclization, we tested its
reactivity as an alternative precursor of bicycle 5w. It was subjected to
the standard conditions (2.5 equiv of BF3·OEt2, 0.1 M DCM, rt) with
MeCHO (1.5 equiv), and we observed that it reacted barely to yield
5w (24 h, 40%), bringing to light the fact that the electronic and steric
environment of the olefin in homoallylic alcohols 2 is key for the
successful EAP cyclization.
(63) See the Supporting Information for the NMR spectra regarding
the evolution of the reaction over time and for a mechanistic proposal.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.8b01182
J. Org. Chem. 2018, 83, 9039−9066
9065
(64) Feuillet, F. J. P.; Robinson, D. E. J. E.; Bull, S. D. An (E)-
selective synthesis of trisubstituted (E)-α,β-unsaturated acid deriva-
tives. Chem. Commun. 2003, 17, 2184−2185.
(65) Papillon, J. P. N.; Taylor, R. J. K. The Preparation of
Nonracemic Secondary α-(Carbamoyloxy)alkylzinc and Copper
Reagents. A Versatile Approach to Enantioenriched Alcohols. Org.
Lett. 2002, 4, 119−122.
(66) Kende, A. S.; Kawamura, K.; DeVita, R. J. Enantioselective
Total Synthesis of Neooxazolomycin. J. Am. Chem. Soc. 1990, 112,
4070−4072.
(67) Lange, H.; Huenerbein, R.; Wibbeling, B.; Fröhlich, R.;
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